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This	PhD	 thesis	 reports	on	 recent	experiences	concerning	 the	use	of	EQ-5D	 in	China.	
The	EQ-5D	 instrument	 is	 the	most	widely-used	quality	of	 life	questionnaire	 in	health	
economic	 evaluation	 world-wide	 and	 has	 recently	 been	 introduced	 in	 China.	 EQ-5D	
invites	respondents	to	report	their	level	of	functioning	on	five	basic	dimensions	of	health.	
The	responses	define	that	person’s	EQ-5D	health	state.	All	EQ-5D	health	states	can	have	
a	value	attached	to	them	which	indicates	how	good	or	bad	the	quality	of	life	is	of	people	
living	in	that	state.	In	this	way,	EQ-5D	describes	and	values	health.	The	values	attached	
to	 all	 EQ-5D	 states	 represent	 a	 key	 feature	of	 EQ-5D,	 as	 they	enable	 comparisons	of	
health	across	population	subgroups	(e.g.	stratified	by	region,	disease	area,	or	treatment	
received),	and	such	indicators	of	health	can	inform	health	care	investment	decisions.	
A	basic	 requirement	 that	 follows	 from	the	context	 in	which	EQ-5D	values	are	used	 is	
that	values	must	reflect	the	health	preferences	of	the	target	population.	Hence,	it	is	a	
recommended	approach	to	establish	values	in	the	local	context	of	the	EQ-5D	user.	Health	
valuation	is	the	field	of	science	involved	with	constructing	such	value	sets.	The	increased	
use	 of	 EQ-5D	 in	 China	 has	 spurred	 the	 development	 of	 the	 field	 of	 health	 valuation	
in	that	country.	Initial	research	aimed	to	develop	a	local	value	set	for	EQ-5D	in	China,	
but	this	research	has	expanded	and	also	addressed	methodological	questions	around	
optimal	ways	to	establish	values	in	a	valid	and	cost-effective	way.	These	developments	
form	the	background	for	the	studies	reported	in	this	thesis.	
1 .1 	HTA	AND	ECONOMIC	EVALuATION	 IN	CHINA
The	introduction	of	EQ-5D	in	China	reflects	an	increased	interest	in	economic	evaluation	
and	Health	 Technology	Assessment	 (HTA).	 EQ-5D	 is	 a	 preferred	 outcome	measure	 in	
economic	evaluation,	which	can	be	seen	as	the	most	important	component	of	HTA.	HTA	is	
a	multidisciplinary	field	of	policy	analysis,	studying	medical,	economic,	social	and	ethical	
effects	of	the	development,	diffusion,	and	use	of	health	technologies	(1).	HTA	research	
supports	decisions	about	the	inclusion	of	health	technologies	in	the	collectively	financed	
health	benefit	package.	China	started	its	HTA	programme	in	the	1980s,	encouraged	by	
the	World	Bank.	As	in	many	other	countries,	when	HTA	was	introduced	in	China,	it	was	
characterised	as	a	body	of	academic	activities.	 Since	 then	 it	has	become	 increasingly	
accepted	and	 there	 is	a	growing	use	of	HTA	 in	 listing,	pricing,	and	 reimbursement	of	
pharmaceuticals	(1).	
In	the	last	two	decades,	health	expenditure	grew	at	a	rate	of	11.6%	per	year,	which	outpaced	
the	economic	growth	rate	of	9.9%	in	China	(2).	Economic	evaluation	provides	a	tool	for	
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containing	increasing	health	care	costs	by	promoting	more	efficient	allocation	of	health	
resources	(3).	Since	resources	are	limited,	the	funding	decisions	need	to	be	made	between	
different	 treatments/drugs/interventions	etc.	By	 comparing	different	alternatives’	 costs	
and	effects	(health	outcomes),	decisions	can	then	be	made	against	either	some	threshold	
values	or	by	considering	other	possible	concerns,	e.g.	disease	burdens.	
Cost-utility	analysis	(CuA)	is	one	type	of	economic	evaluation.	This	method	uses	Quality	
Adjusted	 Life	 Years	 (QALY)	 to	 measure	 health	 effects.	 The	 QALY	 measures	 health	
outcomes	 by	 combining	 length	 of	 life	with	 health-related	 quality	 of	 life	 (HRQoL)	 (3).	
HRQoL	 is	a	broad	concept	capturing	quality	of	 life,	utility	or	wellbeing	 that	 is	 related	
to	health.		By	combining	mortality	and	morbidity	information,	the	QALY	is	a	preferred	
measure	in	cost-effectiveness	studies	around	the	world	as	it	allows	comparison	between	
different	diseases	and	treatments.	EQ-5D	is	the	most	widely-used	questionnaire	in	the	
world	to	determine	the	‘adjustment	factor’,	i.e.	the	quality	part	of	the	QALY.	
In	 addition	 to	 its	 use	 in	 health	 economic	 evaluation,	 as	 explained	 above,	 EQ-5D	 can	
also	be	used	to	measure	and	describe	health.	For	 instance,	when	used	to	measure	the	
health	status	of	a	given	patient	group,	the	disease	burden	of	this	group	can	be	estimated	
by	comparing	 its	health	with	 that	of	 the	healthy	population.	The	health	of	 the	healthy	
population	measured	by	EQ-5D	 is	 called	a	population	norm,	which	provides	normative	
values	for	the	general	public	and	has	served	as	a	benchmark	in	quantifying	disease	burdens.	
A	well-established	EQ-5D	value	set	is	a	necessary	asset	if	China	aims	to	expand	its	HTA	
activities.	The	intention	of	this	thesis	is	to	contribute	in	this	endeavour	by	improving	the	
validity	and	cost-effectiveness	of	 the	methods	used	 for	EQ-5D	valuation	 research.	An	
additional	aim	is	to	provide	an	EQ-5D	population	norm	for	the	urban	Chinese	population.	
1 .2 	EQ-5D	AND	 ITS 	uSE	 IN	MEASuRING	HEALTH	
The	EQ-5D	system	includes	two	essential	parts:	page	2	displays	the	EQ-5D	descriptive	
system	 and	 page	 3	 contains	 the	 EQ	 visual	 analogue	 scale	 (EQ-VAS).	 Figure	 1	 shows	
an	 example	of	 EQ-5D-5L	descriptive	 system	 in	 English.	 The	 EQ-5D	descriptive	 system	
comprises	 five	 dimensions:	 mobility,	 self-care,	 usual	 activities,	 pain/discomfort	 and	
anxiety/depression	(4).	 It	has	two	versions,	 the	three-level	EQ-5D	(EQ-5D-3L)	and	the	
five-level	 EQ-5D	 (EQ-5D-5L).	 	 In	 total,	 EQ-5D-3L	 defines	 a	 total	 of	 243	 unique	 health	
states,	while	EQ-5D-5L	defines	3,125	health	states.	The	higher	number	of	health	states	
in	the	5L	version	is	aimed	at	ensuring	improved	sensitivity.	
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Figure 1: EQ-5D-5L	descriptive	system
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By	reporting	one’s	health	through	ticking	the	corresponding	response	level	from	each	of	
these	five	dimensions,	EQ-5D	health	states	can	be	simply	described	using	five-digit	codes,	
for	example,	13245	represents	a	health	state	with	no	problems	in	walking	about,	moderate	
problems	 in	 self-care,	 slight	problems	 in	usual	activities,	having	severe	pain/discomfort	
and	being	extremely	anxious/depressed.	It	is	a	credit	to	its	descriptive	richness	and	simple-
to-use	nature	that	EQ-5D	has	been	used	to	measure	population	health	in	many	countries,	
and	population	norms	have	been	established	by	age,	gender	and	socio-economic	status	
(4).	A	 set	of	norm	scores	provides	an	 important	 reference	point	 for	 clinical	 and	health	
economic	 research	 outcomes,	 as	 the	 effects	 of	 medical	 conditions	 and/or	 treatments	
can	 be	 quantified	 by	 comparing	 patients	 and/or	 intervention	 groups	 with	 the	 general	
population	(5).	Currently,	there	are	no	EQ-5D-5L	norms	for	the	Chinese	population,	which	
hampers	expansion	in	the	use	of	EQ-5D-5L	in	China.	In	this	thesis,	we	aim	to	provide	such	
norms	and	to	evaluate	how	health	varies	between	demographic	groups.	
The	EQ-5D	descriptive	system	provides	a	way	to	classify	and	measure	health,	but	direct	
comparison	 between	 two	 health	 states	 is	 difficult	 as	 a	 health	 state	which	 is	 good	 in	
certain	 dimensions	 may	 not	 be	 good	 in	 others,	 for	 example,	 13245	 versus	 51153.	
The	former	state	 is	good	 in	mobility,	 ‘severe’	 in	pain/discomfort,	whilst	 the	 latter	has	
extreme	 problems	 in	mobility	 and	 pain/discomfort	 but	 no	 problems	 in	 self-care	 and	
usual	activities.	This	comparison	between	states	can	be	facilitated	using	the	attached	
unidimensional	 value	 for	 each	 state,	which	 reflects	 the	 desirability	 of	 that	 state.	 For	
instance,	if	the	state	13245	has	a	value	of	0.53	and	state	51153	has	a	value	of	0.31,	then	
it	could	be	concluded	that	state	13245	is	better	than	state	51153	as	0.53>0.31.	The	next	
section	describes	how	to	obtain	such	values.	
1 .3 	VALuATION	OF	EQ-5D
As	mentioned	above,	the	use	of	EQ-5D	in	economic	evaluation	requires	its	corresponding	
value	set,	which	provides	the	index	values	(health	utilities)	of	all	defined	health	states.	
Such	value	sets	are	usually	derived	using	a	two-step	approach:	first,	a	subset	of	health	
states	of	the	EQ-5D	instrument	is	directly	valued	by	members	of	the	general	public,	and	
second,	 the	observed	values	are	modelled	to	predict	values	 for	all	health	states.	This	
two-step	approach	is	preferred	over	the	direct	valuation	of	all	EQ-5D	states,	because	the	
latter	strategy	requires	a	huge	sample	size	and	thus	becomes	extremely	time-consuming	
and	costly,	which	 is	deemed	not	feasible.	The	reason	 is	that	many	health	states	need	
to	be	valued	 (243	for	 the	3L	version	and	3,125	for	 the	5L	version	of	EQ-5D)	by	many	
respondents	(N	=	30	to	100)	in	order	to	obtain	reliable	mean	values,	but	the	maximum	
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number	of	health	states	respondents	can	value	is	usually	around	20	to	30.
A	 challenge	 in	 conducting	 valuation	 research	 using	 the	 above-mentioned	 two-step	
approach	is	that	a	crucial	aspect	of	designing	such	studies	is	not	fully	understood.	In	this	
thesis,	‘design’	typically	refers	to	a	specific	question:	the	subset	chosen	for	direct	valuation.	
In	the	literature	on	health	state	valuation	there	has	been	much	debate	concerning	how	
to	select	the	subset	of	health	states	for	which	empirical	values	are	collected.	Different	
desirable	properties	for	such	subset	have	been	identified	(e.g.	plausibility	of	the	states,	
severity	balance	across	the	design),	but	these	desirable	properties	cannot	all	be	satisfied	
at	the	same	time	because	of	a	resources	constraint.	In	the	absence	of	straightforward	
statistical	rules	to	trade	off	the	desirable	properties,	the	selection	of	health	states	for	
the	sample	has	thus	far	been	consensus-based	at	the	research	team	level.	This	approach	
caused	studies	to	differ,	without	justification.	In	other	words:	when	estimating	a	value	
set,	researchers	take	a	leap	of	faith	because	the	trade-offs	between	available	designs	are	
unclear.	This	thesis	attempts	to	shed	light	on	these	trade-offs,	mostly	in	the	context	of	
EQ-5D	work	undertaken	in	China.	
The	dissemination	of	EQ-5D	in	China	has	been	facilitated	by	the	ground-breaking	research	
of	Dr.	Nan	Luo	from	National	university	of	Singapore	and	Prof.	Gordon	Liu	from	Peking	
university.	They	pioneered	the	establishment	of	an	EQ-5D	value	set	for	a	large	country	
such	as	China,	using	limited	resources.	In	their	research	they	were	confronted	with	two	
difficulties,	 given	 these	 limited	 resources.	 First,	 they	did	not	have	 the	opportunity	 to	
investigate	 design	 properties	 beforehand,	which	 resulted	 in	 the	 concerns	mentioned	
above.	Second,	they	did	not	have	the	resources	to	engage	respondents	from	rural	areas.	
It	is	likely	that	people	living	in	such	areas	have	different	preferences	compared	to	people	
in	 urban	 areas,	 since	 health	 preferences	 are	 known	 to	 be	 affected	 by	 demographic	
and	cultural	 factors	(6,	7).	Since	HTA	decisions	affect	all	 residents	equally,	democratic	
principles	suggest	all	people	should	have	a	chance	to	express	their	preferences.	This	is	
also	true	for	China,	where	the	distinction	between	rural	and	urban	populations	reflects	
a	variety	of	social	and	economic	inequalities.	It	is	desirable	to	avoid	value	hegemony	of	
the	advantaged	groups	and	deepening	the	divide.	Thus,	it	is	relevant	to	know	that	the	
values	respondents	give	to	EQ-5D	health	states	relate	to	their	experiences	with	ill	health,	
personal	interests	and	circumstances,	and	the	environment	etc.(8).	
Both	difficulties	are	linked	in	the	sense	that	an	efficient	design	can	free	up	resources	to	
engage	the	more	difficult-to-reach	respondents	from	rural	areas.	The	way	to	establish	
a	more	efficient	design,	and	hence	better	opportunities	to	arrive	at	such	representative	
samples,	is	the	theme	of	the	thesis.
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1.4	AIMS	AND	OuTLINE	OF	THIS 	THESIS
Six	studies	were	conducted	aimed	at	 improving	the	use,	and	especially	the	valuation,	
of	EQ-5D	in	China.	First	in	Part	1	(Chapter	2	and	Chapter	3),	there	is	an	exploration	of	
the	2012	Chinese	valuation	data	to	see	how	demographic	factors	affect	individual’s	self-
reported	health	states	and	understanding	of	 the	TTO	task.	Then	part	2	 (Chapter	4	 to	
Chapter	7)		reports	on	how	different	design	choices	affect	the	predictions	of	health	state	
values	for	both	EQ-5D-3L	and	EQ-5D-5L.
Part  1: 
The	first	part	of	the	thesis	 is	 focussed	on	how	demographic	factors	affect	 individuals’	
self-reported	HRQoL	and	understanding	of	the	TTO	valuation	task.	EQ-5D-5L	data	from	
China’s	2012	valuation	study	was	utilized,	the	same	data	that	was	used	to	establish	the	
EQ-5D-5L	value	set	for	urban	China	(9).	With	this	data,	the	thesis	aims	to	answer	the	
following	research	questions:	
Research question 1	 – What	 are	 the	 EQ-5D-5L	 norm	 scores	 for	 the	 urban	 Chinese	
population	and	are	there	disparities	in	self-reported	HRQoL	in	urban	China?
A	 set	 of	 norm	 scores	 provides	 an	 important	 reference	 point	 for	 clinical	 and	 health	
economic	 research	outcomes,	as	 the	effects	of	medical	conditions	and/or	 treatments	
can	be	quantified	by	comparing	patients	and/or	 intervention	groups	with	the	general	
population	 (5).	Moreover,	 previous	 research	 has	 shown	HRQoL	 inequalities	 between	
different	 socio-demographic	 groups	 and	 regions	 in	 China	 (10-13).	 Reporting	 the	
norm	scores	by	demographic	groups	helps	us	 to	understand	this	 issue	 further:	 this	 is	
accomplished	 in	Chapter 2	 for	 the	 urban	 Chinese	 population	which	 also	 shows	 how	
demographic	factors	affect	individuals’	self-reported	HRQoL.	
Research question 2	–	 Is	 the	TTO	valuation	method	equally	valid	across	respondents/
interviewers	in	China?	
We	know	from	previous	studies	that	the	TTO	task	is	difficult	for	some	respondents	(14).	
This	is	more	problematic	if	certain	groups	of	respondents	(e.g.	those	with	a	low	level	of	
education)	are	excluded	due	to	data	quality	reasons,	as	the	representativeness	of	the	
sample	would	be	compromised.	Similarly,	an	interviewer	could	prove	problematic	if	his/
her	respondents	consistently	showed	higher	levels	of	inconsistency.	Hence,	in	Chapter 
3,	 the	 validity	 of	 the	 composite	 time	 trade-off	method	 in	 the	 Chinese	 population	 is	
assessed	by	looking	at	individual-level	inconsistencies.
15
G E n E r a l  I n t r o D u C t I o n
1
Part  2: 
In	this	part,	I	focus	is	upon	an	important	design	issue	for	valuation	studies:	how	to	select	
health	states	for	direct	valuation?	As	discussed	above,	a	modelling	approach	is	used	to	
obtain	the	values	of	all	defined	health	states	in	EQ-5D.	In	this	approach,	first	a	subsample	
of	health	states	is	selected	for	direct	valuation,	then	the	values	of	other	health	states	are	
predicted	from	these	empirical	values.	For	EQ-5D-3L	valuation	studies,	different	designs	
were	 used	 in	 different	 countries	 (15).	 For	 EQ-5D-5L,	 a	 standardized	 EQ-VT	 protocol	
was	established	and,	using	the	same	design,	value	sets	were	established	for	different	
countries	(9,	16-22).	An	open	question	is	how	the	different	design	choices	for	EQ-5D-
3L	valuation	studies	and	the	standardized	EQ-VT	design	of	EQ-5D-5L	valuation	studies	
performed	in	predicting	the	values	of	all	health	states.	
Research question 3	–	How	to	select	health	states	for	EQ-5D-3L	valuation	studies?
Published	 EQ-5D-3L	 valuation	 studies	 have	 utilized	 from	 17	 to	 43	 states	 for	 direct	
valuation	and	the	performance	of	these	designs	is	unknown.	Additional	to	the	published	
designs,	 an	 examination	 of	 two	 oft-used,	 but	 competing	 criteria,	 in	 selecting	 health	
states	 is	 proposed.	 The	 first	 criterion	 is	 commonness	 of	 the	 states.	 In	 relying	 on	 the	
general	public	to	value	health	states,	these	health	states	should	be	imaginable	to	the	
respondents,	 otherwise	 reliable	 values	may	 not	 be	 obtained.	 The	 second	 criterion	 is	
that	the	selected	states,	taken	together,	should	possess	balanced	statistical	properties,	
allowing	 unbiased	 decomposition	 of	 health	 effects.	 In	Chapter 4,	 the	 validity	 of	 the	
published	designs	versus	newly	proposed	designs	 in	 selecting	health	 states	 for	direct	
valuation	in	EQ-5D-3L	is	assessed,	using	an	external	saturated	VAS	dataset	as	validation.	
Research question 4 –What	are	implausible	EQ-5D	health	states	and	how	do	members	of	
the	general	public	value	implausible	EQ-5D-5L	health	states?	
As	 many	 members	 of	 the	 general	 public	 do	 not	 have	 much	 ill-health	 experience,	
some	 EQ-5D	 health	 states	 are	 inevitably	 hypothetical	 for	 them	 (23).	 One	 issue	 in	
valuing	hypothetical	health	 states	 is	 that	 some	states	may	be	considered	 implausible	
or	unrealistic	by	respondents.	Perceived	 implausibility	may	prevent	respondents	from	
accurately	 imagining	 the	 concerned	 health	 states,	 which	 is	 pivotal	 to	 the	 thought	
process	for	valuation.	In	Chapter 5,	the	characteristics	of	implausible	health	states	are	
identified	and	there	is	an	examination	concerning	how	values	differed	over	plausible	and	
implausible	observations.	
Research question 5 – can	we	use	a	smaller	design	to	estimate	EQ-5D-5L	value	sets?
Arguably,	the	fewer	health	states	used	for	direct	valuation,	the	more	feasible	a	valuation	
study	would	be.	Nonetheless,	the	selected	health	states	for	direct	valuation	should	enable	
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adequate	predictions	for	the	non-valued	health	states.	Previous	EQ-5D-3L	research	has	
shown	that,	by	optimising	the	statistical	efficiency	of	a	design,	less	states	can	be	used	
for	 direct	 valuation	 without	 compromising	 prediction	 accuracy.	 Hence,	 it	 would	 be	
helpful	to	know	how	many	health	states	are	needed	for	an	acceptable	level	of	prediction	
accuracy	and	how	to	select	 these	health	states	 in	EQ-5D-5L.	 In	Chapter 6,	applying	a	
similar	method	used	in	examining	design	performance	in	EQ-5D-3L,	the	current	EQ-VT	
design	and	a	possibly	more	efficient	design	in	terms	of	prediction	accuracy	is	evaluated.	
To	achieve	this,	an	EQ-5D-5L	VAS	saturated	dataset	is	collected.	In	Chapter 7,	as	TTO	is	
the	main	method	of	collecting	valuation	data	for	EQ-5D,	a	25-state	orthogonal	design	is	
applied	to	TTO	data	to	assess	whether	findings	from	Chapter	6	using	VAS	data	can	be	
generalized	to	TTO	data.
Finally,	 in	 Chapter 8,	 the	 findings	 of	 the	 thesis	 are	 discussed	 alongside	 some	 other	
relevant	matters.
1 .5 	TERMINOLOGY
As	 health	 economics	 is	 a	 multi-disciplinary	 field,	 the	 terms	 used	 are	 not	 always	
standardized.	 Terms	 used	 throughout	 the	 thesis	 are	 employed	 as	 consistently	 as	
possible.	 EQ-5D	 ‘index	 value’	 is	 sometimes	 referred	 to	 as	 ‘health	 state	 utility’.	 The	
‘Misery	 Index’	 is	 sometimes	 referred	 to	 as	 ‘the	 sum	 of	 five	 digits’.	 Some	 terms	 look	
similar	but	are	fundamentally	different,	notably,	‘implausible	health	states’	are	different	
from	 ‘uncommon	health	 states’.	 The	 commonness	of	a	health	 state	 is	defined	as	 the	
prevalence	of	that	state	in	reality,	whereas	the	plausibility	of	a	health	state	is	defined	as	
whether	a	respondent	considers	it	as	likely	to	exist	and	therefore	imaginable.	Another	
example	is	the	word	‘design’.	In	this	thesis,	‘design’	typically	refers	to	a	specific	question:	
the	subset	chosen	for	direct	valuation.	
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2.1	 INTRODuCTION
EQ-5D	is	a	health-related	quality	of	life	(HRQoL)	questionnaire	widely	used	in	economic,	
clinical,	 and	 population	 health	 studies.	 The	 EQ-5D	 descriptive	 system	 comprises	 five	
dimensions:	mobility,	self-care,	usual	activities,	pain/discomfort	and	anxiety/depression	
(4).	It	has	two	versions,	a	three-level	EQ-5D	(EQ-5D-3L)	and	a	five-level	EQ-5D	(EQ-5D-
5L).	Although	EQ-5D-3L	has	been	widely	used,	it	is	reported	to	suffer	from	ceiling	effects	
and	measurement	insensitivity	(24).	By	increasing	the	number	of	levels	in	the	descriptive	
system,	 EQ-5D-5L	 has	 demonstrated	 improved	 measurement	 properties	 in	 ceiling	
effects,	and	in	discriminatory	power	in	comparison	to	EQ-5D-3L	(9,	25-27).	In	addition	
to	classifying	health	states	in	terms	of	the	5	dimensions	of	health,	EQ-5D	permits	the	
valuation	of	these	health	states.	This	is	accomplished	from	both	the	respondent’s	own	
perspective	by	using	a	Visual	Analogue	Scale	(EQ-VAS)	and	from	the	perspective	of	the	
general	public’s	by	attaching	the	appropriate	EQ-5D	index	score	to	the	described	health	
state	of	the	respondent.	
EQ-5D	has	been	used	to	measure	population	health	in	many	countries,	and	population	
norms	have	been	established	by	age,	gender	and	socio-economic	status	(4).	A	normative	
data	set	provides	an	important	reference	point	for	clinical	and	health	economic	research	
outcomes,	as	the	effects	of	medical	conditions	and/or	treatments	can	be	quantified	by	
comparing	patients	and/or	intervention	groups	with	the	general	population	(5).	At	this	
juncture,	there	are	no	EQ-5D-5L	norms	for	the	Chinese	population,	which	hampers	the	
increasing	use	of	EQ-5D-5L	in	China.	
The	objective	of	 this	paper	 is	 to	provide	normative	data,	 including	 the	prevalence	of	
EQ-5D-5L	health	problems,	and	EQ-VAS	and	EQ	index	scores	by	age	and	gender,	in	the	
Chinese	urban	population.	In	addition,	we	also	examine	the	relationships	between	socio-
economic	factors	and	(i)	the	components	of	the	EQ-5D-5L	descriptive	system,	(ii)	EQ-VAS	
scores	and	(iii)	EQ	index	scores.
2 .2 	METHODS
2.2.1  Sampl ing and recruitment
The	study	drew	data	from	a	large	EQ-5D-5L	valuation	study	in	China	(9).	The	aim	of	this	
study	was	to	estimate	a	country	specific	scoring	algorithm	to	calculate	EQ-5D-5L	index	
scores.	 The	 scoring	 algorithm	has	been	 reported	elsewhere	 (9).	 The	 sample	 size	was	
decided	by	the	EQ-5D-5L	valuation	protocol,	which	was	aiming	at	constructing	country	
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specific	 EQ-5D-5L	 value	 set	 (28).	Members	 of	 the	 general	 population	were	 randomly	
recruited	 from	 five	 urban	 areas	 of	 five	 cities	 (Beijing,	 Shenyang,	 Nanjing,	 Chengdu,	
and	Guiyang).	From	each	city,	respondents	were	recruited	from	at	least	five	difference	
administrative	districts	and	at	different	time	of	day.	Specific	recruitment	sites	included	
library,	 hospital,	 university,	 local	 community,	 park	 and	 shopping	 areas	 etc	 (6).	 These	
five	cities	were	selected	as	representative	urban	areas	 in	terms	of	size	of	population,	
geographical	 region	and	economic	development	 status	 in	China	 (9).	Within	each	city,	
quotas	were	set	to	recruit	equal	numbers	of	participants	from	each	city	and	to	ensure	
the	study	sample	resembled	the	general	Chinese	urban	adult	population	with	respect	
to	age,	gender,	and	education	level	according	to	the	Sixth	National	Population	Census	
(6).	 In	each	 city,	members	of	 the	general	public	who	were	at	 least	16	years	old,	 and	
were	literate	and	able	to	understand	survey	questions,	were	recruited	through	personal	
invitation	(9).	Response	rate	was	calculated.	
Each	 respondent	 was	 interviewed	 face-to-face	 by	 a	 trained	 interviewer	 using	 the	
EuroQol	valuation	technology	(EQ-VT)	(9,	29).	EQ-VT	is	a	standardized	software	design	
by	the	EuroQol	Group	in	order	to	facilitate	the	data	collection	for	valuation	study	(28).	
The	 interview	had	four	sections.	The	first	section	was	for	respondents	to	report	their	
own	health	using	the	EQ-5D-5L	questionnaire:	the	five-dimensional	descriptive	system	
and	 the	EQ-VAS.	 In	 the	second	section	 respondents	were	asked	 to	value	10	different	
EQ-5D-5L	health	states	using	a	composite	time	trade-off	(cTTO)	method	(8).	The	third	
section	contained	7	pairs	of	EQ-5D-5L	discrete	choice	tasks.	The	fourth	section	assessed	
respondents’	 socio-economic	 and	 other	 background	 characteristics.	 This	 paper	 used	
data	collected	in	the	first	and	fourth	sections	only.
2.2.2  the EQ-5D quest ionnaire
The	EQ-5D-5L	descriptive	system	consists	of	five	dimensions	(mobility,	self-care,	usual	
activities,	 pain/	 discomfort	 and	 anxiety/depression)	 with	 five	 ordinal	 severity	 levels	
each	(no	problems,	slight	problems,	moderate	problems,	severe	problems,	and	extreme	
problems/unable	to),	thus	defining	3,125	(55)	distinct	health	states	(24).	The	respondent	
is	asked	to	indicate	his/her	health	state	against	the	most	appropriate	statement	in	each	
of	 the	5	dimensions	 and	 this	 leads	 to	 a	1-digit	 number	expressing	 the	 level	 selected	
for	each	dimension	(4),	i.e.	12211	means	the	respondent	had	no	problems	in	mobility,	
pain/discomfort,	and	anxiety/depression,	but	had	slight	problems	in	self-care	and	usual	
activities.	 A	 VAS	was	 used	 in	 the	 interview,	with	 anchor	 points	 0	 (‘worst	 imaginable	
health	 state’)	 and	100	 (‘best	 imaginable	health	 state’).	Respondents	 first	 report	 their	
own	health	state	using	the	EQ-5D-5L	descriptive	system	and	then	their	overall	health	on	
the	EQ-VAS	based	on	their	health	on	the	day	of	survey.	
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In	 2012,	 the	 Chinese	 version	 of	 EQ-5D-5L	 was	 translated	 using	 a	 response	 scaling	
method	(24),	and	 its	descriptors	were	proven	to	have	similar	 interpretations	to	those	
of	the	English,	Spanish	and	French	versions	(30).	This	version	demonstrated	validity	and	
increased	sensitivity	in	diabetes	and	hepatitis	B	patients	(31,	32).
2.2.3  Data analys is 
For	each	respondent,	the	EQ-5D-5L	health	state	and	the	EQ-VAS	were	directly	observed	
from	 respondent’s’	 self-report	 questionnaire	 while	 the	 EQ	 index	 score	 was	 derived	
from	the	Chinese	EQ-5D-5L	value	set	(9).	In	the	EQ-5D-5L	value	set,	the	EQ	index	score	
of	 all	 3,125	health	 states	were	estimated	 (9).	 For	 each	 respondent,	we	derived	 their	
corresponding	EQ	index	score	from	their	self-reported	health	states.	
First,	descriptive	statistics	of	EQ-5D-5L	health	state,	EQ-VAS	and	EQ	 index	score	were	
calculated	for	the	whole	sample	and	by	different	demographic	variables	and	cities	(age,	
gender,	 employment	 status	 etc.).	 For	 each	 demographic	 variable,	 the	 percentage	 of	
reported	problem	in	EQ-5D	dimension,	the	means	(and	95%	confidence	interval)	of	EQ-
VAS	and	EQ	 index	scores	were	calculated	 for	each	subgroup	and	 the	difference	were	
tested	statistically.	Second,	we	used	multivariable	analysis	to	examine	the	associations	
between	demographic	characteristics	with	reported	problems	in	EQ-5D-5L,	EQ-VAS	and	
EQ	 index	 scores	 respectively.	 For	 the	 reported	problems	 in	each	dimension,	we	used	
logistic	 regression	 (‘no	problems’	 coded	 as	 0;	 ‘slight	 problems’,	 ‘moderate	problems’,	
‘severe	 problems’,	 or	 ‘extreme	 problems/unable’	 coded	 as	 1)(4).	 For	 EQ-VAS	 and	 EQ	
index	 scores,	we	used	 linear	 regression.	All	 demographic	 variables	 including	 age	 and	
education	 level	 were	 entered	 into	 the	models	 as	 categorical	 variables.	Multivariable	
analysis	was	used	to	identify	significant	demographic	characteristics	using	a	backward	
selection	 procedure	 to	 remove	 covariates	 with	 p>0.05.	 Odds	 ratio	 was	 reported	 for	
logistic	 regression	and	coefficient	was	 reported	 for	 linear	 regression	 respectively,	 the	
corresponding	95%	CI	was	calculated	using	robust	standard	error.
For	this	study,	ethical	approval	was	not	needed	in	China	at	the	time	of	data	collection.	A	
waiver	of	the	informed	consent	was	approved	as	this	study	did	not	provide	any	intervention	
to	participants.	Participants	can	withdraw	at	any	time	without	any	consequences.
2 .3 	RESuLTS
A	total	of	1332	individuals	(response	rate:	68.6%)	who	met	the	inclusion	criteria	were	
recruited.	Among	 these,	1296	 (97.3%)	who	 successfully	 completed	 the	questionnaire	
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were	included	in	the	analysis.	The	mean	age	of	the	sample	was	42	years	(SD:	16	years),	
the	 age	 ranged	 between	 16	 years	 to	 85	 years	 old.	 Females	 comprised	 49.9%	 of	 the	
sample.	Other	demographic	information	is	shown	in	Table	1.
table 1:	Demographic	characteristics	of	all	respondents
Variables Our	sample
Age group, years N %
<19 109 8.4
20-29 229 17.7
30-39 244 18.8
40-49 272 21.0
50-59 220 17.0
60-69 155 12.0
>70 67 5.2
Gender
Female 646 49.9
Male 650 50.2
Education
Primary	or	lower 138 10.7
Junior & Senior high school 867 66.9
College or higher 291 22.5
Employment	status
Full time employees 382 29.5
Temporary worker & freelancer 451 34.8
Retired 240 18.5
Student 132 10.2
Other 91 7.0
Residence	of	origin
City 757 58.4
County 86 6.6
Township or village 453 35.0
Health	insurance
Urban employee 551 42.5
Urban residence 304 23.5
New rural 296 22.8
Other 88 6.8
No 57 4.4
In	total,	54%	of	the	sample	reported	their	health	as	‘11111’,	followed	by	‘11121’,	‘11112’,	
‘11122’,	 and	 ‘21121’.	 The	 percentages	 of	 ‘no	 problems’	 were:	 94.37%	 for	 mobility,	
98.92%	for	self-care,	95.45%	for	usual	activity,	70.14%	for	pain/discomfort,	and	73.15%	
for	anxiety/depression.	The	mean	EQ-VAS	and	EQ	index	scores	were	86.0	(SD:	11.4)	and	
0.957	(SD:	0.069),	respectively.
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table 2:	Percentage	of	a	general	population	sample	reporting	levels	1	to	5	by	dimension,	
EQ-VAS	&	EQ	index	score	by	age	group	for males
EQ-5D	dimension Age	Groups
Total
N=650<19
N=56
20-29
N=116
30-39
N=123
40-49
N=135
50-59
N=110
60-69
N=84
>70
N=26
Mobility No problems 100% 98.3% 98.4% 91.9% 96.4% 85.7% 69.2% 94.0%
Slight problems 0% 1.7% 1.6% 8.2% 3.6% 13.1% 26.9% 5.7%
Moderate problems 0% 0% 0% 0% 0% 1.2% 3.9% 0.3%
Severe problems 0% 0% 0% 0% 0% 0% 0% 0%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 5.69 (0.000)
Self-care No problems 100% 100% 100% 98.5% 100% 96.4% 96.2% 99.1%
Slight problems 0% 0% 0% 1.5% 0% 3.6% 3.9% 0.9%
Moderate problems 0% 0% 0% 0% 0% 0% 0% 0%
Severe problems 0% 0% 0% 0% 0% 0% 0% 0%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 2.65 (0.008)
usual	Activity No problems 96.4% 94.8% 95.9% 93.3% 99.1% 90.5% 92.3% 94.9%
Slight problems 3.6% 5.2% 4.1% 5.9% 0.9% 7.1% 7.7% 4.6%
Moderate problems 0% 0% 0% 0.7% 0% 2.4% 0% 0.5%
Severe problems 0% 0% 0% 0% 0% 0% 0% 0%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 0.95 (0.342)
Pain/
Discomfort
No problems 78.6% 75.9% 78.1% 71.1% 64.6% 64.3% 57.7% 71.4%
Slight problems 19.6% 23.3% 20.3% 26.7% 29.1% 31.0% 30.8% 25.4%
Moderate problems 1.8% 0% 0.8% 1.5% 6.4% 4.8% 11.5% 2.8%
Severe problems 0% 0.9% 0.8% 0.7% 0% 0% 0% 0.5%
Extreme problems 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 3.44 (0.001)
Anxiety/
Depression
No problems 67.9% 65.5% 66.7% 78.5% 75.5% 77.4% 88.5% 72.8%
Slight problems 30.4% 32.8% 29.3% 20.7% 21.8% 20.2% 11.5% 25.1%
Moderate problems 1.8% 1.7% 2.4% 0% 1.8% 0% 0% 1.2%
Severe problems 0% 0% 0.8% 0.7% 0.9% 2.4% 0% 0.6%
Extreme problems 0% 0% 0.8% 0% 0% 0% 0% 0.3%
Z (P value) -2.94 (0.003)
EQ-VAS Mean 87.4 86.9 85.5 85.5 84.8 82.9 83.9 85.4
95%CI 84.4
90.4
85.2
88.5
83.8
87.2
83.3
87.8
82.6
87.1
79.9
85.9
76.9
90.9
84.5
86.3
Z (P value) -1.68 (0.093)
EQ	index	score Mean 0.968 0.963 0.961 0.959 0.956 0.943 0.932 0.957
95%CI 0.957
0.978
0.953
0.973
0.950
0.972
0.948
0.971
0.946
0.967
0.921
0.964
0.897
0.966
0.952
0.962
Z (P value) -2.21 (0.027)
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table 3:	Percentage	of	a	general	population	sample	reporting	levels	1	to	5	by	dimension,	
EQ-VAS	&	EQ	index	score	by	age	group	for	females
EQ-5D	
dimension
Age	Groups
Total
N=646<=19
N=53
20-29
N=113
30-39
N=121
40-49
N=137
50-59
N=110
60-69
N=71
>=70
N=41
Mobility No problems 96.2% 96.5% 99.2% 97.1% 95.5% 90.1% 73.2% 94.7%
Slight problems 3.8% 3.5% 0.8% 2.9% 3.6% 8.5% 19.5% 4.5%
Moderate problems 0% 0% 0% 0% 0% 1.4% 7.3% 0.6%
Severe problems 0% 0% 0% 0% 0.9% 0% 0% 0.2%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 4.68 (0.000)
Self-care No problems 98.1% 99.1% 99.2% 100% 99.1% 97.2% 95.1% 98.8%
Slight problems 1.9% 0.9% 0.8% 0% 0% 1.4% 4.9% 0.9%
Moderate problems 0% 0% 0% 0% 0% 1.4% 0% 0.2%
Severe problems 0% 0% 0% 0% 0.9% 0% 0% 0.2%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 1.42 (0.156)
usual	Activity No problems 96.2% 99.1% 98.4% 97.8% 96.4% 93.0% 78.1% 96.0%
Slight problems 3.8% 0.9% 1.7% 2.2% 1.8% 7.0% 22.0% 3.7%
Moderate problems 0% 0% 0% 0% 0.9% 0% 0% 0.2%
Severe problems 0% 0% 0% 0% 0.9% 0% 0% 0.2%
Unable to 0% 0% 0% 0% 0% 0% 0% 0%
Z (P value) 4.36 (0.000)
Pain/Discomfort No problems 66.0% 74.3% 76.0% 69.3% 65.5% 64.8% 51.2% 68.9%
Slight problems 30.2% 24.8% 23.1% 28.5% 32.7% 32.4% 39.0% 28.8%
Moderate problems 1.9% 0.9% 0.8% 1.5% 0.9% 2.8% 7.3% 1.7%
Severe problems 1.9% 0% 0% 0.7% 0.9% 0% 2.4% 0.5%
Extreme problems 0% 0% 0% 0% 0% 0% 0% 0.2%
Z (P value) 2.56 (0.010)
Anxiety/
Depression
No problems 56.6% 62.8% 76.9% 75.9% 76.4% 85.9% 78.1% 73.5%
Slight problems 37.7% 31.9% 20.7% 21.9% 21.8% 14.1% 19.5% 23.7%
Moderate problems 5.7% 4.4% 2.5% 1.5% 1.8% 0% 2.4% 2.5%
Severe problems 0% 0.9% 0% 0% 0% 0% 0% 0.2%
Extreme problems 0% 0% 0% 0.7% 0% 0% 0% 0.2%
Z (P value) -4.02 (0.000)
EQ-VAS Mean 88.3 85.8 87.8 87.5 86.2 84.5 85.3 86.6
95%CI 85.4
91.2
83.6
88.0
86.0
89.6
85.6
89.3
84.0
88.3
81.8
87.2
82.0
88.6
85.8
87.5
Z (P value) -1.75 (0.081)
EQ	index	score Mean 0.945 0.959 0.971 0.962 0.954 0.957 0.912 0.957
95%CI 0.926
0.963
0.949
0.968
0.962
0.979
0.952
0.972
0.933
0.975
0.943
0.971
0.881
0.943
0.951
0.962
Z (P value) -1.04 (0.300)
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Tables	2	and	3	show	the	percentage	of	reported	problems	for	each	severity	level	and	EQ-
5D	dimension,	and	the	mean	(SD)	of	EQ-VAS	and	EQ	index	scores	for	males	and	females	
by	age	groups,	respectively.	In	both	male	and	female	groups,	the	number	of	problems	
increased	with	age	in	the	dimensions	of	mobility,	self-care,	and	pain/discomfort	(p<0.05,	
trend	 test	 for	 ordered	 groups).	 In	 contrast,	 anxiety/depression	 was	 more	 prevalent	
in	younger	age	groups	(p<0.01,	trend	test	 for	ordered	groups).	As	could	be	expected,	
the	means	of	both	EQ-VAS	and	EQ	 index	scores	decreased	with	age,	but	only	 the	EQ	
index	score	for	male	was	statistically	significant	(p<0.05,	trend	test	for	ordered	groups).	
Females	 reported	 higher	 EQ-VAS	 values	 than	males	 (p<0.05,	 two-sample	 t-test).	 The	
highest	mean	EQ	index	score	was	observed	for	females	of	30-39	years	(0.971),	the	lowest	
mean	score	for	females	of	>	70	years	(0.912).	The	mean	VAS	score	ranged	between	88.3	
for	females	of	<19	years	and	82.9	for	males	of	60-69	years.
Beside	age	and	gender,	Table	4	shows	the	percentage	of	any	reported	problem	for	each	
EQ-5D	dimension,	and	 the	mean	 (SD)	of	EQ-VAS	and	EQ	 index	scores	by	other	socio-
demographic	 characteristics.	 Lower	 education	 indicated	 more	 problems	 in	 mobility,	
usual	activities	and	more	pain	(p<0.05,	chi2	test).	Lower	education	also	had	lower	EQ	
index	score	(p<0.05,	one-way	analysis	of	variance).	Percentage	of	any	reported	problem	
all	differed	by	employment	status	(p<0.01,	chi2	test),	full	time	employees	reported	least	
problems	with	self-care	and	usual	activities;	students	reported	the	least	problems	with	
mobility	and	less	pain/discomfort;	retired	reported	least	anxiety/depression.	Students	
reported	the	highest	score	in	EQ-VAS	and	EQ	index	score.	Insurance	status	seem	did	not	
affect	 the	percentage	of	 reported	problems	 in	any	dimension,	but	 the	EQ-VAS	of	 the	
insured	was	higher	than	those	without	insurance	(p<0.05,	two-sample	t-test).	In	terms	
of	original	place	of	residence,	residents	from	the	city	reported	less	anxiety	(p<0.01,	chi2	
test).	Difference	were	also	found	between	cities	in	pain/discomfort,	anxiety/depression,	
EQ-VAS	and	EQ	index	score.	
Socio-demographic	 characteristics	which	 significantly	 predicted	 any	 problems	 in	 EQ-5D	
dimensions,	and	EQ-VAS	and	EQ	index	scores,	are	reported	in	Table	5,	where	the	reported	
problem	 in	 each	 dimension	was	 reported	 as	 an	 odds	 ratio,	 and	 the	 EQ-VAS,	 EQ	 index	
scores	were	reported	as	regression	coefficients.	Notably,	reported	problems	with	anxiety/
depression	declined	along	age	groups	(odds	ratio:	0.58	for	30-59	years;	0.40	for	>=60	years	
respectively).	Males	had	1.45	lower	EQ-VAS	value	than	females.	All	outcomes	varied	with	
employment	status.	For	example,	compared	to	the	group	with	full	time	job,	unemployed	
group	 reported	4.04	 lower	EQ-VAS	value	and	0.03	 lower	EQ-index	 score,	 retired	group	
reported	3.93	lower	EQ-VAS	value	and	0.02	lower	EQ-index	score.	Respondents	from	the	
county	were	found	more	reported	problem	in	usual	activities	(odds	ratio:	2.58).	
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2.4	DISCuSSION
This	is	the	first	EQ-5D-5L	norms	study	from	China.	These	general	population-based	norms	
provide	 insights	 into	HRQoL	 in	China	and	how	HRQoL	varies	between	different	socio-
economic	groups.	More	importantly,	it	facilitates	interpretation	of	the	cost	effectiveness	
studies	which	use	QALY	as	a	health	outcome.	As	HRQoL	instruments	measure	postulated	
constructs,	the	set	of	normative	values	provides	a	reference	point	to	interpret	an	HRQoL	
study’s	results	by	comparing	HRQoL	between	the	general	population	and	patients	with	
specific	conditions	from	similar	age	and	gender	groups	(33,	34).
Compared	to	the	Chinese	EQ-5D-3L	norms	reported	in	2008	(11),	our	study	showed	a	
significant	increase	in	problems	reported	in	the	last	two	dimensions.	This	could	be	either	
because	there	were	more	problems	in	these	two	dimensions	compared	to	the	past,	or	
that	the	five-level	EQ-5D	was	more	sensitive	in	identifying	the	mild	problems	in	these	
dimensions.	While	 it	 is	 not	 possible	 to	detangle	 such	 change	 in	 our	 study,	 in	 several	
studies	 comparing	 normative	 data	 between	 EQ-5D-3L	 and	 EQ-5D-5L,	 the	 researchers	
reported	the	5L	questionnaire	suffered	less	ceiling	effect	,	had	less	standard	deviation	in	
the	index	value,	and	had	wider	spread	of	health	states,	which	all	suggests	the	improved	
sensitivity	for	the	5L	questionnaire	(25,	32,	35).	HRQoL	inequalities	were	shown	in	China	
between	different	socio-demographic	groups	and	regions,	based	on	previous	research	
(10-13).	Such	disparities	were	confirmed	by	our	multivariable	analysis,	with	lower	socio-
economic	status	related	to	lower	HRQoL.	
Some	 results	 from	our	 study	were	 in	 line	with	other	 countries’	 EQ-5D-5L	norms	 (25,	
27,	 30,	 32,	 35-38):	 the	 first	 three	 dimensions	 of	 EQ-5D	 had	 less	 reported	 problems	
compared	to	the	last	two	dimensions,	with	pain/discomfort	being	the	most	prevalent	
dimension;	women	reported	lower	EQ	index	score	than	men;	EQ-VAS	&	EQ	index	score	
declined	with	age.	Two	differences	were	noted,	first,	in	previous	EQ-5D	norms	studies	
conducted	in	China	and	other	countries,	the	percentage	of	reported	problems	in	anxiety/
depression	increased	with	age	(4,	25,	27,	30,	32,	39),	our	results	suggest	the	opposite:	
the	anxiety/depression	problem	was	more	prevalent	 in	 the	 younger	population.	One	
possible	 explanation	 is	 that	 the	 younger	 generation	 living	 in	 urbans	 areas	 perceived	
more	psychological	 pressures	 than	 the	older	 generation	 due	 to	 the	 fast-paced	 life	 in	
urban	China.	Second,	females	reported	slightly	higher	EQ-VAS	values	than	males,	which	
is	inconsistent	with	EQ-5D-3L	norm	values	in	China	(11):	this	discrepancy	could	be	due	
to	the	difference	in	the	two	study	samples’	compositions.	The	EQ-VAS	score	is	predicted	
by	several	demographic	variables	and	in	our	study	sample,	females	were	in	higher	socio-
economic	groups.	
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One	 limitation	 of	 this	 study	 is	 that	 the	 sample	 was	 collected	 in	 five	 urban	 areas	 in	
China,	which	is	not	representative	of	the	whole	Chinese	population.	As	socio-economic	
differences	exist	between	different	areas,	also	between	urban	and	rural	areas	in	China,	
the	 health	 status	 of	 residents	 may	 differ	 by	 type	 of	 area	 (40).	 Furthermore,	 most	
respondents	were	recruited	in	public	locations,	therefore	the	sample	may	have	left	out	
those	who	were	not	able	to	go	outside.	This	may	have	led	to	a	selection	bias	towards	
healthy	 respondents	 and	 underreported	 problems	with	mobility	 and	 usual	 activities.	
Nevertheless,	we	did	not	correct	for	this	bias	in	our	result	as	we	did	not	know	the	exact	
proportion	of	respondents	missed	out	in	the	sample.	Third,	this	is	a	cross-sectional	study,	
which	provided	insights	into	relationship	between	HRQoL	data	and	socio-demographic	
variables.	 In	 terms	 of	 understanding	 the	 causal	 relationship	 between	 variables	 and	
controlling	for	unobserved	heterogeneity,	longitudinal	data	is	needed	(41-43).	
2 .5 	CONCLuSIONS
This	study	has	offered	the	first	EQ-5D-5L	urban	population	norms	for	China.	Disparities	
exist	in	self-reported	health	status	measured	by	EQ-5D-5L	across	socio-economic	groups.	
Further	 research	 into	 rural	HRQoL	and	 into	using	a	national	 representative	 sample	 is	
warranted.	
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3.1	 INTRODuCTION
EQ-5D-5L	 is	a	preference-based	quality	of	 life	 instrument	which	 is	mainly	designed	to	
generate	health-state	utility	values	that	are	required	for	calculation	of	quality-adjusted	
life	years	 (QALYs)	and	cost-utility	analysis	 (44).	With	a	 classification	 system	consisting	
of	 five	 dimensions	 (mobility,	 self-care,	 usual	 activities,	 pain/discomfort	 and	 anxiety/
depression)	 and	 five	 levels	 of	 severity	 for	 each	 dimension	 (1=no	 problems,	 2=slight	
problems,	 3=moderate	 problems,	 4=severe	 problems	 and	 5=extreme	 problems),	 the	
instrument	defines	(55)	=	3,125	unique	health	states,	each	of	which	can	be	represented	
using	a	5-digit	number	or	vector	between	11111	(no	problems	in	any	dimension)	and	
55555	 (extreme	 problems	 in	 all	 five	 dimensions).	 An	 important	 component	 of	 the	
instrument	 is	 the	 social	 tariff	 or	 value	 set	 that	 contains	 the	 utility	 values	 for	 all	 the	
health	states	it	defines.	With	the	value	set	available	investigators	can	easily	obtain	the	
utility	values	of	the	EQ-5D-5L	health	states	of	interest,	or	find	the	utility	values	for	their	
study	populations	by	describing	their	health	using	the	EQ-5D-5L	classification	system.	
Establishing	the	value	set	for	a	preference-based	health	related	quality	of	life	instrument	
is	not	a	trivial	task.	The	general	approach	is	to	elicit	the	utility	values	for	a	subset	of	the	
health	states	defined	by	the	instrument	and	develop	a	regression	model	to	predict	the	
values	for	all	the	health	states,	including	those	not	directly	valued.	In	the	case	of	EQ-5D-
5L,	 the	currently	recommended	study	protocol	 (29)	requires	1,000	or	more	members	
of	the	general	public	each	to	value	10	different	health	states	using	the	time	trade-off	
(TTO)	technique.	After	the	TTO	task,	the	current	EuroQol	Valuation	Technology	(EQ-VT)	
protocol	also	includes	7	pairs	of	discrete	choice	experiment	(DCE)	for	each	respondent.	A	
number	of	countries	have	used	the	study	protocol	to	establish	their	local	EQ-5D-5L	value	
sets	(16,	18).	In	this	paper,	we	focus	mainly	on	the	TTO	task.
One	 issue	 that	 has	 occurred	 in	 the	 valuation	 of	 EQ-5D-5L	 health	 states	 is	 that	 some	
respondents	give	logically	inconsistent	values.	That	is,	better	health	states	are	valued	as	
more	undesirable	than	worse	health	states	(45).	For	example,	the	state	11121	is	valued	
lower	 than	 the	 state	 22321.	 Logical	 inconsistency	 could	 be	 due	 to	 random	mistake,	
however,	 if	 it	 occurs	 among	 a	 large	 proportion	 of	 respondents,	 it	 could	 signify	 the	
failure	 in	 the	way	 the	valuation	 technique	 is	 implemented.	Regardless	of	 the	 reason,	
such	data	lowers	the	precision	of	the	estimated	values.	Specifically,	logical	inconsistency	
may	attenuate	the	differences	 in	values	between	health	states	(46)	and	consequently	
lead	to	underestimated	health	 improvements	when	the	values	are	used	in	cost-utility	
analysis	(47).	In	some	valuation	studies,	inconsistent	observations	were	excluded	when	
constructing	 the	 value	 set,	 thereby	 potentially	 affecting	 representativeness	 if	 certain	
sub-groups	of	respondents	score	more	inconsistencies	than	others	(45,	47-49).	Hence	
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the	magnitude	of	this	 issue	and	the	underlying	reasons	should	be	investigated	and,	 if	
possible,	interventions	should	be	implemented	to	minimize	the	potential	bias	caused	by	
inconsistency.	
Previous	 EQ-5D-3L	 valuation	 studies	 found	 that	older	 and	 less-educated	 respondents	
were	more	likely	to	make	inconsistent	valuations	(46,	49).	EQ-5D-3L	is	similar	to	EQ-5D-
5L	except	that	there	are	only	three	descriptive	levels	for	each	dimension	(no	problems,	
moderate	 problems,	 and	 extreme	 problems).	 This	 result	 is	 not	 surprising	 as	 logical	
inconsistency	could	be	due	to	poor	understanding	or	misinterpretation	of	the	valuation	
task	(50,	51)	.	However,	it	is	not	clear	whether	this	is	the	case	in	the	valuation	of	EQ-5D-
5L	health	states	and	to	what	extent	 logical	 inconsistency	 is	related	to	 interviewers.	 In	
EQ-5D-5L	valuation	studies,	 interviewers	play	an	 important	role	 in	the	conduct	of	the	
valuation	tasks,	and	they	are	trained	to	 follow	a	standardized	protocol.	Nevertheless,	
interviewer	effects	have	been	observed	in	previous	studies	(52).	
The	aim	of	 the	present	 study	was	 to	 ascertain	 the	 factors	underlying	 individual-level	
logical	 consistency	 in	 an	 EQ-5D-5L	 valuation	 study.	 We	 hypothesized	 that	 logical	
inconsistency	was	related	to	multiple	factors	with	respect	to	interviewers,	the	interview	
process,	and	respondents’	background	characteristics.
3 .2 	METHODS
3.2.1  Data source
This	study	makes	use	of	data	collected	 in	 the	EQ-5D-5L	valuation	study	 in	China.	The	
purpose	of	the	valuation	study	was	to	establish	the	EQ-5D-5L	value	set	in	China	from	a	
societal	perspective.	The	target	population	was	urban	residents	 in	China	 (9).	Detailed	
description	of	the	valuation	study	have	been	published	elsewhere	(9).	In	the	valuation	
study,	the	EQ-5D-5L	was	translated	through	a	response	scaling	approach,	which	ensured	
the	 Chinese	 descriptors	 have	 similar	 interpretations	 with	 English	 counterpart	 (24).	
Briefly,	the	study	recruited	members	of	the	general	population	from	five	cities,	namely:	
Beijing,	 Nanjing,	 Shenyang,	 Chengdu,	 and	 Guiyang	 (9).	 In	 each	 city,	members	 of	 the	
general	population	were	recruited	from	a	number	of	public	places	including	community	
centers,	 parks,	 shopping	 centers,	 and	 university	 campuses.	 Sampling	 quotas	 were	
applied	so	that	the	sample	resembled	the	target	population	in	terms	of	age,	sex,	and	
education	 (6,	 9).	 Inform	consent	was	 given	 to	 the	 respondent	before	 conducting	 the	
interview	(9),	and	ethics	approval	was	not	needed	for	this	study	in	China	as	the	valuation	
task	 is	not	seen	as	a	medical	 intervention.	Each	respondent	was	 interviewed	 face-to-
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face	 by	 a	 trained	 interviewer	 using	 the	 EQ-VT	 platform	 (28).	 The	 interview	 had	 four	
sections.	The	first	section	was	for	respondents	to	report	their	own	health	using	the	EQ-
5D-5L	questionnaire,	and	their	experience	with	serious	illness.	The	second	section	asked	
respondents	to	complete	10	TTO	tasks,	each	valuing	a	different	EQ-5D-5L	health	state.	
The	third	section	contained	a	set	of	discrete	choice	questions	designed	for	valuation	of	
selected	EQ-5D-5L	health	states	based	on	random	utility	theory.	Data	collected	in	this	
section	was	not	used	 in	 the	present	 study.	 The	 fourth	 section	assessed	 respondents’	
socio-economic	and	other	background	characteristics.	
The	‘composite’	TTO	technique	was	used	in	the	study.	This	employs	conventional	TTO	and	
lead-time	TTO	(53)	to	value	better-than-dead	and	worse-than-dead	states,	respectively.	
The	two	TTO	variants	are	described	in	detail	elsewhere	(54).	Briefly,	conventional	TTO	
elicits	the	raw	value	x	(0	≤	x	≤	10)	at	which	the	respondent	is	indifferent	between	two	
alternatives:	1)	living	in	full	health	for	x	years,	and	2)	living	in	an	EQ-5D-5L	health	state	
for	10	years.	The	utility	value	is	given	by	x/10.	For	health	states	considered	to	be	worse	
than	dead,	 the	 two	alternatives	 in	 the	valuation	 task	are:	1)	 living	 in	 full	health	 for	x	
years,	and	2)	living	in	full	health	for	10	years	and	then	in	an	EQ-5D-5L	health	state	for	
another	10	years.	The	utility	value	is	given	by	x/10	-1.	
At	 the	 interviews,	 the	 interviewer	 demonstrated	 and	 explained	 how	 the	 composite	
TTO	works	to	the	respondent	using	the	state	of	‘in	a	wheelchair’	as	an	example,	before	
proceeding	 to	 the	 formal	TTO	tasks	 for	 the	valuation	of	10	different	EQ-5D-5L	health	
states	 (29).	 The	EQ-VT	platform	was	designed	 to	value	a	 total	of	86	EQ-5D-5L	health	
states	considered	sufficient	for	the	estimation	of	a	value	set.	These	86	health	states	were	
divided	into	10	blocks	in	such	a	way	that	each	block	consisted	of	the	worst	state	(55555),	
one	of	 the	 five	mildest	 states	 (21111,	12111,	11211,	11121,	11112),	 and	eight	other	
unique	health	 states.	 Each	 respondent	was	 randomized	 to	 value	one	block	 of	 health	
states	which	were	presented	to	the	respondent	in	a	random	order.
A	total	of	20	interviewers,	4	for	each	city,	conducted	the	interviews	(9).	The	interviewers	
were	students	and	researchers	from	local	universities.	They	were	trained	at	a	full-day	
workshop	by	their	respective	site	project	leaders	who	were	trained	in	the	same	way	by	
the	principal	investigator.	The	training	focused	on	the	use	of	a	standardized	protocol	to	
conduct	 the	 interview,	the	principles	of	 the	TTO	technique,	and	the	objectives	of	 the	
valuation	study.	As	the	TTO	task	was	difficult	to	conduct,	interviewers	were	instructed	
to	perform	multiple	‘practice’	interviews	during	and	after	the	workshop	with	their	peers	
and	friends	or	family	members.		
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3.2.2  measures  of  inconsistency
At	the	respondent	level,	the	magnitude	of	logical	inconsistency	was	assessed	using	three	
indicators:	 inconsistency	rate,	distance,	and	ΔTTO.	Inconsistency	rate	was	the	number	
of	 inconsistently	 valued	 pairs	 of	 health	 states	 divided	 by	 all	 possible	 logical	 pairs.	
Inconsistency	 distance	was	 calculated	 as	 the	 sum	of	 the	 squared	 difference	 in	 levels	
for	corresponding	dimensions	of	the	two	health	states	involved.	For	example,	the	level	
differences	between	health	states	12344	and	44444	were	respectively	3,	2,	1	in	the	first	
three	dimensions	and	0	 in	the	 latter	two,	and	thus	the	distance	was	32	+	22	+	1	=	14.	
ΔTTO	was	the	difference	in	utility	values	of	two	inconsistently	valued	health	states.	For	
example,	if	one	respondent	gave	21222	a	utility	0.8	and	11112	a	utility	0.5,	the	ΔTTO	of	
this	inconsistency	would	be	0.3.	
Owing	 to	 the	 highly	 skewed	 distribution	 of	 inconsistency	 in	 all	 3	 indicators	 across	
respondents,	as	 in	other	studies	(46,	50),	respondents	were	categorized	 into	3	 levels:	
none,	 slight,	 and	 severe.	 ‘None’	 was	 defined	 as	 no	 observed	 inconsistency;	 ‘severe’	
was	defined	as	inconsistency	rate	higher	than	10%,	average	inconsistency	ΔTTO	larger	
than	0.2,	and	average	inconsistency	distance	larger	than	9;	and	‘slight’	was	applied	for	
respondents	whose	inconsistency	profiles	were	neither	‘none’	nor	‘severe’(48,	55).	So,	a	
respondent	is	classified	as	severe	inconsistent	if	he/she	made	more	inconsistencies	and	
those	inconsistencies	were	more	severe.	
3.2.3  Data analys is
Inconsistency	 factors	 studied	 included	 respondents’	 demographic	 characteristics,	
interviewer	identity,	and	interview	process	indicators.	Respondents’	characteristics	were	
age	 (16-24	 years,	 25-34	 years,	 35-44	 years,	 45-54	 years,	 55-64	 years,	 65-74	 years,	 ≥75	
years),	gender,	and	education	 (primary	or	 lower,	 junior	high	school,	senior	high	school,	
college	or	university,	Masters	or	PhD).	Interview	process	indicators	were:	time	spent	on	
the	wheelchair	example,	number	of	iterations	in	the	wheelchair	example,	and	time	spent	
on	the	10	TTO	tasks.	The	number	of	iterations	indicated	how	many	steps	a	respondent	had	
moved	before	the	indifferent	point	was	reached	in	a	TTO	task.	The	number	of	iterations	
and	the	time	spent	on	the	wheelchair	example,	and	the	formal	TTO	tasks	may	reflect	to	
what	extent	respondents	and	interviewers	were	engaged	in	the	valuation	tasks.
An	 additional	 process	 characteristic	 examined	 was	 the	 sequence	 of	 the	 interviews,	
that	 is,	 the	rank	order	of	 the	 interviews	conducted	by	 the	same	 interviewer	 in	 terms	
of	 the	 interview	date	 and	 time.	 It	was	hypothesized	 that	 there	was	 a	 learning	 curve	
for	the	interviewers	in	the	study	such	that	the	quality	of	the	interviews	increased	with	
the	number	of	 interviews	 that	an	 interviewer	completed.	As	a	 result,	more	 interview	
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experience	would	lead	to	a	lower	level	of	logical	inconsistency.	
A	two-level	multi-nominal	logistic	model	(Equation	1)	with	the	interviewer	as	the	upper	
level	and	the	respondent	as	the	 lower	 level	was	used	to	explore	 logical	 inconsistency	
factors.	 This	 model	 estimated	 the	 average	 effects	 of	 the	 lower-level	 factors	 among	
the	 interviewers.	 The	 requirement	 to	 discern	 levels	was	 determined	 using	 likelihood	
ratio	tests	(56).	Age,	gender,	education	level	(edu),	interview	sequence,	TTO	time,	TTO	
iteration	(ttoit),	wheelchair	time	and	wheelchair	 iteration	were	entered	as	covariates.	
The	covariates	sequence,	times,	and	iterations	were	standardized	(by	dividing	the	raw	
data	with	its	Standard	Error)	in	order	to	enhance	interpretation	of	the	relative	risk	ratios	
(RRR)	for	category	i	compared	to	the	reference	category	no	inconsistencies.	A	RRR	>	1	
suggests	 an	 increased	 risk	of	 that	outcome	compared	 to	 the	 reference	group.	A	RRR	
between	0	and	1	suggests	a	reduced	risk	compared	to	the	reference	group.
𝑅𝑅𝑅=𝑒𝛽00+𝑢0𝑗+𝛽1𝑖𝑎𝑔𝑒+𝛽2𝑖𝑒𝑑𝑢+…+𝛽8𝑖𝑡𝑡𝑜𝑖𝑡  (1)
Where	 β
00
	 is	 the	 overall	 mean	 intercept	 and	 u
0j
	 is	 the	 random	 intercept	 to	 identify	
clusters,	here:	interviewers.
Additional	 analysis	 determined	 whether	 there	 were	 differences	 in	 inconsistencies	
between	the	interviewers.	As	‘interviewer’	was	included	as	a	between-subject	factor	in	
this	analysis,	a	single-level	multi-nominal	regression	model	(Equation	2)	which	included	
both	interviewer	and	the	above-mentioned	covariates	was	used.	Relative	risk	ratios,	their	
95%	 confidence	 intervals,	 and	p-values	of	 the	 independent	 variables	were	estimated	
using	STATA	version	13.1.	Covariates	were	deleted	in	a	backward	procedure,	with	p>0.05	
as	the	criterion	for	deletion.	Interaction	terms	between	statistically	significant	covariates	
were	created	and	examined	based	on	the	results	of	the	two	models.
𝑅𝑅𝑅=𝑒𝛽0𝑖+𝛽1𝑖𝑎𝑔𝑒+𝛽2𝑖𝑒𝑑𝑢+…+𝛽8𝑖𝑡𝑡𝑜𝑖𝑡+𝛽9𝑖𝑖𝑛𝑡𝑒𝑟2+…+𝛽23𝑖𝑖𝑛𝑡𝑒𝑟20  (2)
3.3	RESuLTS	
3.3.1  Data descr ipt ion
Of	 1,302	 participants	 in	 the	 valuation	 study,	 1,296	 finished	 the	 interview.	 Each	 of	 the	
20	 interviewers	conducted	at	 least	50	 interviews.	Table	1	summarizes	the	demographic	
information	of	the	interviewees	and	the	summarized	information	of	the	interview	process.
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table 1:	Demographic	information	of	interviewees	and	the	summarized	information	of	interview	
process
Variables Total	sample
Age	group	(years)  (N, %)
16-24 235, 18%
25-34 231, 18%
35-44 237, 18%
45-54 258, 20%
55-64 222, 17%
65-74 79, 6%
≥75 34, 3%
Gender (N, %)
Male 650, 50%
Female 646, 50%
Education (N, %)
Primary or Lower 138, 11%
Junior high school 405, 31%
Senior high school 462, 36%
College or University 225, 17%
Masters or PhD 66, 5%
Interview	Sequence	(Rank	orders) (Mean, SD)
33.4,19.6
Time	spent	on	TTO	task	(Minutes) (Mean, SD)
14.2,5.3
Time	spent	on	Wheelchair	example	task	(Minutes) (Mean, SD)
6.3,3.2
Iterations	spent	on	TTO	task	(steps) (Mean, SD)
7.9,2.5
Iterations	spent	on	Wheelchair	example	task	(steps) (Mean, SD)
22.1,11.9
Out	of	1,296	respondents,	723	(56%)	did	not	display	any	inconsistency;	the	remaining	
44%	gave	at	 least	one	 inconsistent	 response.	The	numbers	of	 respondents	who	were	
‘slightly’	 and	 ‘severely’	 inconsistent	 amounted	 to	 499	 and	 74	 respectively.	 The	 rate,	
distance,	and	ΔTTO	of	logical	inconsistency	are	summarized	in	Table	2.
3.3.2  Factors  associated with inconsistency
Significant	variables	associated	with	logical	 inconsistency	and	their	effects	in	the	two-
level	model	are	displayed	in	Table	3.	The	likelihood	ratio	test	showed	that	both	levels	
(interviewers	and	respondents)	were	statistically	significant	 (P	<0.01).	Three	variables	
were	significantly	associated	with	slight	inconsistency	and	another	two	variables	were	
associated	 with	 severe	 inconsistency	 (Table	 3).	 Specifically,	 more	 time	 spent	 on	 the	
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wheelchair	 example,	 less	 time	 spent	 on	 the	 TTO	 task,	 and	 interviews	 completed	 at	
a	 later	 sequence,	were	 associated	with	 less	 likelihood	of	 slight	 inconsistency;	 female	
respondents,	and	interviews	completed	at	a	 later	sequence	were	associated	with	 less	
likelihood	of	severe	inconsistency.	The	RRR	is	interpreted	as,	for	example,	compared	to	
reference	group,	the	risk	of	being	slightly	inconsistent	is	1.246	times	higher	for	every	one	
unit	of	more	time	spent	on	TTO	task.	
table 3:	Inconsistency:	multi-level	multinomial	logistic	model	in	full	dataset,	N=1,269
Variables RRR	(unadjusted) 95%CI RRR	(adjusted) 95%	CI
0		(Reference	level:	no	inconsistency) Base outcome Base outcome
1		(Slight	inconsistency)
Sequences (Rank orders) 0.810** 0.720, 0.912 0.806** 0.707, 0.918
Standardized time spent on TTO task 1.081 0.957, 1.220 1.246** 1.076, 1.441
Standardized time spent on wheelchair 
example
0.855* 0.755, 0.967 0.815* 0.699, 0.952
2		(Severe	inconsistency)
Sex 1.997** 1.230, 3.243 2.347**  1.429, 3.855
Sequences (Rank orders) 0.540** 0.417, 0.699 0.511**   0.385, 0.678
“Sex” is coded “0” for female respondent, and “1” for male respondent.
** Significant at 0.01 level.
* Significant at 0.05 level.
Two	interviewers	were	found	to	be	associated	with	a	higher	likelihood	of	slight	and/or	
severe	logical	inconsistency	in	the	single-level	model	(Table	4).	One	of	the	interviewers	
was	 particularly	 unusual	 as	 the	 relative	 risk	 ratio	 were	 found	 to	 be	 much	 higher	
compared	to	those	conducted	by	an	averagely	performed	 interviewer,	after	adjusting	
for	covariates.	Interaction	terms	(i.e.	education	level	of	respondent*interviewer)	were	
explored	and	proved	less	interesting	in	terms	of	statistical	significance.
table 2:	Inconsistency	severity	measured	by	three	criteria
Measurement	criteria Severity	
degree
Numbers	
identified	
Total	
inconsistency	
rate
Average	
inconsistency	
distances
Average	
inconsistency	
ΔTTO
Inconsistency rate Slight 447 0.045 14.287 0.235
Severe 126 0.169 22.713 0.333
Inconsistency distance Slight 160 0.040 4.966 0.254
Severe 413 0.085 20.469 0.257
Inconsistency ΔTTO Slight 325 0.059 15.317 0.096
Severe 248 0.090 17.219 0.467
Inconsistency fulfilled all criteria Slight 499 0.056 14.946 0.223
Severe   74 0.189 24.194 0.482
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table 4:	Interviewer	effect	on	inconsistency:	multinomial	logistic	model	in	full	dataset,	N=1,296
Variables RRR	(unadjusted) 95%	CI RRR	(adjusted) 95%	CI
0	(Reference	level:	no	inconsistency) Base outcome Base outcome
1	(Slight	inconsistency)
Interviewer 7 3.486** 1.506, 8.071 3.476** 1.475, 8.191
Interviewer 9 2.242* 1.073, 4.683 2.659*  1.241, 5.696
2	(Severe	inconsistency)
Interviewer 7 8.054** 2.205, 29.411 7.335** 1.908, 28.195
Dummy variables ‘interviewer’ represent different interviewers, the reference level is ‘interviewer1’ from 
Shenyang, whose inconsistency level is the median among all interviewers.
** Significant at 0.01 level.
* Significant at 0.05 level.  
3.4	DISCuSSION
As	hypothesized,	 the	 factors	 interviewer,	 interview	process,	 and	 respondent	were	 all	
related	 to	 individual	 level	 logical	 inconsistency	 in	 the	 valuation	 of	 EQ-5D-5L	 health	
states.	In	terms	of	respondents’	characteristics,	male	gender	was	associated	with	severe	
logical	 inconsistency.	 One	 explanation	 could	 be	 that	 male	 respondents	 might	 have	
had	poorer	engagement	 than	 females	 in	 the	present	 study.	 In	 the	previous	EQ-5D-3L	
valuation	study	conducted	in	China,	young	and	well-educated	respondents	were	more	
likely	to	give	inconsistent	TTO	answers	(40).	unlike	previous	studies	(46,	49,	50),	older	
age	was	not	associated	with	 logical	 inconsistency	 in	 the	present	valuation	study.	This	
could	be	due	to	the	efficiency	of	the	survey	tool:	a	computerized	software	program	was	
used	to	demonstrate	the	valuation	tasks	in	the	EQ-5D-5L	valuation	study	while	a	time	
board	was	used	in	previous	studies.	It	should	be	noted	that	respondents’	characteristics	
such	as	gender	are	not	modifiable	factors	in	valuation	studies	aiming	at	establishing	a	
societal	 value	 set.	 For	 such	 studies,	 samples	 should	be	 representative	of	 the	 general	
population	 in	 terms	of	demographics.	Hence,	 respondents	who	are	more	 susceptible	
to	logical	inconsistency,	cannot	be	removed	from	EQ-5D-5L	valuation	studies;	the	only	
intervention	is	to	have	interviewers	pay	more	attention	to	these	respondents.	
More	 importantly,	 we	 found	 that	 interviewer	 and	 interview	 process	 indicators	 were	
independently	associated	with	logical	 inconsistency.	Specifically,	 interviews	conducted	
by	certain	interviewers,	those	conducted	earlier	on	by	interviewers	(sequence	effect),	
and	 those	 in	 which	 less	 time	 was	 spent	 on	 the	 wheelchair	 example,	 suffered	more	
from	this	 issue.	The	variations	across	 interviewers	suggest	that	some	interviewers	did	
not	 perform	 to	 the	 expected	 standards.	 This	 could	 be	 due	 to	 poor	 understanding	 of	
the	valuation	tasks	or	poor	compliance	to	the	interview	protocol.	The	sequence	effect	
suggests	that	interviewers	might	still	have	been	on	a	learning	curve,	that	is,	they	had	not	
43
l o G I C a l  I n C o n S I S t E n C Y  I n  t I m E  t r a D E - o F F  D ata
3
been	versed	enough	in	conducting	the	interviews	at	the	time	they	started.	Wheelchair	
time	might	 be	 an	 indicator	 of	 training	 adequacy:	 when	 this	 was	 inadequate,	 logical	
inconsistency	would	increase.	It	is	notable	that	the	more	time	spent	on	TTO	tasks,	the	
more	inconsistency	occurred.	One	explanation	could	be	that	if	the	respondents	did	not	
understand	or	engage	in	the	task,	it	took	them	longer	to	finish	the	TTO	tasks	while	this	
did	not	warrant	consistent	responses.	
Therefore,	 our	 study	 supports	 the	 extension	 of	 EQ-5D-5L	 valuation	 protocol	 with	 a	
quality	control	(QC)	tool	(57).	It	also	should	be	noted	that	this	data	collection	was	done	
in	the	first	version	of	EQ-VT	protocol.	The	new	protocol	with	the	several	modification	to	
the	original	protocol,	including	the	QC	process	lower	the	inconsistency	rate	from	11%	to	
3%	(57).	By	using	the	new	valuation	protocol	with	QC	tool,	individual	interviewers	are	
monitored	during	the	entire	data	collection	period	for	their	performance	including	time	
spent	on	explaining	the	wheelchair	example	(57).	This	monitoring	 is	possible	because	
the	 information	 is	 collected	by	 the	 survey	program	and	uploaded	by	 interviewers	on	
a	daily	basis.	Nevertheless,	our	study	suggests	that	 future	EQ-5D-5L	valuation	studies	
could	 benefit	 from	more	 training	 for	 interviewers.	 In	 addition,	 our	 findings	 could	 be	
generalizable	to	other	 interviewer-administered	health-state	valuation	study.	The	role	
of	interviewers	and	the	importance	of	interviewer	training	might	be	more	crucial	than	
hitherto	considered,	especially	for	the	valuation	study	that	is	done	without	proper	QC	
process	during	the	data	collection.	
This	 study	 raised	 the	 question	 concerning	 how	 to	 handle	 logical	 inconsistency	 in	
establishing	an	EQ-5D-5L	value	set:	should	the	inconsistent	data	be	removed?	Past	studies	
showed	that	keeping	inconsistent	data	will	attenuate	the	differences	in	values	between	
health	states	(58).	On	the	other	hand,	if	inconsistent	responses	are	systematically	higher	
in	 certain	 groups	 of	 respondents	 (e.g.	 male	 respondents),	 removing	 these	 data	 will	
affect	 the	 representativeness	of	population	 samples	 (45).	Only	 a	 few	EQ-5D-3L	 value	
sets	were	estimated	by	excluding	some	of	 the	 logically	 inconsistent	data	(40,	47,	55).	
Nevertheless,	it	can	be	postulated	that	values	of	extreme	health	states	may	be	biased	if	
logical	inconsistency	occurs	with	respect	to	these	states.	For	example,	good	health	states	
are	unlikely	 to	be	overestimated	because	 the	 logical	 inconsistency	 is	one-sided:	 such	
health	states	are	more	likely	to	be	valued	lower	rather	than	higher	because	the	valuation	
tasks	are	designed	in	a	way	that	no	health	states	can	be	valued	as	>	1.0,	the	upper	bound	
of	utility	value.	Hence	it	is	advisable	to	assess	the	effect	of	logical	inconsistency	on	the	
estimated	EQ-5D-5L	value	set.
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One	 limitation	of	 this	 study	 is	 that	we	 limited	our	analysis	of	 logical	 inconsistency	 to	
logistic	 analysis	 due	 to	 the	 skewed	 distributions	 of	 inconsistency	 at	 individual	 level.	
Moreover,	the	classification	of	inconsistency	in	the	logistic	model	was	arbitrary.	There	
is	 no	 a	 well-accepted	 definition	 for	 ‘slight’	 inconsistency	 or	 ‘severe’	 inconsistency.	
However,	in	this	study,	in	order	to	identify	between	“those	who	made	careless	mistakes”	
and	“those	who	seem	do	not	understand	the	task	at	all”,	the	line	was	drawn.
In	conclusion,	logical	inconsistency	in	the	valuation	of	EQ-5D-5L	health	states	is	associated	
not	only	with	respondents’	characteristics	but	also	with	interviewers’	performance	and	
the	 interview	 process.	 Our	 study	 has	 highlighted	 the	 importance	 of	 interviewers	 for	
health-state	valuation	using	the	TTO	elicitation	procedure.	
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4.1	 INTRODuCTION	
The	 EQ-5D-3L	 instrument	 is	 the	 most	 widely	 used	 preference-based	 health-related	
quality	of	life	questionnaire	(59).	The	EQ-5D	descriptive	system	consists	of	5	dimensions	
(mobility,	 self-care,	 usual	 activities,	 pain/	 discomfort	 and	 anxiety/depression)	 with	 3	
ordinal	severity	levels	each	(no	problems,	some	problems	and	extreme	problems),	thus	
defining	243	distinct	health	states	(60).	The	key	feature	of	a	preference-based	instrument	
is	that	health	state	‘values’	(some	prefer	‘utilities’	or	‘index	values’)	are	derived	for	all	of	
its	health	states,	which	indicate	how	good	or	bad	each	health	state	is.	These	numbers	
are	assumed	to	have	ratio	properties	and	can	be	used	to	estimate	quality-adjusted	life	
years	(QALYs).	
The	QALY	is	a	preferred	health	outcome	measure	in	cost-effectiveness	studies	around	
the	world	(61-64).	The	results	of	cost-effectiveness	studies	could	be	biased	if	values	of	
health	states	cannot	be	well-estimated.	Nevertheless,	arriving	at	a	set	of	243	values	for	
all	separate	states	is	a	challenge:	the	valuation	methods	used	can	be	demanding	to	the	
respondent,	leading	to	data	collection	methods	where	every	respondent	usually	values	
only	a	defined	subset	of	all	243	states.	From	such	a	data	subset,	typically,	parametric	
regression	 analysis	 enables	 prediction/extrapolation	 of	 the	 values	 for	 all	 the	 health	
states.	Different	design	choices	(selection	of	subsets)	have	been	documented	in	other	
areas	(65,	66),	but	in	the	literature	on	health	state	valuation,	it	is	an	open	question	how	
to	select	health	states	for	inclusion	in	the	subset	for	direct	valuation.	Different	desirable	
properties	have	been	identified	which	cannot	all	be	satisfied	at	the	same	time.	In	the	
absence	of	straightforward	statistical	rules,	selection	has	thus	far	been	consensus-based.	
Hence,	researchers	take	a	leap	of	faith	when	estimating	a	value	set	while	the	advantages	
and	disadvantages	of	 their	design	 choice	are	unknown.	 In	 this	paper,	we	aim	 to	 find	
the	best	design	(subset	of	health	states)	for	EQ-5D	valuation	studies	by	comparing	the	
performance	of	different	desirable	design	properties	in	prediction	accuracy.
A	key	EQ-5D	valuation	study	in	the	context	of	design	choices	was	the	Measurement	and	
Valuation	of	Health	(MVH)	study	conducted	in	the	uK.	Its	consensus-based	design	has	
been	 replicated	 frequently	 (67).	 In	 the	MVH	study,	 the	 following	design	criteria	were	
selected	(67):	
• The	set	of	states	should	spread	widely	over	the	valuation	space	so	as	to	include	
as	most	combinations	of	levels	across	the	five	dimensions.	
• Prima	facie	implausible	states	were	excluded	to	sustain	the	credibility	of	the	task,	
and	to	reduce	errors	in	assigned	values.
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• All	 plausible	 combinations	 of	 dimension	 levels	 were	 to	 be	 included	 to	 allow	
identification	of	(first	level)	interactions.
• All	 respondents	 should	 value	 2	 out	 of	 the	 5	 mildest	 states	 which	 were	most	
prevalent,	and	all	respondents	had	to	value	the	anchor	state	‘33333’,	so	that	for	
every	individual	the	utility	range	was	known	(‘11111’	was	defined	as	1.0).
• Some	 of	 the	 selected	 health	 states	 had	 been	 used	 in	 previous	 studies,	 thus	
maintaining	a	link	to	these	studies.
using	 the	 above	 criteria	 the	MVH	 study	 selected	 42	 health	 states,	where	 the	 health	
data	of	the	respondents	themselves	were	used	to	determine	common	health	states.	The	
valuation	of	these	42	states	was	used	to	predict	the	values	of	all	243	states,	including	the	
201	not	included	in	the	data	subset	(68).	In	later	research	,	the	possibility	that	the	MVH	
approach	contained	redundant	values	was	 investigated	(60),	but	without	returning	to	
the	desirability	of	the	requirements	shown	above	that	were	originally	imposed	on	this	
approach.	
While	the	face	validity	of	the	above	sampling	criteria	appears	apparent,	a	disadvantage	is	
the	lack	of	attention	to	the	statistical	properties	of	the	resulting	design.	From	a	statistical	
point	of	view,	desired	properties	of	a	design	are	level	balance	and	level	pair	balance	(i.e.	
orthogonality).	These	two	properties	allow	for	statistical	decomposition	of	all	separate	
dimension	 effects	 dependent	 on	 the	 level	 of	 other	 dimensions.	 Nevertheless,	 both	
properties	were	ignored	in	order	to	adhere	to	the	desirable	properties	emphasized	in	
the	MVH	design.	Whether	this	design	reflects	the	best	compromise	with	given	resources	
is	hitherto	unknown.	
Any	comparison	of	design	strategies	requires	quantitative	criteria	on	what	constitutes	
the	 ‘best’	 strategy.	 Bonsel	 et	 al	 (69)	 systematically	 compared	 designs	 on	 the	 MAE	
(mean	 absolute	 error)	 criterion,	 exploiting	 the	 possibilities	 of	 a	 ‘saturated	 data	 set’	
that	contained	observed	values	of	all	243	EQ-5D-3L	health	states.	The	emphasis	was	on	
questions	around	the	type	(flat,	stressed,	mild,	and	severe)	and	number	of	health	states	
that	may	be	selected	for	valuation	exercises	(affecting	estimation	bias),	and	on	whether	
or	not	the	introduction	of	interaction	terms	in	the	model	increased	or	reduced	the	risk	of	
mis-specifying	the	value	of	out-of-sample	health	states.	In	their	study,	random	selection	
of	health	states	worked	better	than	selection	of	states	of	specific	types	(as	above)	and	
the	predictions	became	acceptable	when	the	sampling	ratio	reached	10%	(in	EQ-5D-3L,	
that	is	25	health	states.)	In	addition	the	‘main	effects’	model	appeared	to	be	a	crude	but	
‘safe’	tool	for	estimation	bias	analysis	(69).	
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The	present	study	built	upon	the	work	outlined	in	the	last	paragraph,	with	a	specific	focus	
on	strategies	for	selecting	health	states.	There	were	2	competing	design	principles	at	issue	
that	both	have	their	merits.	1)	Historically,	health	states	for	inclusion	in	a	design	tended	
to	be	hand-picked,	based	on	the	properties	of	those	health	states	(such	as	whether	they	
were	common),	and	on	easily	recognizable	properties	of	the	set	as	a	whole	(spanning	the	
value	range),	but	without	an	eye	for	the	statistical	properties	of	the	set.	2)	Optimization	of	
statistical	properties	was	an	alternative	route	to	follow,	with	an	orthogonal	design	looking	
like	a	promising	alternative	to	the	designs	that	had	been	used	historically.
This	study	aimed	to	assess	the	comparative	performance	of	the	designs	created,	while	
giving	different	weight	to	these	principles.	For	this	purpose,	we	compared	designs	on	
the	basis	of	root	mean	squared	errors	(RMSEs),	whilst	also	taking	into	account	that	from	
a	user’s	perspective,	misprediction	of	common	health	states	could	be	considered	as	a	
mistake	to	be	penalized	more	heavily	than	misprediction	of	rare	health	states	(defined	
below).	At	first	glance,	over-representation	of	common	health	states	(with	assumed	better	
face	validity	and	data	quality	compared	to	rare	health	states)	could	lead	to	more	accurate	
estimations	for	the	common	health	states	which	shared	the	mild	 levels.	On	the	other	
hand,	this	could	also	lead	to	reduced	statistical	efficiency	compared	to	balanced	designs.	
Thus	it	would	be	unknown	whether	the	best	prediction	of	a	common	state	was	achieved.	
While	we	were	aware	that	employing	more	design	choices	(the	number	of	respondents,	
the	 number	 of	 health	 states	 per	 respondent,	 and	 the	 use	 of	 blocks	 (69))	may	 affect	
misprediction,	this	study	focused	on	the	above	2	design	principles.	Hence	‘design’	refers	
only	to	the	deliberate	selection	of	a	subset	of	health	states.	Our	research	questions	were	
addressed	by	testing	a	variety	of	designs,	using	a	pre-existing	saturated	data	set	with	
observations	on	all	health	states	for	reference	purposes,	and	by	using	different	RMSE-
based	performance	measures	with	and	without	focus	on	common	health	states.
4 .2 	METHODS	
4.2.1  research strategy 
We	used	an	existing	data	set	with	visual	analogue	scale	(VAS)	values	from	126	students,	
each	of	whom	valued	all	 243	EQ-5D-3L	 states.	We	generated	a	 series	of	designs	and	
subsequently	modelled	data	subsets	derived	from	each	design.
Some	of	these	designs	were	used	previously,	e.g.	the	MVH	subset;	others	were	newly	
generated,	based	on	our	proposed	design	strategies.	The	performance	of	the	different	
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designs	was	evaluated	in	terms	of	the	lowest	RMSEs	for	all	health	states	taken	together,	
and	for	common	and	rare	states	separately.	Common	health	states	were	defined	in	terms	
of	the	frequency	of	their	occurrence	in	the	3	reference	data	sets	(see	below).
4.2.2  Exist ing data set  with VaS values
In	1996	a	students’	panel	(n=126)	provided	EQ-VAS	values	for	all	243	EQ-5D-5L	health	
states.	Such	a	dataset	is	called	‘saturated’	and	if	the	resulting	data	set	was	regarded	as	
suitable,	no	regression	was	needed	to	generate	a	value	for	each	health	state.	
The	EQ-VAS	was	displayed	as	a	standard	vertical	20	cm	scale	to	record	an	individual’s	
rating	for	a	health	state.	By	using	the	EQ-VAS,	each	health	state	could	be	valued	on	a	
scale	from	0	(the	worst	score)	to	100	(the	best	score).	The	students	received	41	sheets	of	
paper,	each	containing	6	EuroQol	health	states,	except	for	the	last	sheet	which	contained	
1	health	state	plus	the	states	‘unconscious’	and	‘dead’.	11111	and	33333	were	valued	
twice	at	the	outset	before	valuing	all	other	states,	and	then	with	all	 the	other	health	
states.	The	 first	 time	the	values	of	11111	and	33333	were	used	as	anchors	while	 the	
second	time	these	values	were	used	for	analysis.	The	EQ-VAS	was	shown	on	a	separate	
paper.	The	standard	abbreviations	for	the	health	states	(e.g.	‘11132’)	were	printed	above	
the	health	 states	 in	order	 to	provide	a	 shortcut	 for	 the	 stimuli.	Next	 to	 the	 standard	
abbreviations,	the	students	were	able	to	fill	in	the	values	of	the	health	states.	In	order	
to	eliminate	framing	effects,	the	health	states	were	presented	in	10	different	random	
orders.	The	students	were	instructed	to	value	all	health	states,	even	when	they	thought	
that	a	health	state	was	unrealistic.	The	 investigators	piloted	the	procedure	(70).	Each	
student	was	awarded	35	Dutch	guilders	(equivalent	to	€	16.35	today).
4.2.3  three reference data sets  for  the identi f icat ion of  common 
health states
The	classification	of	each	of	the	243	possible	health	states	as	common	or	rare	in	our	study	
was	based	on	the	frequency	of	their	occurrence	in	3	patient	and	population	pooled	data	
sets	holding	data	on	N=5,269	people	in	total.	The	data	sets	are	described	elsewhere	(26,	
71,	72).	We	defined	the	health	states	that	never	occurred	in	our	sample	as	‘rare	health	
states’,	and	the	ones	we	did	observe	were	classified	as	‘common	health	states’.	
4.2.4  tested experimental  designs 
Table	1	provides	a	summary	of	the	10	different	designs	that	were	compared	in	this	study.	
53
u S E  S tat I S t I C a l  E F F I C I E n t  D E S I G n  F o r  E Q -5 D  Va l uat I o n
4
table 1: Tested	designs	&	their	characteristics
ID Design names # health states # mild, moderate, 
severe health states
#common health states 
in design (percentage)
1. MVH 42 13,12,17 32 (76.2)
2. Japan 17 08,04,05 13 (76.5)
3. Paris 25 09,05,11 19 (76.0)
4. Bagust 47 16,10,21 45 (95.7)
5. Small Orthogonal 18 / /
6. Random (Common states only) 18 06,06,06 18 (100)
7. Random (All states) 18 06,06,06 /
8. Large Orthogonal 54 / /
9. Random (Common states only) 54 18,18,18 54 (100)
10. Random (All states) 54 18,18,18 /
* Italicized designs (5-10) repeated 100 times as such designs include randomization sampling.
Designs	1-3	have	been	used	historically	in	EQ-5D	valuation	studies	(59,	68,	73-76).	The	MVH’	
design	is	one	of	the	earliest	designs	used	in	EQ-5D	valuation	studies	(68),	and	both	‘Paris’	
and	‘Japan’	designs	were	generated	on	the	basis	of	the	‘MVH’	design,	aiming	at	lowering	
the	number	of	states	that	needed	to	be	valued	in	valuation	studies	(59,	60,	75,	76).The	
designs	of	EQ-5D	valuation	studies	have	been	critiqued	by	Bagust	(67),	and	design	4	was	
proposed	by	him	as	an	alternative.	Designs	6,	7,	9	&10	comprised	health	states	that	were	
randomly	selected	from	3	groups	with	differing	average	severity.	We	began	by	categorizing	
all	health	states	into	3	groups	(mild,	moderate	and	severe)	based	on	their	misery	index	
(e.g.,	misery	 index	of	 ‘32121’=3+2+1+2+1=9).	 In	designs	6	and	9	 the	candidate	set	was	
restricted	to	common	health	states;	in	7	and	10	all	health	states	were	included.	Designs	
5	and	8	were	built	starting	from	the	experimental	generating	principle,	hence	these	were	
orthogonal,	and	the	arrangement	of	levels	across	all	different	health	states	is	commonly	
called	an	‘orthogonal	array’.	Design	9	was	obtained	from	an	orthogonal	main	effects	plan	
[http://neilsloane.com/oadir/index.html;	 design:	 oa.18.7.3.2](77),	 whereas	 design	 10	
[Hedayat	et	al	1997;	design:	oa.54.5.3.3.c](78)	represented	an	orthogonal	array	that	also	
enabled	identification	of	two-way	interactions.	From	the	emerging	set,	a	large	number	of	
equivalent	yet	different	designs	could	be	derived	which	maintained	orthogonality.
As	neither	the	principle	of	randomization	nor	the	principle	of	orthogonality	always	produced	
the	same	design,	we	created	multiple	(100	times)	variants	of	each	(designs	5	to	10)	to	test	by	
how	much,	if	any,	the	misprediction	performance	was	dependent	on	the	variant.
4.2.5  normal izat ion and model l ing of  VaS values
To	deal	with	the	issue	that	each	respondent	may	have	utilized	the	EQ-VAS	scale	differently,	
we	used	Formula	1	 to	 rescale	 the	VAS	value	 to	anchor	 it	on	 the	extremes	 full	health	
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(11111)	and	worst	health	state	(33333).	Note	that	we	did	not	rescale	on	the	value	of	
death,	because	the	value	of	death	is	controversial	and	would	introduce	relatively	more	
variance	(error)	than	the	value	of	33333.	
V	(health	state)	=	(VAS	(health	state)	-VAS	(33333))/	(VAS	(11111)	-VAS	(33333))	 (1)
As	the	VAS	scores	11111	and	33333	were	required	as	anchored	health	states,	we	dropped	
the	observations	with	missing	values	in	11111	and/or	33333.	After	this	data	cleaning,	we	
estimated	the	‘main	effects’	ordinary	least	squared	(OLS)	model	to	predict	values	for	all	
health	states	(68).	In	this	model,	each	dimension	was	assumed	to	be	independent	of	the	
others	and	no	interactions	between	dimensions	were	used	(17,	59,	69).	The	background	
characteristics	of	respondents	such	as	age	and	gender	were	not	entered	into	the	model,	
as	the	purpose	of	the	valuation	study	was	to	predict	the	values	of	health	states	rather	
than	predicting	how	an	individual	evaluates	a	health	state	(68).	
The	equation	was:
	V	(health	state)	=	α	+	β
1
MO
2
	+	β
2
MO
3
	+	β
3
SC
2
	+	β
4
SC
3
	+	β
5
uA
2
	+	β
6
uA
3
	+
																																																		β
7
PD
2
	+	β
8
PD
3
	+	β
9
AD
2
	+	β
10
AD
3
+ε.	 	 (2)
V	(health	state)	is	the	rescaled	VAS	value	given	by	formula	1	and	it	 is	explained	by	10	
variables	and	one	intercept.	Each	dimension	(MO	for	mobility,	SC	for	self-care,	uA	for	
usual	 activity,	 PD	 for	 pain/discomfort,	 AD	 for	 anxiety/depression)	 has	 two	 dummy	
variables	to	represent	the	move	from	level	1	to	level	2	or	level	3,	e.g.	MO
2	
takes	1	if	the	
health	state	has	a	problem	in	the	second	level	of	mobility,	takes	0	if	otherwise	(68).	The	
coefficients	β
i	
indicate	the	‘disvalue’	of	each	variable	associated	with	its	move	away	from	
11111.	Given	that	 the	value	of	11111	 is	1	and	the	 intercept	represents	any	deviation	
from	11111,	the	intercept	is	then	interpreted	as	a	discontinuity	between	the	value	of	full	
health	and	all	other	health	states	(68,	75).
4.2.6  analys is
The	performance	of	different	designs	in	predicting	health	states	values	was	quantified	
through	computation	of	the	RMSE	as	the	primary	measure	of	misprediction.	We	used	
two	approaches	to	report	the	RMSE,	by	distinguishing	between:	i)	health	states	included/
omitted	in	the	design,	and	ii)	commonness	of	the	health	states.	For	overall	comparison	
of	 the	designs,	we	 also	 reported	 the	 general	 RMSE	 for	 all	 243	health	 states.	 For	 the	
designs	with	100	variants	(random	selection	and	orthogonal	designs),	we	also	presented	
the	mean	and	variance	of	RMSEs,	using	Box	plots.	For	reference,	we	listed	the	mean,	
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standard	error,	95%	confidence	interval	and	predictions	from	three	designs	for	10	health	
states	from	different	misery	index	groups.	Additionally,	we	also	estimated	the	number	of	
health	states	with	large	prediction	error	(RMSE	not	applicable,	absolute	error	-AE-	used	
instead,	where	AE>0.05	&	AE>0.10	were	applied	as	 criteria)	 to	 see	whether	a	design	
predicted	fairly	for	all	health	states.
4 .3 	RESuLTS
4.3.1  EQ VaS data
All	 126	 students	 completed	 the	 main	 243	 health	 states	 valuation	 task.	 The	 average	
time	to	complete	this	task	was	1	hour	16	minutes.	The	time	for	the	fastest	decile	was	
50	minutes,	the	time	for	the	slowest	decile	was	1	hour	43	minutes.	Data	cleaning	was	
minimal,	with	only	40	state	values	missing.	Missing	data	was	not	 imputed.	 Individual	
inspection	 of	 the	 outliers	 revealed	 that	 one	 respondent	 reversed	 the	 scale	 and	 one	
respondent	gave	highly	inconsistent	responses,	valuing	many	clearly	good	states	much	
lower	than	clearly	bad	states.	These	2	respondents	were	excluded.
The	mean	V	(health	state)	across	all	states	and	respondents	was	0.370	(SD	0.214).	The	
mean	top	and	bottom	values	were	V	(11111)	=	0.965	(SD	0.165),	and	V	(33333)	=	0.011	
(SD	0.132).	
4.3.2  reference data sets  for  identi f icat ion of  common health states
In	total,	55%	(143)	of	health	states	out	of	243	were	observed	in	our	data	sets.	Among	the	
common	health	states,	43%	(57)	occurred	at	least	5	times.	The	most	frequently	observed	
health	state	was	11111.
4.3.3  Performance of  var ious designs 
Table	 2	 summarizes	 the	 RMSEs	 produced	 by	 different	 designs.	 The	 RMSEs	 were	
calculated	at	an	aggregate	level.	Orthogonal	designs	(5	and	8)	dominated	performance	
compared	to	the	published	designs	(1-4)	and	the	random	selection	designs	(6,	7,	9	and	
10).	Increasing	the	proportion	of	common	health	states	in	a	design	did	not	necessarily	
improve	the	predictions	for	the	common	health	states,	but	resulted	in	larger	RMSEs	for	
rare	health	states.	The	regression	estimates	can	be	found	in	the	Appendix.
To	show	some	examples	of	differences	in	performance,	Table	3	lists	the	observed	means	
and	predictions	for	ten	health	states	in	our	sample.	
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For	the	designs	repeated	100	times	(5-10),	Figure	1	shows	the	distributions	of	RMSEs	
based	on	all	243	health	states.	The	variations	in	the	RMSE	values	of	the	random	selection	
designs	 (6,	 7,	 9	 and	 10)	 were	 greater	 than	 those	 of	 the	 corresponding	 orthogonal	
designs	(5	and	8).	The	large	orthogonal	design	offered	a	stable	performance	over	the	
100	variants,	the	RMSEs	of	which	were	all	below	0.04.
Figure 1:	RMSE	distributi	ons	for	random&	orthogonal	designs
Figure	2	shows	the	number	of	health	states	for	which	the	AEs	were	larger	than	0.05	and	
0.10	for	each	design.	Again,	orthogonal	designs	(9	and	10)	performed	better	than	the	
other	designs.
Figure 2:	Number	of	health	states	with	AE	larger	than	0.05	and	0.10
*Dark grey: number of health states with AE >=0.05 & <0.10; Light grey: number of health states with AE >=0.10. 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Figure	 2	 indicates	 that	 current	 designs	 produced	 large	 prediction	 errors	 for	 many	
health	 states.	 In	 contrast,	 the	 orthogonal	 designs	 provided	 considerably	 fewer	 large	
mispredictions.	
4 .4 	DISCuSSION
The	saturated	data	set	allowed	us	to	judge	the	consequences	of	different	design	strategies	
concerning	health	state	selection	in	valuation	studies.	To	address	our	research	question,	
the	 first	 principle	 of	 ensuring	 design	 orthogonality	 clearly	 outweighed	 the	 second	
principle	of	 the	over-representation	of	 common	health	 states	 in	 the	design.	 In	other	
words,	when	weighing	up	design	properties,	increased	statistical	efficiency	outweighed	
an	increased	error	rate	-	if	any	-	in	rare	health	states.	In	addition,	previously	published	
and	commonly	used	designs	performed	worst	among	all	the	designs	examined.	The	MVH	
design	performed	best	 among	 the	published	designs,	 but	was	 still	worse	 than	either	
orthogonal	designs	or	random	selection	designs.	The	243	health	state	values	were	best	
predicted	by	the	large	orthogonal	design	(with	54	health	states),	despite	the	fact	that	this	
design	contained	many	rare	health	states.	Large	random	selection	design	also	performed	
well,	but	not	when	restricted	to	common	health	states	only.	Notably,	random	selection	
designs	restricted	to	common	health	states	did	not	improve	the	estimation	of	common	
health	states,	but	led	to	misprediction	for	rare	health	states.	Furthermore,	keeping	the	
number	of	health	states	in	the	design	constant,	the	orthogonal	designs	outperformed	
the	random	designs	in	terms	of	overall	performance	and	performance	stability.	
While	our	investigation	used	the	MVH	study	as	a	point	of	reference,	it	should	be	noted	
that	other	published	valuation	studies,	 including	 instruments	such	as	HuI	(the	Health	
utility	Index)	and	SF-6D	(the	Short	Form	Health	Survey),	were	consensus-based	regarding	
sampling,	as	in	the	MVH	study,	and	often	used	similar	criteria	(29).	
It	is	noteworthy	that	published	designs	provided	less	accurate	predictions	overall,	and	
large	estimation	errors	for	many	health	states.	The	magnitude	of	the	 large	prediction	
error	exceeded	the	often-used	minimum	 important	difference	 (MID)	 in	EQ-5D	shown	
in	previous	studies	(79-81).	Hence	the	continued	use	of	the	current	designs	may	not	be	
appropriate.	Generally,	the	predictions	improve	when	the	large	design	approach	is	used	
in	a	valuation	study.	By	focusing	on	the	statistical	properties	required	in	a	study	design,	
we	have	demonstrated	that	orthogonal	designs	may	be	viable	alternatives	for	selecting	
health	 states	 in	 future	 valuation	 studies.	 The	 common	 health	 states	 design	 did	 not	
predict	the	rare	states	well.	In	contrast,	orthogonal	designs	offered	the	best	predictions	
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universally	for	common	and	rare	states.	These	results	suggest	that	orthogonal	designs	
can	safely	be	used,	especially	when	they	are	also	designed	to	capture	level	interactions	
(i.e.	 the	 large	 orthogonal	 design),	 but	 it	 is	 the	 user’s	 decision	 whether	 to	 minimize	
sample	size	or	to	maximize	prediction	accuracy.
Since	most	EQ-5D	valuation	studies	have	been	conducted	using	the	time	trade-off	(TTO)	
approach,	a	limitation	of	this	study	is	that	the	designs	have	been	tested	and	compared	
using	VAS	data.	Theoretically,	VAS	values	do	not	have	ratio	properties	and	should	not	be	
used	for	estimating	QALYs	(82).	For	the	purpose	of	this	study,	we	rescaled	the	VAS	values	
using	 two	 extreme	health	 states	 and	 assumed	 the	 rescaled	 values	 had	 interval	 scale	
properties.	It	also	should	be	noted	that	after	rescaling	the	VAS	values,	the	valuation	space	
of	our	data	was	more	compressed	than	raw	VAS	data	and	TTO	data	(83,	84).	Thus	caution	
is	in	order	when	applying	our	results	in	valuation	studies	that	use	a	different	valuation	
methods.	We	also	restricted	our	analysis	to	a	‘main	effects’	model	only,	as	in	previous	
studies	the	use	of	an	interaction	term	increased	the	likelihood	of	mis-specification	(69).
The	good	performance	of	 the	 large	orthogonal	design	warrants	 further	consideration	
as	this	could	point	to	a	mis-specification	problem	in	the	sense	that	main	effects	models	
perhaps	do	not	capture	all	effects	on	valuations.	For	 instance,	we	could	 imagine	that	
people’s	 values	 are	 subject	 to	 interaction	 effects.	 Interactions	 across	 severity	 levels	
might	reflect	diminishing	marginal	disutility,	or	reflect	that	in	some	health	profiles	both	
causes	(say,	mobility	issues)	and	consequences	(problems	in	usual	activities	or	self-care)	
appear.	 Interactions	will	 affect	 the	value	 that	people	express	 for	a	given	health	 state	
and	hence	model	parameters	that	are	 identified	when	values	are	decomposed	to	the	
underlying	health	characteristics	are	conditional	on	unobserved	interactions.	The	large	
orthogonal	designs	are	balanced	in	the	presence	of	all	possible	two	factor	interactions,	
and	hence	their	performance	was	robust	even	over	different	variants.	Further	research	
is	required.	
It	 is	 an	open	question	what	our	 results	 imply	 for	 EQ-5D-5L	 valuation.	 In	 EQ-5D-5L,	 a	
5-level	response	scale	is	used	as	a	replacement	for	the	3-level	response	scale,	while	the	
descriptive	system	is	 the	same	as	 for	EQ-5D-3L	(28).	By	 increasing	the	response	scale	
levels	from	3	to	5,	the	sensitivity	of	the	instrument	was	improved	and	the	number	of	
unique	health	states	increased	from	243	to	3,125.	A	big	difference	between	3L	and	5L	
valuation	studies	is	the	ratio	between	observed	and	predicted	health	states,	for	example,	
in	the	MVH	design,	this	ratio	was	21%	(42:	201),	whereas	in	the	current	EQ-5D-5L	design,	
it	was	3%	 (86:	3,039).	Hence	 it	 should	be	noted	 that	 the	 risk	of	misprediction	would	
increase	since	more	health	state	values	would	rest	on	extrapolation	when	using	EQ-5D-
61
u S E  S tat I S t I C a l  E F F I C I E n t  D E S I G n  F o r  E Q -5 D  Va l uat I o n
4
5L.	Thus,	future	saturation	data	should	confirm	the	use	of	the	current	EQ-5D-5L	design	
against	other	possible	design	choices,	especially	for	orthogonal	designs.
In	conclusion,	there	is	scope	for	improvement	in	health	state	valuation	design	strategies.	
Published	 design	 strategies	 suffer	 to	 a	 large	 extent	 from	 misprediction	 that	 can	 be	
avoided	 by	 promoting	 statistical	 efficiency	 within	 the	 design,	 and	 by	 reducing	 the	
emphasis	placed	on	over-representing	common	health	states.	The	orthogonal	designs	
may	be	an	alternative	design	for	future	EQ-5D-3L	valuation	studies
4 .5 	APPENDIx
appendix 1.	Regression	estimates	from	Japan,	MVH,	Large	orthogonal	designs
Japan design. 
n=2.139
MVH design. 
n=5.283
Large orthogonal design. 
n=6.795
mo2* -0.032 -2.5 -0.065 -11.79 -0.054 -11,02
mo3 -0.124 -7.96 -0.151 -21.77 -0.155 -31,43
sc2 -0.068 -5.49 -0.054 -9.15 -0.042 -8,55
sc3 -0.059 -4.02 -0.099 -13.94 -0.085 -17,33
ua2 -0.126 -10.06 -0.082 -12.71 -0.056 -11,3
ua3 -0.236 -15.56 -0.175 -25.75 -0.131 -26,62
pd2 -0.076 -7.45 -0.076 -13.72 -0.071 -14,45
pd3 -0.257 -22.35 -0.201 -34.4 -0.186 -37,65
ad2 -0.056 -4.93 -0.085 -14.59 -0.053 -10,7
ad3 -0.175 -15.54 -0.178 -29.9 -0.146 -29,52
Intercept 0.807 105.96 0.78 128.72 0.695 104,06
R squared 0.663 0.574 0.392
Root MSE 0.168 0.163 0.166
*Dummy variable coding: mo2 means ‘mobility’ at second level etc
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5.1	 INTRODuCTION	
In	developing	an	EQ-5D	value	set,	it	is	common	that	a	subset	of	health	states	is	directly	
valued	by	the	general	public	to	provide	a	basis	for	predicting	values	of	all	health	states	
using	 regression	 models.	 An	 important	 decision	 concerns	 the	 selection	 of	 health	
states	 for	 direct	 valuation	 (15,	 69).	 However,	 there	 is	 no	 evidence-based	 guidance	
on	 health	 state	 selection	 criteria.	 One	 commonly	 used	 criterion	 is	 the	 plausibility	 of	
health	states	(67,	68,	85).	Health	states	being	‘implausible’	refers	to	those	health	states	
that	 respondents	may	 find	 unrealistic	 (86).	 The	 inclusion	 of	 such	 states	 in	 valuation	
studies	has	been	assumed	 to	compromise	 respondents’	engagement	 in	 the	valuation	
tasks	 and	 to	 increase	 variations	 in	 health	 states’	 values	 (68,	 87,	 88).	 For	 example,	 in	
the	Measurement	and	Valuation	of	Health	(MVH)	study,	the	investigators	excluded	the	
prima facie	implausible	health	states	from	direct	valuation	in	order	to	sustain	motivation	
and	credibility,	and	to	reduce	error	(68).	
It	has	been	reported	that	the	EQ-5D	valuation	method	was	cognitively	demanding	for	
respondents	as	they	needed	to	understand	the	concept	of	time	trade-off	and	imagine	
various	 ‘health	 states’	 based	 on	 textual	 descriptions	 in	 a	 short	 interview	 (8,	 14,	 29).	
Perceived	implausibility	may	have	further	increased	the	difficulty	in	imagining	the	health	
states	 concerned,	which	 is	pivotal	 to	 the	 thought	process	 for	 valuation.	According	 to	
Karimi	et	al	(6),	lay	respondents	use	several	steps	to	value	EQ-5D	states.	First,	respondents	
use	their	imagination	and	experiences	to	give	substance	to	the	EQ-5D	health	states.	Then	
the	consequences	of	these	health	states	are	determined	by	combining	with	conversion	
factors	(defined	as	personal	and	social	factors	that	affect	how	participants	value	health	
states),	 and	 are	 then	 perceived	 and	weighted	 to	 evaluate	 the	 health	 states.	 In	 their	
research,	 the	 investigators	 found	 respondents	 encountered	 difficulties	 when	 valuing	
implausible	EQ-5D	health	states.	
Dealing	 with	 the	 implausibility	 issue	 is	 not	 easy	 as	 implausibility	 is	 a	 subjective	
judgement.	For	example,	health	states	that	are	easy	to	imagine	for	some	individuals	may	
be	considered	implausible	by	others.	The	question	thus	is	to	what	degree	a	health	state	
is	implausible,	rather	than	whether	a	health	state	is	implausible	or	not.	So	far,	concerns	
about	 implausible	health	states	have	not	been	formally	studied.	First,	 it	 is	not	known	
how	plausible	or	implausible	are	the	health	states	defined	by	standardized	descriptive	
systems	such	as	EQ-5D.	Second,	little	is	known	about	the	effect	of	plausibility	on	health	
state	valuation.	While	it	is	reported	that	implausible	health	states	make	valuation	tasks	
more	difficult	in	some	qualitative	studies,	quantitative	investigation	of	how	implausibility	
affects	health	state	values	is	lacking.	What	is	clear,	however,	is	that	imposing	a	plausibility	
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constraint	on	the	selection	of	health	states	potentially	affects	the	severity	spread	and	
the	level	balance	of	the	selected	subset,	which	may	impact	on	data	modelling	(15,	87).	
Whether	it	is	still	relevant	to	account	for	plausibility	in	health	state	selection	is	unknown.	
In	 this	 study,	 we	 investigated	 how	 likely	 EQ-5D-5L	 health	 states	 were	 perceived	 to	
be	 implausible,	 were	 there	 common	 characteristics	 for	 implausible	 states,	 and	 how	
implausibility	 affected	 health	 state	 valuation.	 We	 conducted	 a	 large	 health	 state	
valuation	study	among	students,	who	valued	health	states	and	rated	the	plausibility	of	
each	state.	The	dataset	allowed	us	to	observe	what	health	states	had	the	highest	chance	
of	being	considered	plausible	or	 implausible,	and	to	analyze	whether	values	obtained	
from	respondents	who	considered	a	state	plausible	agreed	with	their	counterparts	who	
considered	that	same	state	implausible.	 In	addition,	we	used	qualitative	interviews	to	
explore	directly	from	the	respondents	the	reasons	for	implausibility	judgements	and	the	
effect	of	implausibility	on	values.
5 .2 	METHODS
5.2.1  Data col lect ion
university	undergraduate	students	(N=1,600)	at	Guizhou	Medical	university,	China	were	
recruited	for	the	study	through	e-mail	and/or	personal	invitations.	The	inclusion	criteria	
were	aged	18	years	or	above,	full-time	students,	agreement	to	complete	a	questionnaire	
that	may	take	up	to	1	hour,	and	informed	consent.	Data	collection	was	conducted	in	3	
stages.	Consenting	students	were	first	 invited	to	a	classroom	to	complete	a	valuation	
questionnaire	in	a	group	(stage	1).	Two	weeks	later,	the	students	were	invited	back	to	
rate	the	plausibility	of	the	health	states	they	had	valued	previously	(stage	2).	Lastly,	a	
small	group	of	students	was	invited	to	participate	in	a	focus	group/individual	discussion	
of	their	experiences	 in	completing	the	valuation	questionnaires,	with	an	emphasis	on	
the	valuation	of	 implausible	states	(stage	3).	The	detailed	methods	employed	at	each	
stage	are	elaborated	upon	below.
Stage 1  –  Valuat ion of  EQ-5D-5l health states
All	3,125	EQ-5D-5L	health	states	were	valued	using	the	EuroQol	visual	analogue	scale	
(EQ-VAS).	EQ-VAS	is	a	vertical,	20-cm-long,	hash-marked	numerical	rating	scale	ranging	
from	0	(‘the	worst	health	you	can	imagine’)	to	100	(‘the	best	health	you	can	imagine’).	
Previous	 research	demonstrated	 the	 feasibility	of	university	 students	valuing	243	EQ-
5D-3L	health	states	using	EQ-VAS	in	a	single	survey	session	(89).	In	this	research,	each	
student	was	asked	to	value	196	or	197	health	states	in	a	self-administered,	questionnaire-
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based	survey.	We	used	a	stratified	random	selection	procedure	to	divide	all	EQ-5D-5L	
states	(except	for	the	best	and	the	worst	states,	i.e.	11111	and	55555)	into	16	blocks	of	
196	or	197	states.	Details	of	the	data	collection	protocol,	which	aimed	at	an	equivalent	
response	burden	across	respondents,	are	provided	in	the	Appendix.
The	 valuation	 questionnaire	 was	 administered	 using	 paper	 and	 pencil.	 It	 had	 three	
sections.	The	first	section	was	for	respondents	to	classify	their	own	health	on	the	EQ-
5D-5L	questionnaire	and	rate	their	health	using	the	EQ-VAS.	The	second	section	was	for	
respondents	first	to	value	the	states	11111	and	55555	on	one	page	and	then	to	value	a	
randomly	selected	block	of	states	presented	in	separate	pages	with	10	health	states	per	
page.	Students	were	asked	to	value	all	states	using	an	EQ-VAS	that	was	presented	on	a	
separate	piece	of	paper	and	were	instructed	to	write	down	the	VAS	value	for	each	health	
state	beside	the	description	of	the	health	state.
In	 order	 to	 highlight	 the	differences	 in	 the	health	 states	 for	 valuation,	we	presented	
the	EQ-5D-5L	health	state	descriptions	by	separating	the	dimensions	and	severity	levels.	
Figure	1	 illustrates	 this	presentation	 style	using	 the	 state	 ‘13542’	as	an	example	 (the	
original	questionnaire	was	in	Chinese).	In	total,	we	organized	16	group	data	collection	
sessions,	with	each	session	being	attended	by	around	100	students.	In	each	session,	an	
investigator	briefed	the	students	using	a	standard	script	before	they	started	to	complete	
their	questionnaires	and	was	available	to	answer	any	of	their	questions.
Figure 1:	An	example	of	the	health	states	presentati	on	used	in	this	study
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Stage 2  –  rat ing of  health states’  implausibi l i ty
2	weeks	after	the	valuation	survey,	about	half	of	the	total	sample	were	invited	back	to	
rate	the	plausibility	of	health	states	they	had	valued.	The	survey	settings	were	similar	
to	 the	 valuation	 survey	 in	 the	 first	 stage.	 Students	 received	 the	 questionnaires	 they	
had	previously	 valued	 and	were	 asked	 to	 rate	 each	health	 state	 using	 a	 binary	 scale	
by	 responding	 ‘Y’	 =	 ‘yes,	 this	 state	 is	 implausible	 to	me’;	 ‘N’	 =	 ‘no,	 I	 don’t	 think	 this	
state	is	implausible’.	In	total,	9	sessions	of	group	interviews	were	organized,	each	being	
attended	by	around	100	students.	In	the	first	and	second	stages,	students	were	paid	100	
Chinese	Yuan	(approximately	equivalent	to	14	euros)	per	session.
Stage 3  –  Qual i tat ive interviews 
A	small	group	of	students	who	participated	in	both	surveys	was	invited	to	share	their	
thoughts	 about	 implausible	 health	 states	 during	 in-depth	 interviews	 or	 focus	 group	
discussions.	 The	 interviews/focus	 group	 discussions	 were	 conducted	 2	 weeks	 after	
the	 implausibility	 rating	 task.	 All	 interviews	 were	 conducted	 and	 recorded	 by	 the	
same	 investigator	who	conducted	the	stage	1	and	2	surveys.	 In	 the	 interviews/	 focus	
group	discussions,	interviewees	were	asked	to	share	their	experiences/thoughts	about	
implausible	health	states.
5 .2 .2 	ANALYSIS
Quantitat ive data
First,	to	evaluate	the	validity	of	the	VAS	data,	we	examined	the	relationship	between	the	
VAS	values	of	all	health	states	and	their	misery	index.	The	misery	index	was	defined	as	
the	sum	of	the	five	digits	of	an	EQ-5D-5L	health	state,	e.g.,	the	misery	index	of	45133=4	
+5	+1	+3	+3	=16.	It	is	used	as	an	approximation	of	severity,	with	higher	values	indicating	
worse	health.	 The	misery	 index	 ranges	 from	5	 (state	11111)	 to	25	 (state	55555);	 the	
number	of	health	states	with	 the	same	misery	 index	 ranges	 from	1	 (for	misery	 index	
group	 5	 and	 25)	 to	 381	 (for	misery	 index	 group	 15).	 In	 this	 analysis,	 boxplots	 were	
produced	 to	 compare	 the	 distribution	 of	 VAS	 values	 for	 health	 states	 with	 different	
misery	 indexes.	We	hypothesized	that	 the	mean	VAS	values	monotonically	decreased	
with	an	increasing	misery	index.	
In	order	to	measure	implausibility,	we	calculated	an	implausibility	score	for	each	health	
state.	The	rating	of	implausibility	was	coded	as	‘1’	for	implausible,	and	‘0’	for	plausible,	
respectively,	 for	 each	 health	 state	 valued	 by	 each	 respondent.	 By	 averaging	 the	 rate	
for	 each	 health	 state,	 an	 implausibility	 score	was	 calculated	 for	 each	 health	 state	 as	
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the	percentage	of	respondents	who	rated	that	health	state	as	implausible.	For	example,	
the	 implausibility	 score	 for	 state	 45133	was	 0.71	 as	 71%	 of	 respondents	 rated	 it	 as	
implausible.	The	higher	the	implausibility	score,	the	more	implausible	a	health	state.	We	
listed	the	top	ten	most	implausible	states	and	the	least	implausible	states	for	reference.	
We	examined	the	relationship	between	implausibility	and	health	severity.	First,	a	total	
of	21	.,	one	for	each	group	of	health	states	with	the	same	misery	index,	were	generated	
and	arranged	in	increasing	order	of	the	misery	index	to	observe	any	trend.	Second,	we	
used	a	regression	model	to	investigate	which	combinations	of	extreme	levels	between	
dimensions	 (e.g.	 51xxx,	 5x1xx)	 contributed	most	 to	 the	 implausibility.	 Based	 on	 the	
qualitative	results,	health	states	with	such	combinations	were	more	likely	to	be	perceived	
as	implausible	in	valuation	studies.	In	the	model,	we	created	20	dummies	for	all	the	5-1	
level	combinations	(see	formula	1).	The	analysis	was	performed	at	the	individual	level	
using	logistic	regression.	We	ranked	the	most	influential	contrasted	pairs	from	the	top	
downwards.
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To	evaluate	the	effect	of	implausibility	on	VAS	values,	we	calculated	the	mean	VAS	values	
for	all	states	using	observations	from	respondents	who	valued	the	states	and	rated	them	
as	plausible	(mean	VAS	value	
plausible
),	and	the	mean	VAS	values	for	the	same	states	using	
observations	from	respondents	who	valued	and	rated	them	as	implausible	(mean	VAS	
value	
implausible
).	The	agreement	of	the	two	sets	of	mean	VAS	values	was	examined	using	
a	histogram	of	the	mean	VAS	values’	difference	of	each	state	(mean	VAS	value	
plausible	
-	
mean	VAS	value	
implausible
).	We	also	used	a	paired	t-test	to	examine	the	difference	between	
two	means.		
Qual itat ive interviews
All	interviews	and	focus	groups	were	audio-recorded.	One	researcher	(ZY)	transcribed	all	
interviews	and	imported	all	data	into	Nvivo.	Two	independent	researchers	analyzed	the	
qualitative	transcriptions	using	the	thematic	framework.	During	the	coding,	two	coders	
discussed	 if	 disagreement	 occurred.	 After	 coding,	 codes	were	 classified	 into	 themes	
and	sub-themes	and	were	further	discussed	by	two	coders	to	finalize	the	definition	and	
names	for	each	theme.
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5.3	RESuLTS
5.3.1  Part ic ipant  character ist ics 
A	 total	 of	 890	 students	 completed	both	 the	 valuation	and	 implausibility	 rating	 tasks.	
The	average	 time	 to	 complete	 the	valuation	 task	was	65	minutes	 (range:	23	 to	180).	
On	average,	the	students	were	around	21	years	old	and	62%	female.	All	students	had	a	
health-related	education	background,	such	as	pharmacy	and	public	health.	Twenty-one	
students	were	recruited	for	qualitative	 interviews.	Nine	were	 interviewed	 individually	
and	the	remaining	twelve	students	attended	two	focus	group	discussion	sessions	with	
six	students	in	each	session.
5.3.2  Distr ibut ions of  VaS and implausibi l i ty  scores
Figure 2:	Empirical	mean	VAS	values	of	all	health	states	by	misery	index
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The	box	plot	was	sorted	on	the	misery	index	group;	it	should	be	noted	that	one	misery	
index	value	could	result	from	more	than	one	health	state.	
Figure	 2	 shows	 the	 mean	 VAS	 values	 of	 3,125	 health	 states	 plotted	 with	 their	
corresponding	misery	 index	 group,	 which	 ranged	 between	 5	 and	 25.	 An	 outlier	 was	
interpreted	as	the	mean	value	of	one	health	state.	On	average,	the	value	of	11111	was	
around	90,	and	the	value	of	55555	was	around	10,	which	together	represented	the	range	
of	the	values.	The	health	state	values	decreased	along	the	misery	index.	
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The	number	of	observations	for	implausibility	ratings	ranged	from	46	to	73	per	health	
state	except	for	“11111”	and	“55555”,	both	of	which	had	890	observations.	No	health	
state	 was	 rated	 unanimously	 as	 “implausible”	 by	 all	 respondents.	 In	 contrast,	 four	
health	states	had	an	implausibility	score	of	0,	indicating	which	were	universally	rated	as	
plausible	by	all	respondents.	Among	all	3,125	health	states,	910	(29.1%)	health	states	
had	an	implausibility	score	over	0.5.	The	mean	implausibility	score	was	0.386	(SD:0.211).	
Table	1	lists	the	top	10	most	and	least	implausible	states	and	their	mean	VAS	values	(SD)	
for	reference.	The	full	implausibility	score	list	can	be	found	in	the	Appendix.
table 1: Top	10	most	implausible	and	least	implausible	EQ-5D-5L	states.
The	least	implausible	states The	most	implausible	states
Health	
state
Implausibility	
score
Mean	
VAS	value
SD Health	state Implausibility	
score
Mean	VAS	
value
SD
33334 0.000 39.07 20.54 55111 0.932 52.90 17.17
32322 0.000 55.46 17.18 44151 0.930 44.95 17.19
33333 0.000 48.06 14.07 55121 0.927 48.62 14.43
32233 0.000 50.06 19.08 54151 0.926 44.51 14.89
22322 0.000 60.00 14.56 55151 0.924 41.15 16.63
23333 0.017 53.02 15.50 54114 0.907 42.00 14.84
21333 0.017 53.05 17.05 35114 0.907 48.49 15.31
12222 0.019 64.85 17.36 55141 0.889 43.26 15.34
54443 0.019 33.74 15.96 55152 0.889 35.50 13.06
55545 0.020 17.92 14.01 45121 0.885 53.98 14.85
Figure 3: The	implausible	score	of	health	states	over	misery	index
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Figure	3	shows	the	distributions	of	the	implausibility	scores	by	misery	index	using	box	
plots.	It	can	be	observed	that	moderately	impaired	health	states	defined	by	the	misery	
index	were	more	likely	to	be	rated	as	implausible.
table 2:	Odds	ratio	of	5-1	dimension	combinations	on	implausibility
Dimensions	combinations Odds	ratio Standard	error Z P-value
moua 3,525 0,108 40,960 0,000
scua 3,358 0,102 40,010 0,000
pdua 2,631 0,077 33,030 0,000
adua 2,319 0,067 28,960 0,000
uamo 2,305 0,063 30,390 0,000
uasc 2,205 0,061 28,750 0,000
moad 1,798 0,051 20,840 0,000
uaad 1,763 0,049 20,450 0,000
scad 1,637 0,046 17,590 0,000
pdad 1,555 0,043 15,960 0,000
mopd 1,456 0,041 13,390 0,000
uapd 1,450 0,040 13,390 0,000
mosc 1,371 0,039 11,220 0,000
scpd 1,308 0,037 9,580 0,000
pdsc 1,184 0,033 6,100 0,000
pdmo 1,171 0,033 5,650 0,000
scmo 1,169 0,033 5,540 0,000
admo 1,050 0,030 1,750 0,080
adpd 1,047 0,030 1,610 0,107
adsc 1,047 0,029 1,620 0,105
*all 5-1 levels combinations, in each dummy, the former was on 5th level, the latter was 1st level, e.g. ‘moua’ 
is a health state with pattern 5X1XX.
Table	2	shows	the	ranking	of	20	pairs	of	extreme/no	problem	combinations	in	causing	
implausibility.	Some	patterns	can	be	spotted,	for	example,	usual	activities	was	the	most	
prominent	dimension,	 i.e.	extreme	problems	in	other	dimensions	would	always	cause	
problems	 in	 usual	 activities.	 In	 contrast,	 the	 last	 three	 ‘not	 significant’	 combinations	
suggested	 that	 extreme	 anxiety/depression	would	 not	 cause	 a	 problem	 in	 any	 other	
dimension	except	for	usual	activities,	but	not	the	other	way	around:	extreme	problems	
in	other	dimensions	would	cause	anxiety/depression.	
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Figure 4: Histogram	of	 the	mean	VAS	 difference	 (mean	VAS	 value	 plausible	 -	mean	VAS	 value	
implausible)
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Figure	4	 shows	 the	distribution	of	 the	mean	VAS	difference	 (mean	VAS	 value	
plausible
	 -	
mean	VAS	value	
implausible
).	Four	states	were	not	 included	 in	this	analysis	because	of	nil	
implausibility	ratings.	In	general,	the	distribution	was	almost	symmetrical	around	0	with	
more	states	having	higher	mean	VAS	values	based	on	plausible	observations.	The	paired	
t-test	 suggested	 that	 the	mean	VAS	value	based	on	plausible	observations	was	0.911	
higher	than	the	mean	VAS	value	based	on	implausible	observations	(P=0).
5.3.3  thematic  analys is  results
Most	 of	 the	 respondents	 reported	 that	 they	 noticed	 some	 ‘strange’	 states	 and	 the	
values	they	gave	were	vague.	Four	broad	themes	came	up	during	the	thematic	analysis	
regarding	 implausible	 health	 states:	 1)	 reasons	 for	 states	 being	 rated	 as	 implausible,	
2)	difficulties	 in	valuing	 implausible	health	states,	3)	strategies	for	valuing	 implausible	
health	states,	and	4)	values	of	implausible	health	states.	
reasons for  states  being rated as  implausible
Different	 respondents	 interpreted	 EQ-5D	 health	 states	 differently	 and	 had	 different	
judgements	 about	 the	 plausibility	 of	 health	 states.	 For	 example,	 some	 respondents	
reported	 that	 ‘11111’	&	 ‘55555’	were	 implausible	 as	 they	believed	 that	 one’s	 health	
cannot	 be	 perfectly	 good	 or	 extremely	 bad.	 More	 often,	 respondents	 reported	
implausible	health	state	as	having	‘logical	conflict	between	dimensions’.	Within	the	latter	
idea,	the	interpretation	of	relationships	between	dimensions	varied	across	respondents.
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(1)	Mutual	inclusiveness:	some	dimensions	were	deemed	to	cover	other	dimensions.	
For	example,	many	respondents	stated	that	usual	activities	included	mobility	or	
self-care,	so	if	experiencing	mobility	or	self-care	problems,	one’s	usual	activities	
could	not	be	without	any	problem.
(2)	Causality:	a	problem	in	one	dimension	would	certainly	cause	a	problem	in	other	
dimensions.	 Some	 respondents	 followed	 the	 sequence	 of	 the	 five	 dimensions	
and	interpreted	the	sequence	as	a	causality,	e.g.	if	the	first	four	dimensions	had	
no	problems,	then	the	health	state	should	not	have	any	anxiety,	as	it	was	believed	
there	was	no	reason	to	be	anxious	or	depressed	if	one	was	healthy	in	the	first	four	
dimensions.	
(3)	Close	 relatedness:	 some	 dimensions	 were	 deemed	 to	 be	 closely	 related	 (not	
necessarily	 having	 the	 causal	 and	 inclusion	 relationships),	 so	 if	 someone	 had	
problems	in	one	dimension,	they	would	also	experience	some	problems	in	a	related	
dimension.	For	example,	usual	activities	and	self-care	were	perceived	to	be	 two	
closely	related	dimensions	as	they	both	required	individuals	to	use	their	limbs.
Diff icult ies  in  valuing implausible  health states
When	asked	what	kinds	of	problem	respondents	encountered	when	valuing	implausible	
health	states,	they	replied	that	they	were:	
(1)	Reluctant	to	put	more	effort	in	imagining	a	health	state	that	they	could	not	think	
of	/	perceive.	Once	a	respondent	deemed	a	state	to	be	 implausible,	she	or	he	
became	 reluctant	 to	 value	 it	 ‘properly’.	 Other	 respondents	 claimed	 that	 they	
simply	could	not	imagine	implausible	health	states.	
(2)	unable	to	foresee	the	consequences	of	being	in	that	health	state.	Respondents	
reported	that	after	perusing	the	health	states,	they	could	not	think	of	what	the	
impact	of	such	health	states	on	life	would	actually	be.
Strategies  for  valuing implausible  health states
The	strategies	respondents	employed	to	value	implausible	health	states	included:
(1)	To	focus	on	the	severe	dimension:	respondents	focused	on	valuing	the	dimension	
with	the	most	severe	problem.	Respondents	reported	that	they	normally	valued	
one	 dimension	 at	 a	 time,	 starting	 from	 the	 most	 important	 dimension,	 and	
then	perceived	all	dimensions	together	as	a	health	state.	When	two	dimensions	
conflicted,	 they	 focused	more	on	 the	more	 severe	dimension	 and	 valued	 that	
dimension	instead	of	the	whole	health	state.
(2)	Reference	to	a	similar	health	state:	when	valuing	an	implausible	health	state,	they	
referred	to	the	value	of	a	similar	health	state	and	made	some	adjustment	to	that	
value.
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(3)	Rationalize	 the	health	 state:	 respondents	 re-wrote	 the	 severity	 levels	of	 some	
dimensions	 to	 render	 an	 implausible	 health	 state	 plausible.	 For	 example,	 if	
respondents	noticed	that	the	first	four	dimensions	did	not	have	many	problems,	
but	the	last	had	rather	severe	problems,	they	would	assume	that	the	first	four	
dimensions	could	be	affected	by	the	 last	dimension	and	then	value	the	health	
state.
Values of  implausible  health states
The	 valuation	 task	 required	 respondents	 to	 attach	 a	 value	 to	 a	 health	 state.	 Since	
implausible	health	states	imposed	more	difficulty	during	the	thought	process,	we	asked	
respondents	how	they	felt	about	the	values	they	gave	to	implausible	health	states.
(1)	‘Vague’/	‘less	reliable’/	‘just	about	right’:	respondents	suggested	that	the	values	
they	gave	to	implausible	health	states	were	less	precise	compared	to	the	values	
they	gave	to	plausible	health	states.	
(2)	Low:	 most	 respondents	 stated	 that	 they	 felt	 that	 the	 values	 they	 gave	 to	
implausible	health	states	were	lower	than	they	should	have	given.
5 .4 	DISCuSSION
This	is	the	first	study	to	investigate	the	effect	of	implausible	health	states	on	respondents’	
values.	unlike	previous	studies	searching	for	evidence	from	existing	datasets	(67,	88),	this	
study	took	its	point	of	view	from	that	of	its	respondents.	For	convenience	reasons,	we	
used	the	term	‘implausible	health	states’	to	refer	to	those	states	with	high	implausibility	
scores	judged	by	our	student	panel.	It	should,	however,	be	emphasized	from	our	results	
that	 there	was	 strong	heterogeneity	 concerning	 the	 judgement	of	 implausibility,	 and	
there	was	not	one	health	state	that	could	be	deemed	totally	implausible.
In	 summary,	 around	 30%	 of	 the	 3,125	 EQ-5D-5L	 health	 states	 were	 considered	 as	
implausible	by	at	least	half	of	the	sample	(i.e.	an	implausibility	score	>0.5).	From	both	
quantitative	and	qualitative	analysis,	we	observed	that	the	major	reason	for	implausibility	
was	 due	 to	 perceived	 conflicts	 between	 two	 dimensions.	 Thus,	 the	moderate	 health	
states	on	 the	misery	 index	scale	were	more	 likely	 to	be	 judged	as	 implausible	 states,	
as	 health	 states	 in	 this	 range	 could	 have	 some	 extreme/no	 problems	 combinations	
between	dimensions.	By	analyzing	the	extreme/no	problems	combinations,	a	common	
pattern	could	be	found,	such	as	usual	activities	being	more	likely	to	interact	with	other	
dimensions,	 for	 example.	Nevertheless,	 from	 the	 thematic	 analysis,	 respondents	 had	
different	interpretations	concerning	how	EQ-5D	dimensions	interacted	with	each	other.	
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We	found	the	mean	VAS	values	from	plausible	observations	to	be	slightly	higher	than	the	
counterparts	from	implausible	observations,	but	the	difference	did	not	vary	along	the	
severity	scale	nor	among	different	implausibility	scores.	By	reviewing	the	strategies	used	
for	valuing	implausible	states,	two	strategies	could	be	linked	with	the	lower	scores,	i.e.	
focusing	on	the	severe	dimension	and	rewriting	the	health	state.	using	either	strategy,	
respondents	tended	to	pay	more	attention	to	the	severe	part	of	a	health	state.	
using	a	saturated	VAS	dataset,	Yang	et	al	confirmed	that	health	state	selection	strategy	
focusing	 on	 using	 common	 states	 for	 valuation	 led	 to	 large	mispredictions	 for	 other	
states	(15).	Instead,	a	statistically	efficient	design	(i.e.	the	subset	of	health	states	used	for	
direct	valuation)	could	produce	more	accurate	predictions	for	non-valued	health	states.	
As	a	statistically	efficient	design	often	includes	implausible	states,	then	the	trade-off	is	
between	a	statistically	efficient	design	with	some	implausible	states	versus	a	plausible	
states-only	design	with	limited	statistical	efficiency.	If	the	purpose	of	a	valuation	study	
is	to	provide	as	accurate	as	possible	predictions	for	all	defined	health	states,	then	we	
would	 prioritize	 the	 concern	 of	 statistical	 efficiency	 over	 the	 concern	 of	 implausible	
states.	As	the	output	of	design	generators	like	N-gene	could	permit	any	transformation 
of	the	basic	permutation	scheme	from,	for	example,	an	orthogonal	design,	researchers	
could	opt	for	a	variant	with	the	most	plausible	states.
There	are	several	limitations	of	this	study.	First,	instead	of	the	general	population,	our	
respondents	 were	 university	 students.	 Second,	 each	 respondent	 was	 asked	 to	 value	
around	200	health	states	using	EQ-VAS.	The	number	of	health	states	valued	was	much	
higher	than	in	the	standard	valuation	task	using	composite	TTO.	Last,	as	all	respondents	
were	 interviewed	 several	weeks	after	 the	 valuation	 task	and	 the	 implausibility	 rating	
task,	there	could	be	a	recall	bias	and	interviewees	may	mix	the	thoughts	they	had	during	
the	valuation	task	and	implausibility	rating	task. 
5.5	CONCLuSION
To	conclude,	health	states	with	a	logical	conflict	between	dimensions	were	more	likely	
to	be	judged	as	implausible	states.	Health	states	considered	as	implausible	were	more	
difficult	to	value	accurately	and	the	values	from	respondents	who	deemed	certain	states	
implausible	tended	to	be	lower	than	those	from	respondents	who	thought	they	were	
plausible.	Evidently,	respondents	interpreted	health	states	differently,	and	showed	large	
heterogeneity	with	respect	to	views	about	implausible	states.
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5.6	APPENDIx
The	process	of	assigning	EQ-5D-5L	 states	 to	blocks	was	as	 follows:	we	computed	 the	
‘misery	 index’	 of	 all	 EQ-5D-5L	 states,	 as	 the	 sum	of	 the	 five	 digits	 of	 a	 health	 state,	
e.g.	 the	misery	 index	 for	state	 ‘12345’	 is	15.	The	misery	 index	defines	19	strata	 (sum	
score	 ranges	 from	5	 to	 25)	 and	 the	 number	 of	 health	 states	 in	 each	 stratum	differs:	
e.g.	 in	the	stratum	with	misery	 index	6,	there	are	only	5	health	states,	21111,	12111,	
11211,	11121,	11112,	while	in	others	there	might	be	many	more.	From	each	stratum,	
we	randomly	selected	health	states	proportionally	to	the	total	number	of	health	states	
in	that	stratum.	Hence	each	block	contained	similar	numbers	of	health	states	from	each	
stratum,	ensuring	general	severity	balance	across	blocks.
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6.1	 INTRODuCTION
The	EQ-5D	is	a	health-related	quality	of	life	(HRQoL)	questionnaire	widely	used	in	health	
economic,	 clinical,	 and	 population	 health	 studies.	 EQ-5D	 has	 two	 validated	 versions,	
which	 both	 compromise	 five	 dimensions:	 mobility,	 self-care,	 usual	 activities,	 pain/
discomfort	 and	 anxiety/depression,	 the	 three-level	 EQ-5D	 (EQ-5D-3L)	 describes	 each	
dimension	at	three	levels	(roughly	corresponding	to	no,	moderate,	extreme	problems)	
and	 the	 five-level	 EQ-5D	 (EQ-5D-5L)	 expands	 its	 descriptions	 to	 five	 levels	 (roughly	
corresponding	 to	 no,	 slight,	 moderate,	 severe,	 extreme	 problems)	 (9).	 Compared	
to	EQ-5D-3L,	 the	descriptive	richness	of	 the	EQ-5D-5L	 is	an	advantage	when	the	goal	
is	 to	 understand	 the	 health	 state	 of	 a	 respondent,	 but	 potentially	 complicates	 the	
development	of	value	 sets.	Through	a	valuation	 study,	all	health	 state	 ‘values’	 (some	
prefer	‘utilities’	or	‘index	values’)	can	be	derived	from	the	corresponding	value	set.	These	
‘values’	indicate	how	desirable	the	health	states	are.	Performing	such	a	valuation	study	
for	EQ-5D-5L	is	a	challenge	in	terms	of	the	trade-off	between	feasibility	and	validity.	EQ-
5D-5L	defines	3,125	states,	which	ideally	should	all	be	valued,	but	that	is	infeasible	under	
standard	 conditions.	Hence,	 in	 practice,	 only	 a	 subset	 of	 the	health	 states	 is	 directly	
valued,	and	from	this	subset	the	values	of	all	health	states	can	be	estimated	through	
statistical	modelling.	Value	sets	for	SF-6D	and	EQ-5D-3L	have	also	been	developed	using	
this	statistical	modelling	approach	(29).	
Selecting	the	subset	of	health	states	for	direct	valuation	(‘the	empirical	state	set’)	is	an	
important	design	matter	for	valuation	studies	and	it	is	still	evolving.	For	EQ-5D-3L,	the	
Measurement	and	Valuation	of	Health	(MVH)	study	protocol	containing	an	empirical	set	
of	42	EQ-5D-3L	health	states	is	most	widely	used	(60).	Without	applying	explicit	statistical	
considerations,	 the	MVH	 study	 oversampled	mild	 and	 commonly	 seen	 health	 states	
(15).	 For	EQ-5D-5L,	 the	 current	 valuation	protocol	was	built	on	 the	 results	of	 several	
iterative	pilot	studies	(28,	29,	53).	It	was	decided	that	the	number	of	states	in	the	design	
should	be	somewhere	between	80	and	100,	as	the	EQ-5D-5L	main	effects	model	has	21	
parameters	(5	health	dimensions	x	4	dummy	variables	for	severity	levels	+	intercept).	By	
ensuring	that	the	total	number	of	health	states	was	four	times	larger	than	the	number	
of	parameters	in	the	main	effects	model,	multi-level	modelling	could	be	applied,	i.e.	a	
random	coefficient	model	to	account	for	the	effects	of	individual	background	variables	
(53).	Next,	the	number	of	health	states	to	be	valued	by	a	single	respondent	was	maximized	
at	10.	To	arrive	at	around	80	health	states,	a	blocked	design	(10	blocks,	each	block	with	
10	states)	was	utilized,	employing	a	balanced	selection	of	states	with	respect	to	their	
utility	 values.	 Hence	 each	 block	was	 planned	 to	 include	 the	 pits	 state,	 i.e.	 the	most	
severe	health	state:	55555	and	1	of	the	5	very	mild	states:	21111,	12111,	11211,	11121,	
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11112.	This	left	8	unique	states	per	block,	in	total	80	health	states,	to	be	defined;	these	
were	randomly	selected	out	of	the	remaining	3,118	health	states.	The	selection	of	the	80	
health	states	for	the	protocol	was	based	on	Monte	Carlo	simulations	to	predict	the	prior	
values	obtained	from	the	multi-national	pilot	study,	instead	of	choosing	predominantly	
mild	states	(28).	The	‘optimal’	set	of	80	states	was	selected	on	the	mean	squared	error	
(MSE)	between	the	prior	parameters	and	estimated	parameters	 from	a	 ‘main	effects’	
model,	and	level	balance,	but	without	making	orthogonality	an	explicit	criterion	(53).	
using	 an	 EQ-5D-3L	 VAS	 saturated	 dataset	 (a	 dataset	 where	 the	 values	 of	 all	 243	
health	states	are	known),	two	studies	 investigated	the	effect	of	health-state	selection	
on	prediction	adequacy	 (15,	69).	Both	 studies	 found	 that	by	 improving	 the	 statistical	
efficiency	of	the	design,	the	number	of	health	states	in	the	empirical	state	set	in	a	valuation	
study	could	be	reduced	without	loss	of	precision	or	validity	(69,	90).	In	particular,	the	
orthogonal	design	appeared	ideal	as	it	possessed	two	statistical	properties:	level	balance	
and	orthogonality	(i.e.	 level	pair	balance)	 (90).	As	the	EQ-5D-5L	empirical	state	set	of	
86	states	(also	known	as	the	‘EQ-VT	set’)	was	selected	without	constraints	concerning	
orthogonality,	 the	 design	 choice	 of	 EQ-5D-5L	 may	 have	 suffered	 from	misprediction	
effects,	as	found	in	some	design	choices	of	EQ-5D-3L	(90).	
Furthermore,	 while	 larger	 designs	may	 be	 favoured,	 given	 the	 advantages	 that	 they	
offer	in	the	context	of	model	exploration,	we	note	that	published	EQ-5D-5L	value	sets	
have	never	used	models	with	more	than	22	parameters,	leaving	a	surplus	of	64	degrees	
of	freedom	(19).	This	 indicates	that	there	could	be	redundancy	 in	the	current	design,	
but	we	must	proceed	with	caution	when	we	aim	to	 investigate	 this.	 In	EQ-5D-3L,	we	
have	seen	that	a	reduced	design	with	17	states	from	the	original	MVH	design	(42	states)	
introduced	 large	 prediction	 errors	 in	 the	 final	 value	 set	 (90).	 Nevertheless,	 utilizing	
a	 small	design	could	 reduce	 the	cost	of	a	valuation	study	and	 increase	 the	 feasibility	
of	 such	 a	 study	 for	 countries	with	 limited	 resources.	Hence,	 for	 any	 given	 degree	 of	
prediction	 accuracy,	 the	 smallest	 design	 with	 the	 least	 number	 of	 health	 states	 to	
be	directly	 valued	 is	 sought,	 so	 that	 the	 cost	 of	 a	 valuation	 study	 can	be	minimized.	
In	this	paper,	we	revisit	the	EQ-VT	design	through	two	research	questions.	
(1)		Is	there	a	more	efficient	(thus	less	costly)	empirical	set	of	health	states	than	the	
current	86	EQ-VT	set	to	derive	an	equally	valid	EQ-5D-5L	value	set?	
(2)		Since	86	states	in	the	EQ-VT	design	were	divided	into	10	blocks,	and	the	pits	state	
and	5	mild	states	were	over-sampled	given	they	were	in	all	the	blocks,	what	was	
the	impact	on	prediction	performance	of	oversampling	these	particular	states	in	
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the	current	EQ-5D-5L	design?	
To	address	these	questions,	we	collected	values	for	all	3,125	EQ-5D-5L	health	states	in	
a	 dedicated	 direct	 EQ-VAS	 valuation	 study.	 This	 saturated	VAS	 dataset	 enabled	 us	 to	
compare	the	prediction	performance	of	the	86	health	states	subset	with	any	alternative	
subset	of	health	states.	VAS	was	used	in	this	research	for	its	simplicity	and	VAS	values	
served	as	proxies	for	TTO	values.	Even	though	TTO	(a	trade-off	exercise	involving	duration)	
and	VAS	(a	direct	scaling	exercise)	are	two	different	tasks	(91),	they	are	both	used	to	elicit	
cardinal	preference	data	on	the	same	object.	Moreover,	from	past	experience,	we	know	
that	a	VAS	data	set	can	be	close	to	its	TTO	counterpart	(82,	83,	92,	93).	Nevertheless,	the	
results	of	this	research	should	be	seen	in	the	light	of	the	assumption	that	the	selection	
artefacts	are	independent	of	the	valuation	methods	employed.
6 .2 	METHODS
6.2.1  Protocol  to  col lect  the saturated VaS dataset 
The	current	EQ-VT	protocol	requires	each	health	state	to	have	at	least	100	observations	
so	that	the	estimate	of	the	(mean)	value	of	each	health	state	is	sufficiently	precise	(53).	
Adopting	this	sample	size	requirement,	we	obtained	a	saturated	dataset	by	inviting	1600	
university	students	as	respondents,	each	of	whom	provided	VAS	values	for	approximately	
197	 health	 states:	 (1600	 students	 x	 197	 health	 states/respondent)/	 3125	 states	 =	 100	
observations/health	state.	We	divided	3,123	health	states	into	16	blocks	using	a	stratified	
random	 selection	 process	 so	 that	 each	 block	 contained	 around	 197	 states	 (11111	 and	
55555	were	 presented	 in	 all	 blocks).	 For	 details	 of	 the	 data	 collection	 protocol,	which	
aimed	at	an	equivalent	response	burden	across	respondents,	see	the	Appendix.	
We	organized	16	sessions	of	group	interviews.	Around	100	students	were	recruited	to	
participate	in	each	session,	and	each	student	received	a	randomly	chosen	block	of	health	
states.	Each	student	received	100	RMB	(equivalent	of	€15)	as	an	incentive	payment.
6.2.2  tested Designs 
After	we	obtained	the	empirical	values	for	all	3,125	health	states,	we	tested	how	well	
the	EQ-VT	set	with	86	health	states	and	other	candidate	health	state	sets	predicted	the	
values	 for	all	3,125	EQ-5D-5L	health	states.	 In	short:	 subsamples	of	 the	dataset	were	
drawn	to	mimic	the	data	obtained	using	a	particular	design,	then	a	model	was	applied	
to	estimate	all	3,125	health	states,	and	finally	these	predictions	were	compared	with	the	
empirical	values.
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using	the	EQ-VT	86	states	set	as	a	reference	selection,	we	investigated	the	performance	
of	orthogonal,	random	or	D-efficient	designs	of	different	sizes	(number	of	health	states	
in	the	subset).	We	started	the	size	selection	at	25	health	states,	as	this	was	the	smallest	
size	 for	orthogonal	design	 in	a	 five-factor	 five-level	classification	system	(main	effects	
modelling	only).	For	each	design,	size	selections	of	25,	50,	75,	100	and	200	health	states	
were	created.	For	each	design	of	a	different	size,	100	variants	were	produced.	
Both	the	orthogonal	design	and	D-efficient	design	are	standard	design	choices	in	conjoint	
analysis	 and	 both	 designs	 aim	 to	 optimize	 statistical	 efficiency	 (94).	 An	 orthogonal	
design	defines	an	empirical	state	set,	which	satisfies	the	criterion	that	all	severity	levels	
and	all	 severity	 level	combinations	 (to	a	defined	degree	of	 level	 interaction:	2e	or	3e	
etc.	 )	 are	equally	prevalent	and	 therefore	balanced	 (78).	An	orthogonal	design	 is	not	
always	available	as	some	combinations	of	dimension	levels	are	not	feasible	(in	the	case	
of	 EQ-5D,	 the	 combination	 of	 ‘unable	 to	walk’	with	 ‘no	 problems	 in	 usual	 activities’	
appears	to	conflict).	Alternatively,	D-efficient	design	can	be	used.	A	D-efficient	design	
aims	at	minimizing	the	geometric	mean	of	the	eigenvalues	given	|(	x’x)-1|1-p	(94)	from	
the	empirical	state	set,	taking	into	account	level	balance.	Hence,	a	D-efficient	design	is	
efficient	as	the	matrix	of	the	vector	of	parameter	estimates	in	a	least	squares	analysis	is	
proportional	to	|(	x’x)-1|1-p,	which	is	minimized	(94).	In	our	study,	orthogonal	designs	
were	provided	by	N-gene	(36)	and	D-efficient	designs	generated	through	Stata	14.0	by	
selecting	 the	 100	most	D-efficient	 designs	 from	5,000	 random	 candidates.	 The	 Stata	
code	can	be	found	in	the	supplementary	materials.	For	comparison,	we	created	a	series	
of	random	designs,	imposing	the	restriction	that	the	design	should	be	severity	balanced.	
For	this	purpose	we	first	computed	the	‘misery	index’,	that	is	the	sum	score	of	the	digits	
that	 represent	 the	EQ-5D	health	 states:	54321	=	5+4+3+2+1	=	15.	We	 then	classified	
all	 3,125	 states	 into	 five	misery	 index	 groups	 (<=10,	 11-13,	 14-16,	 17-19,	 >=20)	 and	
randomly	selected	health	states	from	each	group.	Hence	across	empirical	sets,	balance	
was	present	in	terms	of	the	number	of	health	states	in	each	of	the	five	‘misery	strata’.	It	
should	be	noted	that	there	are	also	other	designs,	e.g.	Bayesian,	which	take	both	prior	
information	and	statistical	efficiency	into	consideration.
6.2.3  analys is
First,	to	obtain	some	insight	into	the	data,	we	described	the	saturated	dataset	by	plotting	
the	relation	between	the	mean	VAS	values	of	all	health	states	to	their	misery	index	scores	
and	showed	the	distribution	of	all	observations	along	the	VAS	scale.	
The	 performance	 of	 the	 different	 principles	 in	 selecting	 health	 states	was	 quantified	
through	computation	of	the	Root	Mean	Squared	Error	(RMSE)	as	the	primary	measure	
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of	prediction	performance	 (the	higher,	 the	worse	 the	performance).	For	each	design,	
an	 ordinary	 least	 squares	 (OLS)	 main	 effects	 model	 was	 used	 to	 fit	 the	 model	 for	
the	empirical	 data	of	 that	 particular	 design.	 In	 this	 paper,	we	 fitted	 the	model	 using	
individual-level	data	(100	raw	VAS	observations	per	state)	(68-70).	In	the	main	effects	
model,	the	VAS	value	of	a	health	state	was	explained	by	20	dummy	variables	and	one	
intercept.	For	each	dimension	(MO	for	mobility,	SC	for	self-care,	uA	for	usual	activity,	
PD	for	pain/discomfort,	AD	for	anxiety/depression),	four	dummy	variables	were	used	to	
represent	the	deviation	from	level	1	to	the	other	4	levels,	e.g.	MO
3	
takes	1	if	the	health	
state	has	a	problem	in	the	third	level	of	mobility,	and	takes	0	if	otherwise	(68).
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In	the	modelling,	100	observations	per	state	were	used	across	all	design	choices.	This	
meant	 all	 data	 was	 used,	 except	 for	 11111	 and	 55555,	 because	 these	 states	 were	
sampled	in	every	block	of	the	questionnaire.	To	avoid	‘over-weighting’	11111	and	55555,	
the	number	of	observations	was	limited	to	100.	
To	 answer	 our	 first	 research	 question,	 we	 summarized	 the	 RMSE	 of	 all	 designs	
(orthogonal,	random,	and	D-efficient,	all	with	different	sizes	and	100	variants),	using	a	
boxplot	to	combine	the	results	of	the	simulations	per	specific	design.	The	RMSE	of	the	
EQ-VT	design	was	added	in	the	boxplot	as	a	reference.	We	defined	as	the	most	efficient	
design	that	which	systematically	achieved	the	lowest	RMSE	relative	to	sample	size.	The	
most	efficient	design	was	 reported	 in	detail,	with	 further	descriptive	 tables	 including	
comparisons	with	the	EQ-VT	design.	
To	test	our	second	research	question,	we	fitted	the	model	using	weighted	OLS	regression:	
2	times	for	the	5	mildest	states	and	10	times	for	the	pits	state	55555,	as	undertaken	in	
the	EQ-VT	protocol.	The	comparison	was	made	with	the	EQ-VT	design	with	an	equal	100	
observations	for	all	86	states.	Similarly,	we	examined	how	adding	the	5	mildest	states	
and	the	pits	state	in	the	most	efficient	design	identified	from	the	above	analysis	would	
impact	upon	the	misprediction.	In	the	detailed	comparison	of	the	most	efficient	designs,	
we	reported	on	the	RMSE	separately	for	the	empirical	state	set	only,	on	the	validation	
state	set	only,	and	for	all	3,125	states	combined.	We	also	considered	whether	prediction	
error	depended	on	health	 state	 severity.	 For	 this	purpose,	we	categorized	 the	values	
into	10	groups	along	the	VAS	scale:	<30,	>=30	&	<35,	>=35	&	<40,	>=40	&	<45,	>=45	
&	<50,	>=50	&	<55,	>=55	&	<60,	>=60	&	<65,	>=65	&	<70,	>=70.	Finally,	we	estimated	
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the	number	of	health	states	with	large	prediction	errors,	defined	by	the	Absolute	Error	
(AE):	AE>5	&	AE>10.	For	reference,	we	listed	the	following	for	10	random	health	states:	
observed	mean	VAS	values,	standard	error,	95%	confidence	interval,	and	predicted	VAS	
value.
6 .3 	RESuLTS
6.3.1  Descr ipt ion of  the saturated dataset
In	total,	1,603	students	participated	 in	the	study	and	finished	the	valuation	task.	This	
resulted	in	100	observations	for	all	states	except	11111	and	55555,	which	each	had	1600	
observations.	
Figure 1: Empirical	VAS	values	and	mean	VAS	values	of	all	health	states	by	misery	index
The	box	plot	was	sorted	on	the	misery	index	group,	it	should	be	noted	that	one	misery	
index	value	could	result	from	more	than	one	health	state.	The	‘All_observations’	is	based	
on	all	VAS	observations;	the	‘Health_state_mean_VAS_values’	is	based	on	the	mean	VAS	
values	of	health	states.
The	misery	index	for	the	EQ-5D-5L	ranged	from	5	(state	11111)	to	25	(state	55555),	but	
the	number	of	different	health	states	with	the	same	misery	index	ranged	from	1	to	381.	
In	Figure	1,	for	each	misery	index	score	(5-25)	the	following	were	plotted	separately:	(a:	
All_observations)	its	relationship	with	all	VAS	value	observations	of	a	given	misery	index	
(blue	boxplot),	and	(b:	Health_state_mean_VAS_values)	its	relationship	with	the	mean	
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VAS	 value	per	 health	 state	with	 that	misery	 index	 (orange	boxplot).	 For	 comparison,	
we	 put	 (a)	 and	 (b)	 side	 by	 side	 in	 Figure	 1.	 In	 (a)	 an	 outlier	was	 interpreted	 as	 one	
observation,	in	(b)	an	outlier	was	interpreted	as	the	average	value	of	one	health	state.	
On	average,	the	value	of	11111	was	around	90,	and	the	value	of	55555	was	around	10,	
which	together	represented	the	range	of	the	values.	The	health	state	values	decreased	
along	the	misery	index,	as	expected.	Detailed	descriptions	concerning	the	quality	of	the	
saturated	dataset	can	be	found	in	the	Appendix.	
	
6.3.2  Comparison of  design performance
Figure 2: Boxplot	showing	the	variati	ons	of	diff	erent	designs’	Root	Mean	Squared	Error	(RMSE)	of	
the	predicti	ons	for	3,125	health	states
	The	reference	line	is	EQ-VT	design	with	RMSE=3.44.	The	random	design	with	25	states	
was	excluded	due	to	a	large	RMSE.	
We	summarize	design	performance	in	Figure	2	using	boxplots.	The	box	plots	show	the	
median	RMSE	for	designs	of	each	type	and	the	variance	observed	across	the	100	variants.	
The	reference	line	represents	the	EQ-VT	design.	This	design	has	no	variance,	as	it	is	fixed	
by	protocol.	The	EQ-VT	design	performed	well	with	the	RMSE	=	3.44,	but	we	can	also	
note	that	all	the	other	designs	of	the	same	size	performed	even	better.	When	the	sample	
size	was	limited	below	50,	the	orthogonal	design	performed	better	than	the	D-efficient	
and	random	designs.	 In	designs	of	a	size	=	75,	the	orthogonal	and	D-efficient	designs	
performed	 similarly,	 while	 the	 random	 selection	 design	 was	 slightly	 worse.	 Random	
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selection	designs	had	many	more	variations.	Noticeably,	 the	 small	 orthogonal	design	
with	25	states	on	average	performed	about	as	well	as	the	EQ-VT	design.	Other	designs	of	
size	25	performed	poorly.	The	random	designs	with	25	states	were	not	plotted	in	Figure	
4	as	their	RMSE	=7.65	were	beyond	the	range	of	the	Y-axis.	The	D-efficient	design	with	
25	health	states	performed	the	worst	among	all	plotted	designs.	
When	 inspecting	 the	 outlier	 variants	 in	 the	 orthogonal	 design,	 we	 noticed	 that	 the	
outliers	were	mainly	due	to	the	inclusion	of	state	11111.	Given	the	favourable	outcomes	
for	the	small	orthogonal	design,	in	the	following	analysis	we	compared	this	in	detail	with	
the	standard	EQ-VT	design.	
	
table 1:	Root	Mean	Squared	Error	(RMSE)	by	empirical/validation	state	set	for	EQ-VT	design	and	
25	orthogonal	design
No. of 
states
Empirical 
state set
Validation 
state set
All 3,125 states
EQ-VT Protocol (weighted for pits & 5 mildest) 86 2.69 3.69 3.66
EQ-VT Protocol 86 2.65 3.45 3.44
EQ-VT Protocol (excluding pits & 5 mildest) 80 2.39 3.02 3.00
25 orthogonals 25 1.03 3.41 3.40
25 orthogonals (extending pits & 5 mildest) 31 2.61 3.88 3.87
*the italic design was repeated over 100 times.
In	Table	1,	we	report	the	RMSEs	for	the	empirical	health	state	set,	the	validation	health	
state	set,	and	all	health	states	taken	together,	for	the	small	orthogonal	design	and	the	EQ-
VT	design,	and	the	variants	of	both	designs	in	adding/weighting/removing	5	mild	states	
and	the	pits	state.	Excluding	the	5	mildest	states	and	the	pits	state	in	EQ-VT,	or	restricting	
the	design	to	an	orthogonal	design	only,	improved	the	overall	RMSE.	Furthermore,	over-
representing	the	5	mildest	states	and	the	pits	state	following	the	current	EQ-VT	protocol	
increased	the	overall	RMSE.	
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Figure 3: Root	Mean	Squared	Error	(RMSE)	over	VAS	values	for	EQ-VT	design	and	25	orthogonal	design
Figure	3	shows	that	the	EQ-VT	set	predicted	evenly	along	the	scale	when	the	five	mildest	
states	were	 included.	 In	contrast,	 removal	of	 the	5	mildest	states	 from	the	EQ-VT	set	
and/or	restriction	to	only	a	small	orthogonal	design,	improved	the	fit	for	severe	states	
but	increased	mispredictions	for	mild	states.	
Figure 4: Count	of	large	mispredicti	on	errors	(Absolute	Error	>	5,	AE	>	10)	
* random design and orthogonal design with 200 states were added for reference
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Figure	 4	 shows	 that	 large	mispredictions	 occurred	 least	 frequently	 in	 the	orthogonal	
designs,	regardless	of	size.	
table 2: Observed	values	&	predicted	values	for	10	random	health	states
Health state Observed 
value
SE 95% CI Predicted by 
orthogonal* (mean, SE)
Predicted by EQ-VT
21112 73.7 1.5 70.7. 76.6 67.2. 3.1 71.7
13112 68.0 1.6 64.9. 71.1 65.3. 2.9 70.5
23113 61.3 1.5 58.2. 64.3 58.8. 2.6 60.4
25511 51.9 1.8 48.3. 55.4 50.2. 2.5 53.2
14334 43.0 1.8 39.6. 46.5 45.0. 2.1 45.0
44513 41.0 1.5 38.1. 43.9 40.9. 2.3 42.3
13455 35.5 1.7 32.2. 38.8 37.6. 2.0 37.1
24445 35.0 1.6 31.9. 38.0 33.0. 2.0 33.3
45354 30.5 1.5 27.6. 33.3 28.9. 2.1 26.1
55555 14.5 0.4 13.8. 15.2 20.2. 2.3 18.2
CI, confidence interval; SE, standard error.
*for the large orthogonal designs with 100 variants, the averaged predicted means and the SEs were estimated.
Table	2	lists	the	observed	VAS	values	and	predicted	VAS	values	of	a	random	set	of	10	
health	states	with	different	severity	levels.	
6 .4 	DISCuSSION
We	obtained	a	saturated	dataset	that	allowed	for	head-to-head	comparison	of	different	
principles	in	the	selection	of	health	states	in	valuation	studies.	We	found	that	the	EQ-VT	
design	performed	well	in	terms	of	misprediction	effects	measured	by	the	overall	RMSE.	
In	addition,	we	observed	that	designs	with	fewer	states	can	perform	as	well	as	the	EQ-VT	
design	if	they	are	constructed	with	attention	to	their	statistical	properties.	The	orthogonal	
design	with	25	states	performed	closely	to	the	standard	EQ-VT	with	86	states	in	terms	
of	overall	RMSE.	Importantly,	values	generated	on	the	basis	of	a	small	orthogonal	design	
with	25	states	contained	fewer	large	mispredictions	(defined	by	AE>5	&	AE>10)	than	the	
values	generated	on	the	basis	of	the	EQ-VT.	Both	designs	provided	sufficient	prediction	
accuracy,	which	was	below	the	oft-used	minimum	important	difference	(MID)	(80,	95).	
To	answer	our	first	research	question,	the	small	orthogonal	design	with	25	states	was	the	
most	efficient	design	we	identified.
A	caveat	to	the	use	of	the	small	orthogonal	design	lies	in	the	large	mispredictions	in	the	
mild	states	(VAS	value>70)	compared	to	EQ-VT.	There	are	several	possible	explanations	
here.	 First,	 this	 could	 be	 a	 consequence	 of	 under-representing	 the	 mild	 states	 in	
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orthogonal	designs	compared	to	the	EQ-VT	design	(note	that	in	a	small	orthogonal	design	
with	25	states,	only	1	or	no	health	state	is	mild).	Thus,	to	address	our	second	research	
question,	by	 giving	 the	5	mildest	 states	more	weight	 in	 the	blocked	EQ-VT	design	or	
by	extending	a	 small	orthogonal	design	with	 the	5	mildest	 states,	 the	predictions	 for	
mild	states	improved,	at	the	price	of	increased	mispredictions	for	the	moderate/severe	
states.	Second,	we	did	not	take	account	of	the	consideration	that	the	mean	values	for	
mild	states	could	be	seen	as	censored	at	1	(96),	and	that	the	main	effects	model	did	not	
capture	all	effects	on	valuations	(17).	
Moreover,	 the	 models	 that	 we	 used	 could	 introduce	 further	 bias,	 as	 they	 do	 not	
consider	the	possible	heteroskedastic	nature	of	the	data	(96,	97),	i.e.	severe	states	have	
more	variance	than	the	mild	states.	It	is	possible	that	these	issues	also	affect	VAS	data	
differently	than	they	affect	TTO	data,	because	VAS	data	are	characterized	by	relatively	
low	values	for	mild	states,	translating	into	a	large	intercept.	Hence,	while	awaiting	better	
understanding	and	modelling	of	 the	upper	part	of	 the	scale	 in	general,	 consideration	
could	be	given	to	the	use	of	small	orthogonal	designs	extended	with	the	five	mildest	
states	if	the	resulting	values	are	predominantly	used	for	the	‘better’	half	of	the	health	
states.
Another	important	finding	was	that	the	performance	of	the	orthogonal	designs	depended	
on	inclusion	of	state	11111.	Due	to	the	non-additivity	of	domains	in	the	upper	part	of	the	
scale,	a	gap	usually	exists	between	11111	and	all	other	states.	In	this	saturated	dataset,	
the	value	of	11111	was	90.48,	and	the	next	highest	value	was	83.93	for	11121.	Thus,	the	
value	of	the	state	11111	could	not	be	derived	from	the	value	impacts	of	level	1	of	the	
5	dimensions	in	non-11111	states,	and	conversely,	the	impact	of	 level	1	in	general	(in	
non-11111	states)	would	be	mispredicted	if	it	primarily	relied	on	the	empirical	value	of	
11111.	As	the	output	of	design	generators	like	N-gene	could	permit	any	translation	of	
the	basic	permutation	scheme,	researchers	could	opt	for	a	variant	without	state	11111.	
Additionally,	this	upper	gap	issue	(11111	effects)	of	a	VAS	exercise	may	have	disappeared	
in	TTO	data	as	11111	 is	 the	reference	state	 (no	need	to	value	and	have	a	 theoretical	
value	of	1)	and	the	gap	effect	is	then	translated	into	the	model	intercept.
Better	 performance	 for	 statistically	 efficient	 designs	was	 similar	 to	 the	 results	 found	
in	 previous	 EQ-5D-3L	 studies	 (60,	 69,	 90).	 While	 we	 conclude	 that	 in	 using	 a	 main	
effects	model,	an	orthogonal	design	 is	 stable	and	efficient,	 the	D-efficient	design	 is	a	
good	 alternative	 when	 an	 unrestricted	 orthogonal	 design	 is	 deemed	 inapplicable.	
Theoretically,	the	more	the	D-efficient	design	achieves	level	balance	and	orthogonality,	
the	more	efficient	it	is	(94).	Hence,	compared	to	the	orthogonal	design,	which	already	
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optimizes	statistical	efficiency,	D-efficient	design	may	need	more	states	(to	compensate	
for	the	loss	in	efficiency)	in	order	to	achieve	the	same	prediction	accuracy.	Similar	to	EQ-
5D,	the	valuation	of	other	HRQoL	instruments	such	as	SF-6D	and	HuI	may	also	benefit	
from	using	statistically	efficient	designs.	Further	research	is	required.
Some	 general	 limitations	 apply.	 First,	we	 used	 a	 saturated	VAS	 dataset	 to	mimic	 the	
design	choices	in	EQ-5D-5L	valuation	studies	which	use	TTO	as	their	elicitation	method.	
Raw	VAS	values	do	not	have	ratio-properties.	If	we	assume	a	(monotonic)	linear	relation	
between	VAS	and	TTO	(82,	93),	then	we	would	also	expect	our	conclusions	to	be	valid	
for	TTO.	Nevertheless,	it	should	be	noted	that	TTO	data	display	more	heteroscedasticity	
between	states	and	more	heterogeneity	between	respondents,	and	thus	we	may	expect	
to	use	more	states	or	observations	 in	a	TTO	valuation	study.	Second,	 there	may	be	a	
blocking	effect	as	we	divided	all	3,125	states	into	16	blocks	when	collecting	the	saturated	
dataset.	While	 this	 essentially	 suggests	 a	 two-level	 analysis,	 we	 assumed	 there	 was	
no	 such	 effect.	 Third,	we	used	university	 students	 as	 respondents,	who	have	 limited	
experience	 in	 health	 problems	 and	whose	 preferences	may	 be	more	 homogeneous.	
This	may	 have	 led	 to	 smaller	 RMSE	 compared	 to	 studies	 using	 the	 general	 public	 as	
respondents,	but	this	is	a	minor	issue	as	the	purpose	of	this	study	was	to	test	hypotheses	
rather	than	to	generate	value	sets.
Our	results	inspire	faith	in	the	design	of	the	EQ-VT	for	current	EQ-5D-5L	valuation	studies	
(29,	53).	We	noted	that	small	orthogonal	designs	with	25	states	performed	almost	as	well	
as	other	designs	but	produced	biased	estimates	for	mild	states.	Further	research	with	
respect	to	this	phenomenon,	and	strategies	to	avoid	 it,	are	warranted	because	of	the	
potential	benefits	that	can	be	reaped	from	adopting	small	designs.	That	is,	employing	
a	small	orthogonal	design	with	25	states	(or	31,	if	extended	to	add	the	5	mildest	states	
and	the	pits	state)	could	reduce	sample	size	requirements	by	over	50%.	Future	research	
should	also	investigate	the	validity	of	orthogonal	designs	utilizing	TTO	data.	
6 .5 	APPENDIx
6.5.1  appendix  1
We	divided	3,123	health	states	into	16	blocks	using	a	stratified	random	selection	process	
so	that	each	block	contained	around	197	states	(11111	and	55555	were	presented	in	all	
blocks).	The	stratification	was	based	on	health	states’	‘misery	index’:	the	sum	of	the	five	
digits	of	a	health	state,	e.g.	the	misery	index	for	state	‘12345’	is	15.	The	misery	index	
defines	19	strata	(sum	score	ranges	from	5	to	25)	and	the	number	of	health	states	 in	
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each	stratum	differs:	e.g.	in	stratum	with	misery	index	6,	there	are	only	5	health	states,	
21111,	12111,	11211,	11121,	11112,	while	in	others	there	might	be	many	more.	From	
each	stratum,	we	randomly	selected	health	states	proportionally	 to	the	total	number	
of	health	states	in	that	stratum.	Hence	each	block	contained	similar	numbers	of	health	
states	 from	each	 stratum,	ensuring	general	 severity	balance	across	blocks.	using	 this	
design,	each	block	has	196	or	197	health	states.	
For	 the	 purpose	 of	 acquiring	 the	 saturated	 dataset	 we	 condensed	 the	 health	 state	
description.	 To	 achieve	 this,	we	pre-tested	 three	different	 presentations	 of	 EQ-5D-5L	
health	states	in	a	group	of	10	students,	each	of	those	students	valued	24	health	states	in
a.		8	states	with	normal	presentation	(e.g.	I	have	no	problem	walking	about);
b.		8	states	with	bold	font	for	the	severity	level	(e.g.	I	have	no problem	walking	about);
c.		8	 states	 for	 separating	 the	 dimension	 and	 severity	 level	 (Walking	 about---------No	
problem).
Each	 student	 saw	 the	 three	 different	 presentations	 in	 a	 random	 order.	 The	 three	
presentation	 styles	were	 selected	 by	 several	 EuroQol	 scientists.	 After	 that,	we	 asked	
each	student	to	vote	which	presentation	style	he/she	preferred	and	not	preferred,	and	
stated	his/her	reasons.	The	current	version	(c)	received	most	votes,	6	out	of	8	students	
preferred	presentation	style.	When	we	introduced	the	idea	of	valuing	around	200	states	
for	 the	 formal	 task,	 all	 students	 agreed	 that	 the	 chosen	presentation	 style	will	make	
the	task	simpler	as	it	is	easier	to	capture	the	information.	Figure	1	shows	an	example	of	
health	state	‘13542’	in	English	(the	original	questionnaire	was	in	Chinese)
Figure 1. An	example	of	the	health	states	presentati	on	used	in	this	study
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During	 the	 formal	 data	 collection,	 all	 students	 reported	 their	 health	 states	 using	 the	
traditional	style	of	EQ-5D	health	states	before	valuing	the	modified	ones.	At	this	step,	we	
briefed	the	students	about	the	difference	in	wording	between	the	traditional	wording	
and	the	modified	wording	and	stated	that	they	are	the	same.	In	case	of	confusing,	the	
students	 could	 always	 turn	 to	 the	 first	 page	 of	 questionnaire	 to	 see	 the	 traditional	
wording.
To	understand	the	effect	of	changing	wording,	we	graphed	the	values’	relationship	of	
86	 EQ-VT	design	 states	 between	2012	Chinese	 valuation	 study	 and	our	 study.	 In	 the	
figure	below,	the	y-axis	is	the	mean	TTO	values	for	86	states	from	2012	Chinese	valuation	
study,	which	followed	the	EuroQol	protocol	of	valuation	studies;	the	x-axis	is	the	mean	
VAS	values	for	the	same	86	states	from	our	study.	Between	those	two	studies,	several	
differences	existed:	a.	general	public	from	five	cities	versus.	students	from	one	university;	
b.	TTO	method	versus.	VAS	method;	c.	traditional	wording	versus.	modified	wording;	d.	
data	collected	 in	2012	versus.	data	collected	 in	2016.	Despite	all	 the	differences,	 the	
values	 from	 those	 two	 studies	 showed	 good	 linear	 relationship,	 which	 indicates	 the	
validity	of	our	dataset.	
Figure 2. Relati	onship	between	2012	Chinese	TTO	values	and	this	study’s	VAS	values
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The	questionnaires	 had	 three	 sections	 in	 the	 following	 order:	 1)	 questions	 to	 collect	
background	 information	on	 respondents,	 including	 self-report	EQ-5D-5L	health	 status	
and	EQ-VAS	of	the	respondent’s	own	health	state;	2)	VAS	valuations	of	11111	and	55555	
on	one	page;	3)	VAS	valuations	of	all	the	other	200	health	states	in	the	block,	10	states	
per	page,	presented	in	a	random	order	per	block.	An	EQ-VAS	scale	was	always	visible	
for	sections	2	and	3.	The	EQ-VAS	is	a	20cm	vertical	scale	from	0	to	100,	with	endpoints	
labelled	‘the	best	health	you	can	imagine’	and	‘the	worst	health	you	can	imagine’.	The	
respondents	 were	 instructed	 to	 use	 the	 EQ-VAS	 scale	 to	 value	 each	 health	 state	 by	
writing	down	the	VAS	value	beside	each	health	state.	Respondents	were	encouraged	to	
use	different	numbers/values.
6.5.2  appendix  2:  Detai ls  descr ipt ions  of  the saturated data
The	 average	 time	 to	 complete	 the	 valuation	 task	was	 65	minutes	 (range:	 23	 to	 180	
minutes).	On	average,	the	students	were	21	years	old	and	62%	were	female.	All	students	
had	a	health-related	education	background,	such	as	pharmacy,	health	law	etc.
Figure 3. The	count	of	observed	values	for	all	respondents	and	health	states.
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As	can	be	seen	 from	Figure	3,	which	shows	 the	distribution	of	all	observations	along	
the	 VAS	 scale,	 values	 covered	 the	whole	 VAS	 scale,	with	 signs	 of	 digit	 preference	 (a	
preponderance	of	5s	and	10s).	The	distribution	is	skewed	to	the	left,	with	few	observations	
beyond	80.	On	average,	each	respondent	used	45	distinct	values	(standard	deviation:	12)	
for	the	200	states	of	the	valuation	task;	the	minimum	and	maximum	number	of	different	
values	recorded	were	6	and	80	respectively.
We	examined	the	logical	inconsistency	for	each	respondent,	and	identified	all	inconsistent	
observations.	In	total,	30%	of	the	data	had	at	least	1	inconsistency.	To	see	the	effect	of	
removing	the	illogical	observations	we	made	the	comparison	below.	The	first	Table	was	
used	for	the	manuscript	without	excluding	the	illogical	observations	while	the	second	
Table	 was	 the	 results	 excluding	 the	 illogical	 observations.	 Nevertheless,	 we	 did	 not	
exclude	any	 inconsistent	observations	 for	 several	 reasons:	 first,	excluding	 the	 illogical	
observations	 seems	 increase	 the	 prediction	 errors	 proportionally	 across	 all	 designs;	
second,	excluding	 illogical	observations	affect	more	 for	 the	 small	design	 (orthogonal)	
compared	 to	 the	 large	 design	 (EQ-VT).	 This	 is	 reasonable	 as	 in	 the	 small	 design,	 the	
regression	 results	 relied	 more	 on	 each	 observation;	 third,	 similarly	 like	 the	 second	
reason,	some	health	states	may	have	more	illogical	observations,	as	a	result,	we	cannot	
say	that	for	each	health	states,	there	are	100	observations;	fourth,	as	this	valuation	task	
is	done	in	a	non-standard	way	(200	states/respondent	etc.),	it	is	difficult	to	find	a	criteria	
to	 exlude	 illogical	 observations.	 Additionally,	 the	 current	 EuroQol	 valuation	 protocol	
did	not	make	suggestions	on	this	issue,	different	researchers	used	different	criteria	to	
exclude	data.		
table 1.	Root	Mean	Squared	Error	(RMSE)	by	empirical/validation	state	set	for	EQ-VT	design	and	
25	orthogonal	design
Number of 
health states
RMSE for 
empirical 
state set
RMSE for 
validation 
state set
RMSE for all 
3,125 health 
states
EQ-VT Protocol (weighted for pits & 5 mildest) 86 2.69 3.69 3.66
EQ-VT Protocol 86 2.65 3.45 3.44
EQ-VT Protocol (excluding pits & 5 mildest) 80 2.39 3.02 3.00
25 orthogonals 25 1.03 3.41 3.40
25 orthogonals (extending pits & 5 mildest) 31 2.61 3.88 3.87
*the italic design was repeated over 100 times
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table 2. Root	Mean	Squared	Error	(RMSE)	by	empirical/validation	state	set	for	EQ-VT	design	and	
25	orthogonal	design	after	removing	logical	inconsistent	observation
Number of 
health states
RMSE for 
empirical 
state set
RMSE for 
validation 
state set
RMSE for all 
3,125 health 
states
EQ-VT Protocol (weighted for pits & 5 mildest) 86 4.67 5.01 5.00 
EQ-VT Protocol 86 4.67 5.02 5.01 
EQ-VT Protocol (excluding pits & 5 mildest) 80 4.68 4.92 4.92 
25 orthogonals 25 4.62 5.20 5.20 
25 orthogonals (extending pits & 5 mildest) 31 4.66 5.38 5.37 
*the italic design was repeated over 100 times 
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7.1	 INTRODuCTION	
To	 estimate	 an	 EQ-5D-5L	 value	 set,	 the	 EuroQol	 Group	 developed	 a	 standardized	
EuroQol	Valuation	Technology	(EQ-VT)	protocol	(28).	The	design	of	the	EQ-VT	protocol	
includes	the	selection	of	86	different	EQ-5D-5L	states.	These	86	states	are	arranged	into	
10	blocks	of	10	health	states	for	the	composite	TTO	(cTTO)	task.	To	achieve	adequate	
precision	of	the	mean	values,	it	was	decided	each	block	should	have	100	observations.	
The	optimal	 sample	 size	was	estimated	 to	be	around	1000	 respondents	=10	blocks	x	
100	 observations/block	 (29,	 53).	With	 this	 design,	 EQ-5D-5L	 value	 sets	 for	 at	 least	 7	
countries	were	established	and	published	(9,	16-22),	with	more	country	studies	currently	
underway.	
The	choice	of	86	states	for	direct	valuation	through	cTTO	rested	on	the	considerations	
of	 robustness,	 requiring	 that	 each	 parameter	 be	 derived	 from	 multiple	 stimuli.	
Furthermore,	it	would	enable	some	interaction	terms	to	be	included	in	the	regression	
model	while	still	allowing	for	1	degree	of	freedom	per	parameter.	However,	the	latter	
consideration	no	longer	carries	much	weight,	as	practical	experience	and	results	from	
a	number	of	simulations	suggest	that	the	‘main	effects’	model	with	21	parameters	(5x4	
dummy	variables	+	intercept)	performs	well	(16,	96),	leaving	a	surplus	of	65	degrees	of	
freedom	(DF).	The	reduced	need	for	a	large	design	has	raised	the	question	whether	a	
small	design	can	be	used	to	promote	the	feasibility	of	a	valuation	study.	An	important	
criterion	in	adopting	a	small	design	is	that	the	modelling	results	of	a	small	design	should	
not	compromise	prediction	accuracy	at	an	unacceptable	level.	
Two	recent	studies	have	addressed	the	impact	of	design	size	and	the	approach	to	design	
generation	on	the	accuracy	of	predicted	values,	using	saturated	EQ-5D-5L	visual	analogue	
scale	(VAS)	valuation	datasets	(30,	98).	A	saturated	dataset	contains	observed	VAS	values	
for	EQ-5D-5L	states,	allowing	predictive	errors	associated	with	different	designs	to	be	
quantified.	The	research	strategy	taken	in	these	studies	was	that	a	subset	of	health	state	
values	was	modelled	to	estimate	the	value	set,	and	from	that	value	set,	predicted	values	
were	 estimated	 and	 compared	 with	 the	 empirical	 values.	 The	 results	 suggested	 the	
current	EQ-VT	performed	well	among	different	design	choices,	but	it	is	worth	noting	that	
the	orthogonal	design	with	only	25	health	states	performed	as	well	as	the	EQ-VT	design	
assuming	the	‘main	effect’	model	to	be	sufficient.	One	shortcoming	of	the	orthogonal	
design	was	that	it	had	larger	mispredictions	for	the	mild	states	compared	to	the	EQ-VT	
design	 (12).	 Similar	 to	 the	 five-level	 EQ-5D,	 a	 study	 comparing	 design	 choices	 in	 the	
three-level	EQ-5D	VAS	saturated	dataset	also	indicated	the	superiority	of	the	orthogonal	
design	(90).	
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A	limitation	of	the	above-mentioned	studies	 is	that	VAS	was	used	to	collect	observed	
values.	Generalizability	of	the	results	to	valuation	data	collected	using	the	cTTO	method	
is	an	open	question.	VAS	values	have	a	different	distribution	compared	to	cTTO	values.	
For	example,	VAS	values	do	not	display	the	relatively	linear	heteroscedasticity	typically	
observed	 in	 TTO	 values.	 Also,	 a	 property	 of	 VAS	 is	 ‘end	of	 scale	 aversion’.	While	 the	
maximum	 attainable	 score	 is	 100,	many	 people	 hesitate	 to	 assign	 such	 a	 high	 score	
to	 any	 state.	 It	 is	 unclear	whether	 this	 phenomenon	 partially	 accounts	 for	 the	 large	
mispredictions	around	mild	states.	In	this	study,	we	aim	to	investigate	whether	a	small	
design	can	be	used	for	EQ-5D-5L	valuation	using	cTTO,	without	increasing	mispredictions	
in	any	part	of	the	severity	scale	to	an	unacceptable	level.	
7 .2 	METHODS
7.2.1  Strategy
We	collected	TTO	data	for	three	designs	with	500	students.	Three	designs	were	divided	
into	 five	 blocks	 and	 distributed	 across	 the	 respondents	 ensuring	 a	minimum	 of	 100	
observations	per	block.	Each	student	valued	1	block	of	30	EQ-5D-5L	health	states.	By	
design,	we	modelled	the	observed	TTO	data	to	predict	values	for	all	possible	EQ-5D-5L	
health	states.	The	predictive	accuracy	of	the	design	was	compared	with	the	observed	
values	in	calculating	the	root	mean	squared	error	(RMSE).
7.2.2  Experimental  designs
The	study	comprised	three	designs	that	differed	in	terms	of	health	states	included	(see	
the	Appendix	for	the	health	states	in	each	design):	
-	 The	EQ-VT	design	including	86	health	states
-	 An	orthogonal	design	including	25	states	
-	 A	Bayesian-efficient	design,	including	25	states.	
The	 design	 of	 EQ-5D-5L	 valuation	 studies	 has	 been	 standardized	 across	 countries.	 It	
includes	a	TTO	task	for	86	EQ-5D-5L	states.	We	refer	to	this	set	as	the	‘EQ-VT	design’.	
Oppe	et	al	provided	a	detailed	description	of	the	TTO	task	in	EQ-5D-5L	valuation	studies	
(29).	Briefly,	the	selection	of	the	80	health	states	for	the	protocol	was	based	on	Monte	
Carlo	simulations	in	predicting	the	prior	values	obtained	from	the	multi-national	pilot	
study	(28).	In	total	10,000	EQ-VT-like	sets	of	80-state	designs	were	created.	The	‘optimal’	
set	 was	 kept	 as	 the	 final	 design	 for	 EQ-VT	 based	 on	 the	mean	 squared	 error	 (MSE)	
between	the	prior	parameters	and	estimated	parameters	from	a	‘main	effects’	model,	
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and	level	balance	(53).	Six	states	were	manually	selected:	the	worst	EQ-5D-5L	state	and	
the	five	mildest	states	(i.e.	state	55555,	21111,	12111,	11211,	11121,	11112)	to	arrive	at	
a	total	of	86	states.		
An	orthogonal	design	was	generated	by	assigning	dimensions	and	levels	defined	by	EQ-
5D-5L	to	a	pre-existing	orthogonal	array.	For	EQ-5D-5L	an	orthogonal	main	effects	design	
mathematically	contains	a	minimum	of	25	states.	A	theoretical	advantage	of	orthogonal	
designs	 is	 that	 the	absence	of	 correlations	between	dimensions	offers	 a	 strong	basis	
for	 decomposing	 the	 observed	 values	 to	 underlying	 dimension	 severity	 levels	 under	
the	assumption	that	the	model	is	specified	correctly.	Orthogonal	designs	are	also	level	
balanced,	i.e.	each	level	occurs	equally	often	within	each	dimension.	In	this	study,	we	
used	the	best	performing	orthogonal	design	from	the	previous	VAS	saturated	study,	in	
which	100	variants	of	orthogonal	designs	were	created	and	tested	with	respect	to	their	
prediction	performances	for	all	3,125	EQ-5D-5L	states	(98).	To	account	for	the	above-
mentioned	 issue	 concerning	 the	 prediction	 of	 values	 for	 mild	 states	 in	 orthogonal	
designs,	the	five	mild	states	were	added	to	the	orthogonal	array.	The	performance	of	
the	design	was	investigated	with	and	without	the	five	mild	states.	
In	Bayesian-efficient	designs,	prior	information	of	the	model	parameter	estimates	(the	
coefficients	with	their	uncertainty)	guides	the	selection	of	states.	unlike	the	orthogonal	
design	with	a	 fixed	number	of	states,	the	minimum	number	of	states	 in	the	Bayesian	
design	 depends	 on	 the	 required	 degrees	 of	 freedom.	 Furthermore,	 the	 design	 can	
be	 generated	 subject	 to	 constraints,	 for	 example,	 to	 avoid	 implausible	 combinations	
between	dimensions	or	to	include	the	mildest	states	(4	level	1,	1	level	2)	in	the	design.	
Hence	the	Bayesian	design	is	more	flexible	if	constraints	are	considered.	We	developed	
a	 Bayesian-	 efficient	 design	 using	 previous	 Chinese	 valuation	 data.	 For	 comparison	
reasons,	the	number	of	unique	states	sampled	for	the	design	was	set	at	25	and	the	5	
mild	states	were	added	for	a	total	of	30	states.	Performance	criteria	were	D-error,	level	
balance,	mean	absolute	error	(MAE)	using	the	Chinese	published	value	set	(9),	and	MAE	
on	the	Chinese	VAS	saturated	dataset	(98).
7.2.3  Blocking 
The	set	of	136	(86+	25+	25	states)	health	states	was	divided	into	5	blocks.	The	EQ-VT	
design	was	divided	 into	3	blocks.	To	arrive	at	 the	 same	block	 size	of	30,	 some	states	
were	duplicated	across	blocks:	each	block	containing	55555	and	at	least	2	of	the	mildest	
states.	The	orthogonal	design	and	the	Bayesian	design	each	formed	one	independent	
block	of	30	states.	Each	respondent	valued	one	block.
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7.2.4  Interviewers  & respondents
Following	 sample	 size	 considerations	 explained	by	Oppe	et	 al	 (28),	we	 collected	TTO	
values	 for	 the	 5	 blocks	 of	 health	 states	 from	 N=500	 university	 students	 of	 Guizhou	
Medical	 university,	 China.	 A	 student	 sample	 was	 used	 in	 consideration	 of	 the	 large	
number	of	health	states	to	be	valued	(30	states	per	block)	being	over-demanding	for	a	
general	population	sample.	
Data	 were	 collected	 by	 7	 interviewers,	 facilitated	 by	 1	 respondent	 coordinator,	 who	
were	senior	students	from	Guizhou	Medical	university,	China.	Before	data	collection,	all	
interviewers	 including	the	coordinator	received	3	days’	training	regarding	background	
knowledge	of	the	QALY,	EQ-5D,	and	EQ-VT,	to	help	them	understand	the	context	of	the	
TTO	questions.	For	 the	 interview	 location,	we	rented	4	offices	 from	Guizhou	Medical	
university	and	set	up	2	interview	stations	in	each	office.	Each	interviewer	was	assigned	to	
a	fixed	interview	station	and	all	interviews	were	conducted	at	the	interview	station.	The	
recruitment	advertisement	was	circulated	to	university	students	through	e-mails,	and	
interested	respondents	could	contact	 the	coordinator.	The	coordinator	 then	arranged	
appointments	for	the	interviewers	and	respondents.	Each	respondent	was	paid	100	RMB	
(equivalent	to	14	euros)	upon	successful	task	completion.	
All	 interviews	were	conducted	using	EQ-PVT,	which	is	a	PowerPoint	replica	of	the	EQ-
VT	software,	and	was	obtained	from	the	EuroQol	Research	Foundation.	There	were	3	
steps	in	each	interview.	First,	the	background	of	the	study	was	introduced,	and	informed	
consent	was	obtained	orally	before	the	interview,	with	the	respondent	being	requested	
to	sign	a	sheet	 indicating	consent	to	participate	 in	the	study.	Second,	the	respondent	
provided	 background	 information	 and	 reported	 his/her	 health	 state	 using	 EQ-5D-5L.	
Third,	36	health	states	including	3	wheelchair	examples,	3	practice	EQ-5D	states	and	a	
randomly	selected	block	of	30	EQ-5D	states	were	valued	through	a	face-to-face	interview.	
Following	EQ-VT	protocol	V1.1,	each	respondent	was	familiarized	with	the	TTO	task	using	
3	wheelchair	example	states	(wheelchair,	a	situation	worse	than	a	wheelchair,	a	situation	
better	 than	a	wheelchair),	and	3	examples	of	EQ-5D-5L	states	 (21121,	35554,	15411)	
(99).	The	3	wheelchair	examples	were	used	to	familiarize	respondents	not	only	with	the	
cTTO	approach	in	general,	but	also	to	introduce	them	to	the	procedure	by	which	they	
would	value	a	health	state	as	worse	than	death.	The	3	practice	states	were	selected	to	
represent	different	severity	levels	(21121=mild,	35554=severe,	15411=moderate)	of	EQ-
5D-5L	states.	No	feedback	or	debriefing	module	was	provided	to	the	respondents.	
Interviews	were	conducted	in	accordance	with	current	EQ	guidelines	for	quality	control	
(QC)	as	reported	by	Ramos	Goni	et	al	(2017).	QC	reports	indicating	protocol	compliance	
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and	 presence	 of	 interviewer	 effects	 were	 sent	 to	 interviewers	 every	 3	 days,	 with	
individual	suggestions	on	how	to	improve	interview	performance,	if	necessary.	
7.2.5  Data analys is
The	data	were	analyzed	by	design,	using	2	different	model	specifications	plus	2	different	
standard	error	specifications,	based	on	the	original	set	(25	states)	or	the	extended	set	(30	
states).	Both	extending	the	original	set	with	the	5	mildest	states	and	testing	the	standard	
error	specifications	were	explored	to	resolve	the	large	misprediction	issue	found	in	the	
VAS	study.	For	model	specifications,	we	compared	the	performance	of	a	20-parameter	
additive	model	(Equation	1)	and	an	8-parameter	multiplicative	model	(Equation	2).	For	
the	20-parametes	additive	model,	cTTO	utility	was	explained	by	20	dummy	variables	and	
1	intercept.	For	each	dimension	(MO	for	mobility,	SC	for	self-care,	uA	for	usual	activity,	
PD	 for	pain/discomfort,	AD	 for	anxiety/depression),	4	dummy	variables	were	used	 to	
represent	the	disutility	from	level	1	to	the	other	4	levels,	e.g.	MO
3	
took	1	if	the	health	
state	had	a	problem	in	the	third	level	of	mobility,	and	0	if	otherwise	(68).
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The	8-parameter	multiplicative	model	 is	a	variant	of	the	20-parameter	model.	 It	rests	
on	 the	 assumption	 that	 the	 relative	 distance	 between	 levels	 is	 the	 same	 across	 all	
dimensions	 (34).	 In	 this	model,	 5	 dimension	 parameters	were	 used	 to	 represent	 the	
disutility	of	having	problems	at	level	5	on	each	dimension	(β
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β
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β
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and
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);	a	set	
of	scalars	L2-L4	(i.e.	 level	parameters)	was	estimated	to	identify	where	the	cut-offs	of	
the	intermediate	levels	were	located,	subject	to	the	constraint	that	the	relative	distance	
between	levels	was	constant	across	all	dimensions.	Thus,	the	absolute	amounts	of	the	
utility	of	the	dimension	severity	levels	were	computed	by	multiplying	the	relevant	scalar	
L2-L4	with	the	dimension	weights.	For	example,	the	disutility	of	level	4	on	anxiety	was	
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Rand-Hendriksen	et	al	reported	no	difference	in	performance	in	terms	of	out-of-sample	
predictions	 between	 the	 8-	 and	 20-parameter	 models	 on	 Spanish,	 Singaporean	 and	
Chinese	EQ-5D-5L	valuation	data	(34).	The	8-parameter	model	required	fewer	degrees	of	
freedom	compared	to	the	20-parameter	model	and	perhaps	a	better	model	specification	
for	small	designs.	To	address	the	question	with	respect	to	misprediction	of	the	values	
for	mild	states,	we	ran	these	models	by	using	3	designs	with	and	without	the	5	mildest	
states,	 and	 under	 either	 the	 assumption	 of	 homoscedasticity	 (random	effect	 general	
linear	squared)	or	of	heteroscedasticity	(heteroscedastic	regression).	
To	 judge	 design	 performance,	 we:	 (i)	 predicted	 health	 states’	 values	 by	modelling	 3	
designs	respectively	and	computed	the	RMSE	within	the	design/RMSE	across	designs;	(ii)	
compared	the	similarity	of	coefficients	between	designs;	(iii)	compared	the	RMSE	along	
the	misery	indices	to	see	whether	the	mispredictions	depended	on	health	state	severity.	
The	misery	index	is	the	sum	of	5	digits	of	an	EQ-5D	health	state	(e.g.	the	misery	index	of	
state	13255	=	1	+3	+2	+5	+5	=	16)	and	was	used	a	proxy	for	health	states’	severity	levels.	
Considering	that	we	had	multiple	models/designs	for	the	results,	we	reported	the	RMSE	
results	first	and	then	only	the	best	model	for	the	subsequent	analysis.	Additionally,	we	
provided	the	observed	values	and	predicted	values	of	10	states	for	reference.	
7 .3 	RESuLTS
7.3.1  raw data
In	total	557	interviews	were	completed.	For	quality	reasons,	the	first	32	interviews	of	
an	 interviewer	 were	 dropped	 and	 after	 retraining,	 this	 interviewer	 re-conducted	 32	
interviews	with	new	respondents.	Data	for	the	first	unqualified	32	interviews	were	not	
analysed.	On	average,	respondents	spent	46	minutes	(SD:	14	minutes)	and	7.89	moves	
(SD:	2.11	moves)	on	 the	valuation	 task,	 including	6	practice	 states.	The	average	 time	
to	complete	a	single	TTO	task	was	56.9	seconds	for	non-practice	states.	The	observed	
values	for	all	health	states	can	be	found	in	the	appendix.	The	highest	mean	value	was	
0.950	for	state	12111,	and	the	 lowest	mean	value	was	 -0.719	for	state	55555.	 	More	
severe	states	had	larger	standard	deviations.
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Figure 1: TTO	values	distribution	across	three	designs
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Figure	 1	 showed	 similar	 data	 distributions	 for	 the	 EQ-VT	 design	 and	 the	 orthogonal	
design,	while	 the	 Bayesian	 design	 had	 fewer	 observations	 clustering	 at	 -1,	 but	more	
observations	clustering	at	0.95.	
7.3.2  model l ing & Predict ion performance
table 1:	RMSE	full	results
Model All EQ-VT Orthogonal+5 Orthogonal Bayesian+5 Bayesian
# Health states 146 86 30 25 30 25
Multiplicative 0.051 0.053 0.066 0.067 0.063 0.067
GLS additive 0.049 0.053 0.069 0.069 0.063 0.095
Hetero additive 0.051 0.054 0.064 0.072 0.065 0.092
Table	1	 indicates	that	the	EQ-VT	design	performed	better	than	the	2	small	designs	 in	
terms	of	 overall	 RMSE	 (0.053).	 The	 choice	of	model	 specification	 and	 standard	error	
specification	did	not	impact	much	on	the	RMSE	results.	Notably,	extending	the	5	mildest	
states	lowered	the	overall	RMSE	for	the	Bayesian	designs	(from	0.095	to	0.063),	but	not	
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for	the	orthogonal	design	(0.066	versus	0.067).	Next,	we	report	the	results	of	3	designs	
using	 the	 8-parameter	multiplicative	model	with	 the	 5	mildest	 states	 extended	 for	 2	
small	designs.
table 2: Multiplicative	regression	model	output	&	RMSE	results	
Bayesian	+	5	mildest	
states
Orthogonal	+	5	mildest EQ-VT
#Health	states 30 30 86
Constant 0.961
(0.920, 1.002) 
0.943
(0.904, 0.983) 
0.992
(0.961, 1.023) 
Mobility -0.280 
(-0.335, -0.225)
-0.363 
(-0.402, -0.325)
-0.296
(-0.320, -0.272) 
Self-care -0.207
(-0.254, -0.161) 
-0.270
(-0.309, -0.232) 
-0.244
(-0.269, -0.219) 
Usual activities -0.275
(-0.314, -0.235) 
-0.330
(-0.368, -0.291) 
-0.294
(-0.319, -0.268) 
Pain/discomfort -0.425
(-0.464, -0.385) 
-0.356
(-0.395, -0.317) 
-0.404
(-0.430, -0.379) 
Anxiety/depression -0.322
(-0.359, -0.284) 
-0.413
(-0.452, -0.374) 
-0.428
(-0.453, -0.402) 
Level 2 0.127
(0.065, 0.188) 
0.036*
(-0.017,0.089) 
0.115
(0.077, 0.152) 
Level 3 0.316
(0.261, 0.370) 
0.258
(0.211, 0.304) 
0.293
(0.259, 0.326) 
Level 4 0.845
(0.778, 0.913) 
0.674
(0.621, 0.726) 
0.780
(0.748, 0.812) 
RMSE for empirical state set 0.024 0.036 0.051
RMSE for validation state set 0.070 0.072 0.054
RMSE for all states 0.063 0.066 0.053
*not significant on 0.05 level
Table	2	shows	the	regression	output	of	the	8-parameter	model.	In	general,	the	Bayesian	
design	had	the	largest	level	parameters	(L2,	L3	and	L4)	and	the	orthogonal	design	had	the	
smallest	level	parameters.	95%	confidence	intervals	did	not	overlap	for	the	dimension	
parameters	of	Mobility	 (EQ-VT	vs	orthogonal)	and	Anxiety	 (Bayesian	vs	orthogonal	&	
EQ-VT),	and	the	level	parameter	of	level	4	(orthogonal	vs	EQ-VT	&	Bayesian).	In	terms	
of	RMSE,	small	designs	had	better	predictions	for	the	empirical	state	set	than	the	EQ-VT	
design.	EQ-VT	had	the	lowest	RMSE	for	all	states	(0.053)	and	RMSEs	of	two	small	designs	
did	not	differ	much	(0.069	versus	0.063).
All	3	designs	performed	similarly	 in	mild	states	 (i.e.	with	a	maximum	misery	 index	of	
13).	 The	EQ-VT	design	performed	evenly	 along	 the	 scale	except	 for	 group	23,	 and	 in	
that	 group,	 only	 1	 state	presented	 in	 our	 dataset,	 i.e.	 55535,	which	belonged	 to	 the	
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orthogonal	design.	The	predicted	value	 for	55535	using	 the	EQ-VT	design	was	 -0.343	
while	the	actual	value	observed	was	-0.617.	The	orthogonal	design	performed	worse	in	
the	2	misery	index	groups	14	and	17,	while	the	Bayesian	design	did	not	perform	well	in	
the	severe	part	of	the	scale	(misery	index>20).	
table 3:	Observed	values	&	predicted	values	for	10	random	health	states	
Health	
states
Observed	
value
Standard	
error
Lower	
95%CI
upper	
95%CI
Predicted	by	
EQ-VT
Predicted	by	
Orthogonal	+5
Predicted	by	
Bayesian	+5
11221 0.915 0.007 0.901 0.930 0.912 0.916 0.847
12324 0.502 0.038 0.427 0.578 0.498 0.557 0.518
24422 0.437 0.035 0.368 0.505 0.443 0.498 0.421
31514 0.362 0.040 0.283 0.441 0.278 0.241 0.324
34234 0.311 0.041 0.230 0.392 0.229 0.286 0.263
43154 -0.017 0.050 -0.115 0.082 -0.048 -0.005 -0.034
43542 -0.009 0.055 -0.117 0.010 0.032 0.045 -0.006
44355 -0.365 0.048 -0.461 -0.269 -0.347 -0.336 -0.271
55424 -0.259 0.056 -0.370 -0.147 -0.157 -0.203 -0.073
55535 -0.617 0.041 -0.699 -0.536 -0.387 -0.524 -0.239
Figure 2:	RMSE	of	three	designs	over	severity	scale
*In the bracket aft er each misery index group shows the number of health states in that group
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7.4	DISCuSSION
This	study	built	on	the	previous	EQ-VAS	study,	in	which	we	found	that	statistically	efficient	
small	 designs	 could	 be	 used	 for	 valuation	 studies	 without	 compromising	 prediction	
accuracy	(98).	Similar	to	the	EQ-VAS	study,	this	study	using	TTO	data	showed	that	the	
EQ-VT	design	performed	best	in	terms	of	prediction	accuracy.	Smaller	designs	had	higher	
RMSEs,	but	the	difference	was	relatively	small:	0.01	on	a	utility	scale.	It	should	be	noted	
that	in	this	study	the	comparison	was	made	only	on	136	states	instead	of	all	3,125	states	
in	 the	EQ-VAS	 study.	As	 the	EQ-VT	design	accounted	 for	 63%	 (=86/136)	of	 all	 states,	
the	 overall	 prediction	 result	was	more	 advantageous	 towards	 EQ-VT.	 Also,	 using	 the	
same	model,	the	parameters	of	the	3	designs	differed	considerably.	There	are	2	possible	
reasons:	(i)	a	different	design	(subset	of	health	states)	might	produce	a	different	set	of	
coefficients;	(ii)	respondents	may	have	differed	in	health	preferences	across	the	3	arms.	
Further	study	is	needed	to	understand	this	issue.
It	is	notable	that	we	did	not	encounter	the	large	misprediction	problem	found	in	the	EQ-
VAS	study,	as	the	RMSE	of	the	mild	states	(VAS>70)	was	twice	the	size	of	the	other	states	
(98).	A	possible	explanation	for	the	large	misprediction	in	the	VAS	study	was	the	large	
gap	between	the	value	of	11111	and	the	values	of	any	other	states	(98).	The	relative	
magnitude	of	 the	RMSE	 in	 this	 study	was	 larger	 than	 the	RMSE	 reported	 in	 the	VAS	
study.	In	the	VAS	study,	the	RMSEs	for	all	3,125	states	were	3.44	and	3.87	(on	VAS	scale:	
0	to	100)	for	the	EQ-VT	and	orthogonal	design	respectively,	while	the	counterparts	were	
0.053	and	0.066	(on	utility	scale:	-1	to	1)	in	the	current	study.	This	may	have	been	due	
to	the	difference	in	value	distributions	between	VAS	data	and	cTTO	data,	e.g.	VAS	data	
does	not	have	two	parts	separated	by	death	as	inherent	in	cTTO	data.	There	was	more	
heterogeneity	in	the	cTTO	data:	respondents	used	the	scale	differently,	e.g.	some	did	not	
enter	WTD,	some	would	not	go	below	0.5,	and	so	on.	In	contrast,	the	VAS	data	showed	
that	most	respondents	used	the	values	from	the	same	interval	of	20	to	80.	
With	respect	to	the	20-parameter	model,	the	coefficients	of	all	5	level	2	dummy	variables	
were	not	significant	for	the	2	small	designs.	One	possible	explanation	is	that	university	
students	did	not	trade-off	life	years	for	the	mild	problems	in	the	TTO	task,	which	resulted	
in	negligible	effects	for	the	corresponding	variables.	Increasing	the	degrees	of	freedom	
by	extending	the	small	designs	with	the	5	mildest	states	and	using	an	8-parameter	model	
improved	 this	 issue	 for	 the	 Bayesian	 design.	 This	 explained	 the	 improved	 prediction	
performance	of	the	Bayesian	design	when	using	the	8-parameter	model	extended	with	
the	5	mildest	states.	However,	these	2	approaches	did	not	work	on	the	orthogonal	design.	
The	different	impact	of	the	mild	states’	extension	may	be	explained	by	the	different	basis	
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on	which	these	two	designs	were	constructed.	In	the	orthogonal	design,	the	extension	
disrupted	orthogonality	and	level	balance.	By	comparison,	the	focus	of	Bayesian	design	
is	on	 standard	errors	around	parameters.	Hence,	by	extending	 the	number	of	 states,	
modelling	 results	 could	 improve	 as	 extra	 states	 could	 provide	 information	 on	 the	
parameters	which	are	difficult	to	estimate.	Future	research	could	use	the	small	designs	
approach	in	the	general	population	to	further	understand	this	issue.	
From	the	comparison,	the	difference	in	prediction	performance	between	the	two	small	
designs	was	minimal,	but	to	develop	a	Bayesian	design	requires	prior	information,	which	
is	not	always	available	in	practice.	It	should	be	noted	that	the	Bayesian	design	in	this	study	
used	 the	prior	 information	 from	previous	valuation	studies	conducted	 in	China	 (9,	15),	
and	hence	may	not	 be	 the	optimal	 design	 for	 valuation	 studies	 in	 other	 countries.	An	
open	question	is	whether	using	a	different	design	would	result	in	different	results	in	cost-
utility	analysis.	In	previous	research,	the	use	of	different	EQ-5D	value	sets	led	to	different	
incremental	cost-effectiveness	ratios	(ICERS)	(100).	In	our	study,	the	coefficients	for	each	
design	differed	in	the	value	sets,	thus	estimating	different	predicted	health	state	utilities.	
Future	research	could	evaluate	the	effect	of	adopting	small	designs	on	cost-utility	analysis.
This	study	had	several	limitations.	First,	the	TTO	task	that	needed	to	be	completed	by	
each	respondent	included	30	EQ-5D-5L	health	states,	plus	another	6	exercise	states.	The	
working	load	almost	tripled	compared	to	the	standard	EQ-VT	protocol.	Second,	we	used	
university	 students	 as	 respondents.	 Comparing	 the	 value	 variance	 between	 students	
and	the	general	public,	the	mean	standard	deviation	of	the	EQ-VT	86	states	from	our	
student	sample	was	0.416,	while	the	counterpart	from	the	2012	Chinese	general	public	
valuation	study	was	0.479	(9).	It	can	be	observed	that	students	had	more	homogeneous	
health	preferences	than	the	general	public,	who	had	more	socio-economic	differences.	
This	 is	a	minor	 issue	as	the	purpose	of	 this	study	was	to	test	hypotheses	rather	than	
generate	value	sets.
The	empirical	findings	offer	support	for	the	use	of	the	current	EQ-VT	design.	It	is	difficult	
to	tell	precisely	what	the	results	mean	for	smaller	designs	because	the	level	of	concern	
with	the	change	in	RMSE	essentially	rests	on	an	arbitrary	evaluation.	Considering	that	
the	relative	increase	of	RMSE	was	modest,	we	do	not	feel	that	the	results	raise	a	red	flag	
over	the	use	of	small	designs,	especially	if	one	considers	that	valuation	researchers	have	
other	options	to	promote	the	robustness	of	their	results.	An	established	way	to	reduce	
the	risk	of	errors	in	predicted	values	involves	combining	multiple	types	of	valuation	data.	
For	instance,	the	EQ-VT	protocol	has	a	DCE	task	included	alongside	the	cTTO	task	and	a	
hybrid	model	can	be	used	to	model	DCE	data	and	cTTO	data	together	(101).	The	use	of	
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the	hybrid	model	has	proved	superior	to	using	the	TTO	data	alone	(20,	22,	101).	Such	an	
approach	offers	a	way	to	manage	the	risks	of	larger	error	in	predicted	values	associated	
with	smaller	TTO	designs,	while	not	undoing	the	benefits	of	shrinking	the	TTO	design,	
since	collecting	DCE	responses	is	less	resource	demanding.	
7 .5 	CONCLuSION
The	 EQ-VT	 design	 had	 the	 best	 prediction	 performance	 and	 should	 be	 used	 as	 the	
default	design	for	EQ-5D-5L	valuation	studies.	Smaller	designs	also	performed	quite	well,	
and	may	be	considered	for	use	in	some	specified	contexts	such	as	for	methodological	
research,	in	resource-constrained	countries,	and	if	data	collection	is	paired	with	other	
data	collection	approaches,	e.g.	DCE.	
7 .6 	APPENDIx
table 1.	Observed	values	and	standard	deviations
EQ-VT Orthogonal Bayesian
HS Mean SD HS Mean SD HS Mean SD HS Mean SD
21111 0.933 0.080 23514 0.310 0.438 21111 0.922 0.110 21111 0.932 0.075
12111 0.950 0.053 31524 0.254 0.537 12111 0.927 0.093 12111 0.936 0.074
11211 0.932 0.098 53412 0.423 0.343 11211 0.945 0.064 11211 0.930 0.079
11121 0.926 0.094 52431 0.303 0.502 11121 0.934 0.099 11121 0.923 0.123
11112 0.940 0.107 24342 0.383 0.408 11112 0.932 0.095 11112 0.939 0.078
12121 0.917 0.104 22434 0.204 0.533 21331 0.700 0.279 12231 0.741 0.238
11212 0.910 0.091 21444 0.141 0.493 11215 0.536 0.414 31114 0.567 0.374
12112 0.900 0.090 12543 0.193 0.530 24113 0.601 0.271 21125 0.533 0.365
11221 0.915 0.074 35332 0.446 0.355 32511 0.540 0.328 11235 0.461 0.411
11122 0.878 0.127 51451 0.052 0.559 42132 0.547 0.318 22324 0.473 0.372
21112 0.876 0.122 45133 0.280 0.463 12324 0.502 0.393 53113 0.495 0.326
11421 0.700 0.283 33253 0.230 0.516 25222 0.644 0.263 11551 0.234 0.512
13122 0.837 0.124 44125 0.163 0.487 15151 0.329 0.482 44411 0.340 0.400
14113 0.645 0.257 43315 0.145 0.534 53312 0.432 0.367 33341 0.361 0.395
11414 0.393 0.510 35143 0.142 0.536 33125 0.394 0.388 21452 0.200 0.496
13313 0.648 0.295 31525 0.137 0.552 43241 0.290 0.473 11444 0.135 0.505
13224 0.560 0.315 32443 0.292 0.412 13433 0.453 0.346 24422 0.437 0.351
42321 0.516 0.436 45233 0.296 0.422 41523 0.271 0.464 42531 0.278 0.470
11235 0.442 0.473 24443 0.045 0.569 51144 0.109 0.540 32433 0.387 0.377
25122 0.624 0.337 34244 0.045 0.537 31452 0.254 0.502 35223 0.517 0.282
21315 0.386 0.494 53243 0.092 0.557 14542 0.163 0.496 51333 0.357 0.412
12513 0.614 0.245 43514 0.141 0.495 54421 0.192 0.491 42145 0.040 0.522
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EQ-VT Orthogonal Bayesian
HS Mean SD HS Mean SD HS Mean SD HS Mean SD
11425 0.257 0.543 45413 0.260 0.435 34234 0.311 0.421 43513 0.283 0.426
35311 0.525 0.414 55233 0.163 0.516 52253 0.124 0.514 34352 0.134 0.483
53221 0.587 0.289 43542 -0.009 0.560 22445 0.037 0.534 43154 -0.017 0.504
42115 0.350 0.448 54342 -0.055 0.584 45414 -0.044 0.515 24515 0.184 0.463
12334 0.495 0.387 52335 0.031 0.562 35343 0.194 0.520 45414 -0.027 0.529
25222 0.583 0.379 54153 0.108 0.479 23554 -0.063 0.508 25542 0.049 0.512
12244 0.272 0.492 34155 -0.104 0.549 44355 -0.365 0.501 31555 -0.105 0.519
23242 0.550 0.277 45144 -0.125 0.543 55535 -0.617 0.424 25445 -0.246 0.549
23152 0.380 0.453 53244 -0.121 0.589
32314 0.384 0.489 34515 -0.027 0.575
21334 0.437 0.377 14554 -0.146 0.533
15151 0.434 0.379 55225 -0.016 0.542
12514 0.345 0.525 24445 -0.276 0.567
51152 0.358 0.428 35245 -0.109 0.588
34232 0.497 0.344 24553 -0.071 0.564
25331 0.523 0.293 44345 -0.291 0.564
12344 0.159 0.568 55424 -0.259 0.574
31514 0.362 0.408 44553 -0.250 0.519
21345 0.209 0.502 52455 -0.420 0.519
52215 0.199 0.546 43555 -0.434 0.530
54231 0.379 0.424 55555 -0.719 0.356
table 1.	Continued
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In	this	chapter,	first	the	research	questions	raised	in	Chapter	1	are	answered,	then	the	
limitations	of	 the	thesis	are	 identified.	Subsequently,	 the	 implications	of	 the	research	
undertaken	in	the	thesis	are	discussed	and	ideas	for	future	research	offered.	
8 .1 	 KEY	 F INDINGS: 	 RESPONSE	 TO	 THE	 RESEARCH	
QuESTIONS
This	thesis	includes	six	studies	focused	on	EQ-5D	use	and	health	valuation	research	in	
China.	In	Chapter	2,	the	2012	Chinese	valuation	data	was	used	to	establish	population	
norm	scores	for	EQ-5D-5L	and	to	examine	how	demographic	factors	affected	individuals’	
self-reported	 health	 states	 (research	 question	 #1).	 The	 norm	 scores	 were	 reported	
in	Chapter	2,	 in	Tables	2	and	3	for	males	and	females	respectively.	 In	general,	HRQoL	
outcomes	 measured	 by	 EQ-5D-5L	 differed	 over	 age,	 gender,	 education	 level,	 health	
insurance	 status,	 employment	 status,	 and	 the	 residence	 of	 origin	 groups	with	 lower	
socioeconomic	 status	 related	 to	 lower	HRQoL	 outcome.	 There	were	 two	noteworthy	
results.	First,	the	prevalence	of	reported	problems	in	anxiety/depression	decreased	with	
age;	second,	females	reported	higher	EQ-VAS	values	than	males.
In	Chapter	3,	the	potential	cause	of	individual-level	 inconsistency	in	the	TTO	task	was	
explored	(research	question	#2).	It	was	confirmed	that	most	respondents	could	use	the	
TTO	 task	 to	 express	 their	 health	preferences	 following	 the	EQ-VT	 interview	protocol.	
Furthermore,	using	inconsistency	as	a	proxy	to	compare	interviewers’	performance,	it	
was	 found	 that	 the	Chinese	 TTO	data,	which	was	 collected	without	 a	 quality	 control	
procedure,	was	affected	by	interviewer	effects,	i.e.	data	from	certain	interviewers	had	
much	 higher	 inconsistency	 rates	 and	 larger	 inconsistency	 magnitudes.	 These	 effects	
were	 profound	 and	 could	 partially	 explain	 regional	 differences	 in	 the	 2012	 China	
valuation	data.	 In	 that	study,	Beijing	showed	higher	values	 than	the	other	 four	cities.	
Notably,	 as	 different	 teams	 of	 interviewers	 were	 used	 in	 the	 different	 cities	 it	 was	
impossible	to	disentangle	interviewer	effects	from	the	effects	of	regional	differences	in	
that	study.	Hence,	it	is	not	clear	if	the	differences	in	values	reflected	true	differences	in	
health	preferences	or	arose	as	an	artefact	of	the	study	design.	A	safer	approach	would	
be	to	conduct	a	valuation	study	using	one	team	of	interviewers,	to	attempt	to	eliminate	
interviewer	effects	which	might	mask	potential	regional	differences.
From	Chapter	4	to	Chapter	7,	there	is	an	examination	of	one	important	design	choice	
in	health	valuation	research:	how	to	select	health	states	for	direct	valuation	(research	
question	#3).	First,	in	Chapter	4,	an	existing	EQ-5D-3L	saturated	dataset	was	utilized	to	
118
C h a P t E r  8
compare	prediction	performance	between	designs	so	as	to	identify	the	most	important	
design	principle	in	selecting	health	states.	In	Chapter	5,	the	results	of	a	qualitative	study	
concerning	implausible	health	states	were	reported	and	there	was	an	examination	with	
respect	to	how	perceived	implausibility	affected	health	valuations.	In	Chapter	6,	based	
on	the	experience	of	Chapter	4,	a	new	EQ-5D-5L	saturated	dataset	was	collected	to	test	
the	generalizability	of	 results	 found	 in	Chapter	4.	Finally,	given	 the	difference	 in	data	
behaviour/distribution	between	VAS	and	TTO,	in	Chapter	7,	the	most	efficient	TTO	data	
design	identified	in	Chapter	6	was	tested	in	comparison	with	the	standard	EQ-VT	design.
For	the	health	states	selection,	the	study	showed	that	the	concern	for	statistical	efficiency	
within	the	design	outweighed	the	concern	with	respect	to	the	‘commonness’	of	the	health	
state	(research	question	#4).	In	published	EQ-5D-3L	valuation	studies,	different	designs	
were	used	or	proposed	(60,	67,	68,	75).	These	design	choices	were	either	attempting	to	
ease	the	valuation	burden	for	the	respondents	(e.g.	excluding	uncommon	or	implausible	
health	states	from	the	design),	or	to	 increase	the	feasibility	of	the	valuation	study	by	
valuing	 fewer	 states	 (e.g.	using	a	17-state	 subsample	of	 the	42-state	MVH	study).	 To	
test	the	consequences	of	these	concerns,	an	empirical	approach	was	taken	by	imitating	
different	designs’	prediction	performance	in	a	saturated	dataset.	A	three-step	approach	
was	 utilized:	 (i)	 the	 empirical	 values	 of	 a	 design	were	 used	 to	 construct	 a	 value	 set,	
(ii)	 this	value	set	was	used	 to	predict	 the	values	of	all	 the	health	states,	 (iii)	 the	 root	
mean	 squared	 error	 (RMSE)	 was	 computed	 between	 empirical	 values	 and	 predicted	
values.	utilizing	this	approach,	 it	was	found	that	the	use	of	different	designs	affected	
prediction	accuracy	for	the	non-valued	states’	values	and	by	comparison,	a	statistically	
efficient	design	performed	better	than	other	designs.	Specifically,	an	orthogonal	design	
performed	best	among	all	the	comparators.	
Simulations	 performed	on	 the	 5L	VAS	 saturated	dataset	 suggested	 that	 the	 standard	
EQ-5D-5L	design	(EQ-VT)	recommended	by	the	EuroQol	Group	was	valid.	Yet,	similar	to	
findings	in	the	EQ-5D-3L	context,	smaller	designs	with	optimal	statistical	efficiency	could	
achieve	 similar	modelling	 results	 (research	 question	 #5).	 The	 good	 result	 for	 smaller	
designs	was	also	validated	by	the	TTO	data.	As	another	issue	for	health	state	selection,	
the	 results	 provided	 little	 evidence	 to	 exclude	 implausible	 health	 states	 from	 the	
empirical	state	set/experimental	design.	First,	the	observed	effect	of	 implausibility	on	
values	was	quite	small	(0.91	on	the	VAS	scale,	SD:5.58);	second,	there	was	no	agreement	
among	respondents	about	exactly	which	states	needed	to	be	classified	as	implausible.	
Overall,	 the	 work	 undertaken	 here	 on	 the	 design	 issue	 suggests	 that	 the	 individual	
health	 state	 selection	 approach	 is	 not	 appropriate.	 As	 an	 alternative,	 considering	 a	
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selected	subset	of	states	as	a	whole	and	focusing	on	its	statistical	properties	would	be	
more	advantageous.	The	selection	should	lead	to	a	statistically	efficient	design,	which	
could	 produce	 more	 accurate	 estimations.	 The	 issue	 of	 implausible	 or	 uncommon	
health	 states	may	 still	matter	 for	 respondents	 in	 terms	of	 face	validity.	Putting	 these	
two	concerns	together,	the	selection	of	states	for	direct	valuation	is	a	trade-off	between	
efficient	designs	with	some	uncommon/implausible	health	states,	which	have	some	low-
value	observations,	versus	a	statistically	imbalanced	design.	As	the	ultimate	purpose	of	a	
valuation	study	is	to	estimate	values	as	accurately	as	possible,	statistical	considerations	
are	more	important.	
8 .2 	L IMITATIONS
8.2.1  hrQol instruments  other  than EQ-5D
This	thesis	has	focused	on	EQ-5D,	which	is	a	preferred	instrument	for	the	assessment	of	
HRQoL	worldwide	and	thus	a	first	choice	among	Chinese	health	outcome	researchers.	
Alternative	HRQoL	instruments	are	available,	including	SF-6D,	15D,	AQoL,	and	HuI.	These	
HRQoL	 instruments	differ	 in	terms	of	dimensions	and	 level	descriptors.	Differences	 in	
the	description	of	health	states	led	to	different	preference	weights	and	in	many	cases,	
different	utility	results	(102).	For	example,	EQ-5D	has	the	merit	of	it	being	simple	to	use	
and	its	focus	on	offering	an	index	value,	whereas	an	instrument	such	as	SF-6D	has	a	wider	
health	state	descriptive	system.	While	we	are	aware	of	these	instruments’	existence,	it	is	
difficult	to	judge	which	one	is	the	most	suitable	to	use	in	health	description	and	health	
economic	evaluation	in	China.	One	common	characteristic	of	these	instruments	is	that	
all	were	developed	and	most	thoroughly	tested	in	studies	in	western	countries.	Yet	we	
do	not	know	whether,	for	example,	the	five	dimensions	in	EQ-5D	are	the	most	relevant	
health	dimensions	for	the	Chinese	in	terms	of	describing	HRQoL.	
HRQoL	instruments	are	usually	first	developed	for	use	in	one	country	and	then	applied	
elsewhere.	While	this	is	practical,	it	may	not	always	be	appropriate	to	apply	an	instrument	
to	a	culture	other	than	the	one	for	which	it	was	originally	developed.	Culture	influences	
people’s	ways	of	living,	thinking,	expressing	themselves	(103),	and	hence	inevitably	their	
ways	of	conceptualizing	and	evaluating	psychological	concepts	such	as	HRQoL	(104-106).	
Indeed,	the	psychometric	evaluation	of	SF-36	(107-109)	and	the	Center	for	Epidemiologic	
Studies	Depression	(CES-D)	Scale	(110-112)	found	that	their	measurement	models	were	
not	applicable	to	some	cultures.	For	example,	the	relationship	between	the	eight	SF-36	
concepts	and	the	two	SF-36	health	components	(physical	and	mental	health)	in	Japan,	
Singapore,	and	Taiwan	was	different	from	that	in	the	uS	(107-109).	It	should	be	noted	that	
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all	non-English	versions	of	the	SF-36	questionnaire	were	developed	using	a	standardized	
iterative	translation	protocol	(113),	which	suggests	that	good	translation	and/or	cultural	
adaptation	may	not	ensure	cross-cultural	applicability	of	HRQoL	instruments.	
The	 EQ-5D	 questionnaire,	 whether	 EQ-5D-3L	 or	 EQ-5D-5L,	 has	 been	 used	 to	 assess	
the	HRQoL	 or	 health	 status	 of	 populations	 all	 over	 the	world	 (114).	 A	 large	 body	 of	
literature	has	demonstrated	the	psychometric	properties	of	the	EQ-5D	questionnaire	in	
many	different	cultures.	In	contrast,	qualitative	evidence	on	the	content	validity	of	the	
instrument	 (i.e.	 the	 relevance	and	adequacy	of	 the	health	dimensions	 included	 in	 its	
descriptive	system)	is	limited.	To	the	best	of	my	knowledge,	the	content	validity	of	EQ-5D	
has	been	qualitatively	assessed	only	with	uK	and	Australian	research	professionals	(115),	
uK	patients	with	diabetes	(116),	and	elderly	Dutch	people	(117).	Qualitative	research	on	
content	validity	is	an	important	step	in	HRQoL	instrument	development	and	evaluation	
which	cannot	be	 replaced	by	quantitative	assessments	of	psychometric	properties.	 It	
can	be	noted	 that	 the	FDA	of	 the	united	States	 requires	documentation	of	 evidence	
on	content	validity	for	the	patient	reported-outcomes	instrument	used	to	support	label	
claims	(118).
China	 is	 the	world’s	most	 populous	 and	 rapidly	 developing	 country.	 Driven	 by	 rising	
expectations	 and	 population	 ageing,	 health	 outcomes	 and	 health	 policy	 research	 in	
China	 is	 growing	 at	 a	 steady	 pace.	 A	 PubMed	 search	 suggested	 a	 900%	 increase	 (in	
2017:	2,038	,	and	in	2007:	224)	in	publications	using	the	key	words	‘China’	and	‘Health	
outcome’	(119).	To	date,	HRQoL	instruments	used	in	the	region	are	predominantly	those	
developed	in	North	America	or	Europe,	due	to	the	lack	of	locally-developed	instruments	
in	China	itself.	Despite	this	lack,	there	are	concerns	about	the	appropriateness	of	using	
western	 HRQoL	 instruments	 in	 Chinese	 populations	 (120).	 Possibly,	 there	 might	 be	
equally	 or	 even	more	 important	 health	 dimensions	 in	 China	 not	 included	 in	 the	 five	
EQ-5D	health	dimensions,	so	EQ-5D	might	not	be	sensitive	to	culturally	specific	health	
problems	important	to	the	Chinese	citizen.	
All	these	findings	described	above	suggested	that	it	would	be	useful	to	perform	a	study	
to	assess	the	appropriateness	of	the	EQ-5D	questionnaire	for	use	in	Chinese	populations.	
Such	a	study	should	aim	to	ascertain	the	relevance	and	adequacy,	or	content	validity,	
of	the	EQ-5D	descriptive	system	in	the	target	populations.	Specific	research	questions	
are:	What	health	concepts	or	dimensions	are	most	important	to	the	study	populations?	
How	many	of	the	health	concepts	are	covered	by	EQ-5D?	How	important	are	the	EQ-5D	
health	dimensions	to	the	study	populations?	
Addressing	such	questions	could	strengthen	the	evidence	for	the	use	of	EQ-5D	in	China.	
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Currently,	EQ-5D	is	the	only	instrument	that	has	Chinese	value	sets	attached.	While	it	is	
possible	to	establish	Chinese	value	sets	for	SF-6D	and	HuI,	the	valuation	study	designs	
for	other	instruments	have	not	been	examined	as	rigorously	as	has	been	accomplished	
for	EQ-5D.	
8.2.2  Dif ference data character ist ics  between VaS and tto
In	Chapters	4	and	6,	VAS	valuation	data	was	used	as	a	proxy	for	TTO	data.	Differences	
between	the	two	kinds	of	valuation	data	should	be	noted.	First,	VAS	values	generally	
do	not	display	the	relatively	linear	heteroscedasticity	typically	observed	in	TTO	values;	
second,	 VAS	 values	 generally	 display	 unimodal	 approaching	 a	 bell-curve	 distribution,	
particularly	around	the	middle	range;	third,	a	property	of	VAS	is	‘end	of	scale	aversion’.	
While	the	maximum	attainable	score	is	100,	many	people	hesitate	to	assign	such	a	high	
score	 to	 any	 state.	 In	 summary,	 VAS	 values	 are	more	 ‘well-behaved’	 than	 their	 TTO	
counterparts	and	are	therefore	more	likely	to	conform	‘nicely’	to	modelling	efforts.	In	
this	sense,	our	VAS	3L	and	5L	studies	were	conducted	under	‘better’	conditions,	from	a	
modelling	point	of	view,	than	could	be	expected	even	in	the	best-case	scenario	for	TTO	
data.	As	such,	designs	that	may	work	well	using	VAS	data	may	not	work	as	well	with	TTO,	
and	probably	 require	more	observations	 (and/or	number	of	observed	 states)	 in	TTO-
based	research.	
Due	to	the	distributional	difference,	the	relative	magnitude	of	the	RMSE	in	the	TTO	study	
was	larger	than	the	RMSE	reported	in	the	VAS	study.	In	the	VAS	study,	the	RMSEs	for	all	
3,125	states	were	3.44	and	3.87	(on	VAS	scale:	0	to	100)	for	the	EQ-VT	and	orthogonal	
designs	respectively,	while	the	counterparts	were	0.053	and	0.066	(on	utility	scale:	-1	
to	1)	 in	 the	current	 study.	Also,	 the	 ‘end	of	 scale	aversion’	property	 in	VAS	offered	a	
partial	explanation	for	the	large	mispredictions	around	mild	states	shown	in	the	Chapter	
6	where	VAS	data	was	used,	but	not	in	Chapter	7	where	TTO	data	was	used.
8.2.3  Sample issue
In	the	2012	Chinese	valuation	study,	the	sample	employed	was	collected	in	five	urban	
areas	 in	 China,	which	was	 not	 representative	 of	 the	whole	 Chinese	 population.	 This	
posed	a	limitation	to	the	norm	study	reported	in	Chapter	2	as	socio-economic	differences	
exist	between	different	areas	and,	between	urban	and	rural	areas	the	health	status	of	
residents	may	differ	by	type	of	area	(40).	Furthermore,	most	respondents	were	recruited	
in	public	locations,	which	may	have	led	to	a	selection	bias	towards	healthy	respondents.	
In	both	3L	(Chapter	4)	and	5L	(Chapter	6)	saturated	studies,	a	student	sample	was	used	
instead	of	 a	 general	 public	 sample.	 Students	 valuing	 a	 large	number	of	health	 states	
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using	VAS	are	more	likely	to	successfully	develop	mental	shortcuts	to	ensure	consistency	
and	monotonicity	than	respondents	valuing	fewer	health	states	using	the	much	more	
complicated	TTO	method.	This	too	should	be	expected	to	produce	more	‘well-behaved’	
data.	It	is	noteworthy	that	in	this	study	students	were	used	for	the	sample.	For	the	EQ-
VT	design,	 the	mean	standard	deviation	across	86	 states	 for	 the	 student	 sample	was	
0.416	while	the	counterpart	from	the	2012	Chinese	general	public	study	was	0.479.	It	
can	 be	 observed	 that	 the	 students	 had	more	 homogeneous	 health	 preferences	 than	
the	general	public,	since	the	general	public	had	more	socio-economic	differences.	Thus,	
when	adopting	the	small	design	for	use	with	the	general	public,	we	may	expect	to	use	
more	 observations	 or	more	 health	 states	 in	 order	 to	 achieve	 an	 acceptable	 level	 of	
prediction	accuracy.
8 .3 	 IMPLICATIONS
The	 norm	 scores	 presented	 in	 Chapter	 2	 of	 the	 thesis	 are	 a	 valuable	 asset	 for	 EQ-
5D	 users.	 They	 provide	 a	 reference	 point	 for	 clinical	 and	 health	 economic	 research	
outcomes,	so	that	 the	HRQoL	of	a	given	patient	group	can	be	compared	with	that	of	
the	general	population	(5).	For	example,	hypothetically,	one	study	measured	a	patient	
group	(diabetes)	with	an	average	VAS	score	of	67.9	and	an	index	value	of	0.876	for	male	
patients	aged	between	40-49.	From	Table	2	of	Chapter	2,	the	corresponding	VAS	score	
and	 the	 index	value	of	 the	40-49	male	group	 from	 the	general	public	were	85.5	and	
0.959	 respectively.	We	 could	 thus	 calculate	 the	 effect	 of	 having	 diabetes	 on	HRQoL,	
i.e.	the	effect	on	VAS	(85.5-67.9=17.4),	and	the	effect	on	the	index	value	(0.959-0.876=	
0.083).	In	such	a	way,	we	could	estimate	the	burden	of	different	diseases	and	use	such	
information	to	inform	policy-making.	
This	 thesis	 also	 provides	 practical	 guidance	 for	 future	 valuation	 studies.	 In	 terms	 of	
sample	 representativeness,	 similarly	 to	 the	 effect	 on	 self-reported	 HRQoL,	 previous	
studies	have	shown	that	demographic	factors	have	also	influenced	health	preferences	
(26-28).	Hence,	given	the	large	demographic	variance	in	China,	future	valuation	studies	
could	benefit	from	improving	sample	representativeness,	e.g.	also	recruiting	respondents	
from	rural	areas.	Nevertheless,	demands	to	improve	sample	representativeness	came	at	
the	price	of	reduced	feasibility	for	the	valuation	study.	Fortunately,	this	challenge	was	
moderated	by	the	potential	use	of	small	designs.	Small	designs	with	optimal	statistical	
efficiency	could	lower	the	total	number	of	health	states	needed	to	be	valued	whilst	still	
providing	an	acceptable	prediction	level.	Thus,	the	use	of	small	designs	paves	the	way	for	
more	cost-effective	EQ-5D-5L	valuation	studies.	Following	the	EQ-VT	protocol,	each	state	
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needs	 to	be	valued	by	100	 respondents,	and	with	each	 respondent	valuing	10	 states	
we	may	expect	that	by	using	a	small	design,	the	minimum	sample	size	requirement	for	
a	valuation	study	could	be	reduced	 from	1000	respondents	 to	only	300	respondents.	
Hence,	 the	 resources	 freed	 up	 by	 adopting	 small	 designs	 could	 be	 used	 to	 engage	
the	more	difficult-to-reach	 respondents	 from	 rural	 areas	 in	 order	 to	 improve	 sample	
representativeness.	
Another	 implication	 for	health	valuation	 researchers	 is	 that	 the	concern	with	 respect	
to	 inconsistency	 in	 the	 TTO	 task	 has	 been	 largely	 addressed	by	 extending	 the	 EQ-VT	
protocol	to	employ	a	quality	control	(QC)	tool	(57).	Ramos	Goni	et	al	reported	that	the	
implementation	of	the	QC	process	was	found	to	lower	the	inconsistency	rate	from	11%	
to	3%	 in	 the	Spanish	valuation	 study	 (57).	 Thus,	one	 important	 lesson	has	been	 that	
the	 interviewer	 selection/training/monitoring	 process	 is	 the	 key	 to	 successful	 data	
collection.	
To	sum	up,	the	work	reported	in	this	thesis	has	identified	three	important	suggestions	
with	respect	to	the	conduct	of	a	successful	valuation	study.	First,	use	the	right	design,	
such	 as	 an	 orthogonal	 one;	 second,	 recruit	 the	 right	 interviewers	 (who	 are	 open	 for	
feedback	and	would	 like	 to	 learn	on	 the	 job,	who	apply	 soft	 skills	 to	handle	difficult	
topics,	who	maintain	motivation,	etc.),	train	them	well,	and	monitor	their	performance	
during	data	 collection;	 third,	 improve	 sample	 representativeness.	 The	 last	 factor	also	
applies	to	studies	aimed	at	measuring	population	health.	
8 .4 	A	POSSIBLE	MORE	FuNDAMENTAL	APPROACH?
The	identification	of	small	designs	for	TTO	data	promotes	the	feasibility	of	a	valuation	
study,	yet,	for	a	country	as	large	and	diverse	as	China,	it	is	important	to	improve	sample	
representativeness.	Hence,	using	a	 less	resource-demanding	valuation	technique	may	
be	a	more	fundamental	way	to	address	the	sample	issue.	Discrete	Choice	Experiment	
(DCE)	valuation	has	been	an	integral	part	of	the	EQ-5D-5L	valuation	protocol,	and	it	has	
been	argued	that,	as	both	TTO	and	DCE	have	provided	information	for	the	same	object	
(i.e.	health	state),	they	should	be	used	together	for	modelling	purposes	(121).	As	the	DCE	
method	only	requires	a	respondent	to	make	a	choice	between	two	options,	it	is	relatively	
easy	 for	 respondents	 to	 complete	 and	 the	 task	 can	be	 self-completed,	 e.g.	 online	or	
using	postal	surveys,	without	requiring	assistance	from	an	interviewer.	This	allows	the	
possibility	 of	 estimating	 a	 national	 representative	 EQ-5D-5L	 value	 set	 for	 China.	 For	
example,	20	regions	could	be	selected	based	on	their	 level	of	economic	development	
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and	 cultural	 characteristics.	 Each	of	 the	 regions	 could	undertake	a	 regional	 valuation	
study	using	the	small	orthogonal	design	with	30	states	employing	the	TTO	method,	plus	
a	large	online	sample	of	respondents	completing	only	DCE	valuation	tasks.	Thus,	each	
region	could	establish	its	own	EQ-5D	value	set	and,	more	importantly,	utilizing	the	same	
design	 and	 the	 same	 valuation	 techniques	 (e.g.	 EQ-VT,	 QC,	 standardized	 interviewer	
training,	etc),	a	balanced	national	value	set	could	be	established.	In	addition,	research	
has	shown	that	with	some	modification	of	the	basic	DCE	task	(e.g.	adding	time	as	another	
dimension),	a	value	set	anchored	on	a	QALY	scale	could	be	estimated	with	good	validity	
(122).	Either	way,	it	is	reasonable	and	beneficial	for	China	to	invest	further	in	developing	
and	understanding	novel	health	valuation	methods	such	as	the	DCE	approach.
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This	thesis	included	6	studies	which	reported	about	various	aspects	of	the	EQ-5D,	with	
a	focus	on	its	use	in	China.	The	population	norm	study	provided	the	first	set	of	norms	
based	on	urban	Chinese	self-reported	health	status.	This	study	not	only	provided	insight	
into	Health-Related	Quality	of	Life	(HRQoL)	variations	among	subgroups,	but	also	served	
as	a	reference	point	for	other	disease	studies	and	intervention	studies.	The	subsequent	
methodological	studies	of	this	thesis	offered	suggestions	for	improving	the	design	of	future	
valuation	studies.	These	suggestions	will	strengthen	both	health	technology	assessments	
(HTA)	and	cost-utility	analyses	in	China	and	beyond,	as	the	EQ-5D	is	the	most	used	HRQoL	
instrument	in	HTA	and	cost-utility	analyses.	At	present,	the	Chinese	government	has	not	
yet	adopted	cost-utility	analysis	as	a	basis	for	healthcare	coverage	decisions,	but	there	are	
strong	signals	that	this	approach	will	be	implemented	in	the	future.	For	example,	in	the	
latest	‘China	Guideline	for	Pharmacoeconomic	Evaluations’,	it	was	stated	that	cost-utility	
analysis	 is	 preferred	 over	 other	 economic	 evaluation	methods.	 Policymakers	 in	 China	
need	valid	instrument	to	support	cost-utility	studies	in	this	field.	Since	EQ-5D	is	the	most	
widely-used	instrument	worldwide	for	this	purpose	it	is	also	a	good	candidate	for	China.	
Chapter 2	reported	about	the	norm	scores	of	EQ-5D-5L	in	the	urban	Chinese	population.	
Additional	 analysis	 was	 undertaken	 to	 test	 whether	 self-reported	 HRQoL	 varied	
between	 different	 demographic	 groups.	 It	 was	 found	 that	 HRQoL	 outcomes	 differed	
over	demographic	subgroups:	i.e.	age,	gender,	education	level,	health	insurance	status,	
employment	status,	and	the	residence	of	origin	groups.	
In	Chapter 3,	by	analysing	the	relation	of	individual	level	inconsistency	in	the	TTO	task	
with	different	factors	of	the	interview,	it	was	found	that	the	inconsistencies	respondent	
made	in	the	TTO	task	varied	significantly	between	interviewers.	The	results	suggested	
that	 the	 valuation	 process	 have	 been	 influenced	 by	 interviewer	 effects	 when	 done	
without	a	solid	quality	control.	
Commencing	 in	Chapter	4,	possible	designs	to	be	used	for	the	EQ-5D	valuation	study	
were	systematically	examined	and	compared.	First,	in	Chapter 4,	an	EQ-5D-3L	‘saturated	
dataset’	 was	 used	 as	 a	 golden	 standard	 to	 compare	 two	 often-mentioned	 design	
principles	in	selecting	health	states	for	direct	valuation:	‘commonness	of	health	states’	
(the	prevalence)	versus	statistical	efficiency	of	a	design.	By	simulating	the	selection	and	
the	modelling	process,	it	was	found	that	the	principle	of	statistical	efficiency	outweighed	
the	principle	of	commonness	in	achieving	sufficient	prediction	accuracy	for	non-valued	
states.	 This	 result	 suggested	 that	 the	 selection	 of	 health	 states	 in	 previous	 valuation	
studies	were	not	optimal,	and	that	future	valuation	studies	could	use	a	smaller	design	
with	optimum	statistical	efficiency.	
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Chapter 5	described	how	1,600	students	were	invited	to	value	all	EQ-5D-5L	states	using	
a	visual	analogue	scale	and	how	they	judged	the	implausibility	of	each	state.	The	results	
showed	that	respondents	lacked	agreement	concerning	which	states	were	implausible.	
The	mean	value	of	a	state	valued	by	respondents	who	thought	it	was	implausible	was	
lower	than	counterpart	valued	by	respondents	who	thought	it	was	plausible,	but	both	
mean	values	were	still	in	good	agreement.
Learning	 from	 design	 selection	 experience	 with	 EQ-5D-3L,	 the	 research	 presented	
in	Chapter 6 aimed	 to	 test	 the	 selection	 of	 health	 states	 used	 in	 the	 current	 EQ-VT	
design	 and	 to	 identify	 a	 possible	 smaller	 design	 for	 EQ-5D-5L	 valuation	 studies.	 The	
good	 performance	 in	 using	 a	 statistical	 efficient	 orthogonal	 design	 was	 confirmed	
again	with	EQ-5D-5L,	 i.e.	an	orthogonal	design	with	25	states	performed	equally	well	
as	the	EQ-VT	design	with	86	states	in	terms	of	prediction	accuracy	for	all	3,125	states.	
Despite	the	favourable	outcome,	there	were	some	concerns:	first,	large	mispredictions	
from	 the	 orthogonal	 design	 in	 the	 upper	 part	 of	 the	 severity	 scale	 needed	 further	
investigation;	 second,	 VAS	 values	 normally	 differ	 with	 TTO	 values	 in	 terms	 of	 data	
distribution	characteristics,	which	put	the	generalizability	of	the	results	to	TTO	data	into	
doubt.	Accordingly,	in	Chapter 7,	the	most	efficient	design	(the	orthogonal)	was	tested	
in	comparison	with	the	standard	EQ-VT	design	using	TTO	data.	The	favorable	result	of	
25-state	 orthogonal	 design	was	 confirmed	 in	 TTO	data,	 in	 the	 sense	 that	 the	 overall	
prediction	was	as	good	as	the	EQ-VT	design	of	86	health	states.	
Chapter 8 responded	 the	 research	questions	 raised	 in	Chapter 1	 and	provided	 some	
thoughts	for	future	research.	With	this	thesis,	attempts	were	made	to	better	understand	
the	possible	effects	of	sample	and	design	choices	in	previous	Chinese	valuation	studies.	
The	findings	of	this	thesis	can	be	generalized	to	other	countries’	EQ-5D	studies,	or	to	
improve	valuation	studies	employing	other	instruments.	
131
S u m m a r Y
9

ChaPtEr 10
Samenvatting

135
S a m E n Vat t I n G
10
In	dit	proefschrift	worden	6	studies	gepresenteerd	die	zich	richten	op	de	verschillende	
aspecten	van	het	gebruik	van	de	EQ-5D,	met	een	focus	op	het	gebruik	in	China.	De	studie	
onder	de	algemene	bevolking	leverde	een	eerste	normscore	op	van	zelfgerapporteerde	
gezondheidsstatus	 in	 de	 Chinese	 stedelijke	 gebieden.	 Deze	 studie	 geeft	 niet	 alleen	
inzicht	 in	 de	 variantie	 van	 gezondheidsgerelateerde	 kwaliteit	 van	 leven	 (HRQoL)	
tussen	 subgroepen,	 maar	 geeft	 ook	 referentiewaarden	 voor	 ziektelaststudies	 en	
interventiestudies.	 De	 daaropvolgende	 methodologische	 studies	 geven	 suggesties	
voor	verbetering	van	toekomstige	waarderingsstudies.	Die	suggesties	zullen	zowel	het	
evaluatieonderzoek	van	de	gezondheidszorg	(HTA)	als	het	kosten-utiliteitsonderzoek	in	
China	en	daarbuiten	versterken,	omdat	de	EQ-5D	de	meest	gebruikte	HRQoL	vragenlijst	
is	 in	 beide	 onderzoeksvelden.	 Op	 dit	 moment	 heeft	 de	 Chinese	 regering	 kosten-
utiliteitsonderzoek	nog	niet	aangewezen	als	de	basis	voor	allocatiebeslissingen	binnen	
de	gezondheidszorg,	maar	er	zijn	sterke	signalen	dat	dit	in	de	toekomst	wel	zal	gebeuren.	
Zo	 is	 bijvoorbeeld	 in	 de	meeste	 recente	 Chinese	 richtlijn	 voor	 farmaco-economische	
evaluaties	te	vinden	dat	kosten-utiliteitsonderzoek	de	geprefereerde	methode	 is	voor	
economische	evaluaties	 in	de	gezondheidszorg.	Chinese	beleidsmakers	hebben	valide	
instrumenten	nodig	om	kosten-utiliteitsonderzoek	te	ondersteunen.	Aangezien	de	EQ-
5D	wereldwijd	het	meestgebruikte	 instrument	 is	 voor	dit	 doel,	 is	 het	ook	een	goede	
kandidaat	voor	China.	
hoofdstuk 2 beschrijft	 het	 EQ-5D	 normscore-onderzoek	 onder	 de	 Chinese	
stedelijke	 bevolking.	 Aanvullende	 analyses	 werden	 uitgevoerd	 om	 na	 te	 gaan	 of	 de	
zelfgerapporteerde	 HRQoL	 varieerde	 tussen	 demografische	 groepen.	 Hieruit	 bleek	
dat	 HRQoL	 inderdaad	 verschilde	 naar	 leeftijd,	 geslacht,	 opleidingsniveau,	 vorm	 van	
ziektekostenverzekering,	het	beroep	en	de	geboorteplaats.	
In	 hoofdstuk 3	 zijn	 de	 inconsistenties	 in	 TTO-responsen	 gerelateerd	 aan	 interview	
factoren.	 Hieruit	 bleek	 dat	 de	 inconsistenties	 gerelateerd	 zijn	 aan	 verschillen	 tussen	
interviewers.	Deze	 resultaten	 suggereren	dat	het	waarderingsproces	beïnvloed	wordt	
door	interviewereffecten,	wanneer	er	geen	solide	kwaliteitscontrole	wordt	toegepast.	
Vanaf	hoofdstuk	4	zijn	verschillende	opzetten	voor	EQ-5D	waarderingsstudies	systematisch	
onderzocht	 en	 met	 elkaar	 vergeleken.	 Allereerst	 is	 in	 hoofdstuk 4	 een	 verzadigde	
dataset	als	gouden	standaard	gebruikt	om	te	onderzoeken	welk	van	twee	veelgebruikte	
manieren	 om	 gezondheidstoestanden	 te	 selecteren	 voor	 een	 waarderingstaak	 de	
beste	basis	geeft	voor	het	voorspellen	van	de	waarde	van	gezondheidstoestanden	die	
niet	 in	 de	 waarderingstaak	 zijn	 opgenomen.	 Het	 betrof	 het	 selecteren	 op	 basis	 van	
het	 ‘voorkomen’	 van	 de	 gezondheidstoestand	 (de	 prevalentie),	 versus	 de	 statistische	
136
C h a P t E r  10
efficiëntie	 voor	 het	 model.	 Door	 de	 selectie	 en	 het	 modelleerproces	 te	 simuleren,	
bleek	dat	 statistische	 efficiëntie	 de	belangrijkste	 overweging	moet	 zijn,	 terwijl	 in	 het	
verleden	vooral	gelet	werd	op	het	voorkomen.	Dit	resultaat	suggereert	dat	de	selecties	
van	gezondheidstoestanden	bij	eerdere	waarderingsstudies	niet	optimaal	waren,	en	dat	
toekomstige	waarderingsstudies	gebruik	kunnen	maken	van	een	kleinere	selectie	van	
gezondheidstoestanden	zolang	de	statistische	doelmatigheid	geborgd	wordt.	
hoofdstuk 5	 beschrijft	 de	 constructie	 van	 een	 vergelijkbare	 verzadigde	 dataset	
voor	 de	 EQ-5D-5L.	 1600	 studenten	 kregen	 ieder	 een	 block	 van	 200	 EQ-5D-5L	
gezondheidstoestanden,	die	zij	waardeerden	met	behulp	van	een	visual analogue scale.	
Daarnaast	beoordeelden	zij	van	elke	toestand	de	geloofwaardigheid.	uit	de	resultaten	
bleek	dat	de	respondenten	geen	overeenstemming	hadden	over	de	geloofwaardigheid	
van	de	verschillende	toestanden.	De	gemiddelde	waarde	van	een	toestand	beoordeeld	
door	respondenten	die	de	toestand	als	‘ongeloofwaardigheid’	beoordeelden,	was	lager	
dan	 wanneer	 de	 respondenten	 de	 toestand	 ‘geloofwaardigheid’	 vonden,	 maar	 het	
verschil	was	klein.	
Gebruikmakend	 van	 de	 ervaring	 met	 de	 EQ-5D-3L,	 wordt	 met	 het	 onderzoek	 uit	
hoofdstuk 6	de	selectie	van	het	huidige	EQ-VT	protocol	getest	en	wordt	er	gekeken	of	
er	 geen	 kleinere	 selecties	mogelijk	 zijn	 voor	 EQ-5D-5L	waarderingsstudies.	 De	 goede	
prestaties	van	een	selectie	gebaseerd	op	statistische	overwegingen	werd	bevestigd	in	dit	
onderzoek	rondom	de	EQ-5D-5L:	het	orthogonale	model	met	25	gezondheidstoestanden	
scoorde	 net	 zo	 goed	 als	 de	 EQ-VT	 selectie	 met	 86	 gezondheidstoestanden,	
wanneer	 gekeken	 wordt	 naar	 de	 precisie	 waarmee	 de	 waarden	 van	 alle	 3.125	
gezondheidstoestanden	worden	voorspeld.	Ondanks	dit	gunstige	resultaat	waren	er	ook	
zorgen;	zo	laten	de	orthogonale	modellen	grote	fouten	zien	bij	het	schatten	van	de	milde	
gezondheidstoestanden.	 Daarnaast	 zijn	 de	waarden	 die	 verkregen	 zijn	met	 de	 visual 
analogue scale	mooier	verdeeld	dan	de	TTO	waarden,	wat	de	generaliseerbaarheid	van	
de	bevindingen	voor	de	TTO	data	in	twijfel	trekt.	Derhalve	is	in	hoofdstuk 7,	het	meest	
doelmatige	model	 (het	 orthogonale	model)	 getest	 in	 vergelijking	met	 het	 standaard	
EQ-VT	 design	met	 behulp	 van	 TTO	 data.	 De	 studie	 bevestigt	 dat	 het	 ook	mogelijk	 is	
waarderingen	te	schatten	op	basis	van	geobserveerde	waarden	voor	een	selectie	van	
25	toestanden.	Dat	geeft	gezien	over	alle	gezondheidstoestanden	gemiddeld	een	bijna	
even	voorspelling.	
In	hoofdstuk 8	worden	de	onderzoekvragen	uit	hoofdstuk 1	 beantwoord	 en	worden	
gedachten	over	mogelijk	toekomstig	onderzoek	geformuleerd.	Met	dit	proefschrift	wordt	
gepoogd	om	de	effecten	van	selectie	en	modelkeuzen	bij	Chinese	waarderingsstudies	
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beter	 te	 begrijpen.	 De	 bevindingen	 van	 dit	 proefschrift	 kunnen	 ook	 worden	
gegeneraliseerd	naar	EQ-5D	studies	in	andere	landen	,	of	om	waarderingsstudies	voor	
andere	instrumenten	te	verbeteren.	
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